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Abstract
The aim of this project was to investigate the cyclisation reactions of some o-nitroaryl 
derivatives of a-amino acids, with a view to the synthesis of potentially biologically 
active heterocyclic compounds.
Chapter One is concerned with an overview of the synthesis of heterocyclic A-oxides, 
mainly via the cyclisations of ortAo-substituted nitroaromatics. Firstly, the properties of 
heterocyclic A-oxides are considered, then both reductive and non-reductive methods of 
their synthesis by cyclisation reactions are explored. After a discussion of intramolecular 
condensations leading to cyclisation, the possibilities for alternative mechanisms for these 
reactions are deliberated.
Chapter Two begins with an introduction to the specific cyclisation reactions of
o-nitroaryl- and 2,4-dinitrophenyl-amino acids. The preparation and cyclisation reactions 
of o-nitrophenyl derivatives of a-amino acid esters are then described with emphasis on 
the implications for the mechanism of these cyclisation reactions.
Chapter Three discusses the related cyclisations of A-alkyl-o-nitroanilines which have no 
activating group (for example, an ester) on the A-alkyl chain. The mechanistic 
implications of this are explored, in the context of the cyclisations discussed in Chapter 
Two.
In Chapter Four, the synthesis of benzimidazole and quinoxaline acyclic nucleoside 
analogues is briefly described. These have the potential to be biologically active 
compounds.
Ch a pte r  O n e
Introduction
U  General Properties of Heterocyclic A -oxides
Most of the A-oxides described in later chapters of this thesis are those of substituted 
benzimidazoles; it seems appropriate, however, first to consider in outline some general 
characteristics of the A-oxide as a functional group.
The simplest tertiary amine A-oxide, trimethylamine A-oxide, is commercially available 
and used as an oxidising reagent, for example in the oxidation of alkyl halides to 
aldehydes^, and the oxidation of alkylboranes to alcohols^. However, this introduction 
is concerned mainly with heteroaromatic rather than aliphatic A-oxides.
A comparison of A-oxides and their parent heterocycles generally shows a marked 
difference in their properties. The polarity of the N-O bond imparts a greater dipole 
moment to the A-oxide, although the difference in dipole moment is less than the 
difference between the dipole moments of aliphatic amines and their A-oxides. For 
example, the dipole moments (|i) of triethylamine and its A-oxide are 0.65 D and 5.02 D 
respectively, and those of pyridine and its A-oxide are 2.20 D and 4.24 D respectively. 
The N-O bond is comparatively unstable, and so reduction is a relatively straightforward 
process (for instance, by the use of catalytic hydrogenation over Raney nickel, or 
phosphorus trichloride), although the heteroaromatic oxides are more resistant to 
reduction than their aliphatic counterparts because of the resonance effects involving the 
oxygen lone pair of electrons and the aromatic 7t-system.
Interestingly, at the same time as supplying electrons to the ring, the oxygen also exerts a 
strong electron-withdrawing inductive effect on the ring, thereby increasing the reactivity 
of the ring to nucleophilic attack^. Pyridine A-oxide has increased reactivity towards 
electrophilic substitution relative to pyridine itself - substitution occurs mainly in the
4-position3, whereas in pyridine itself, electrophilic substitution occurs (albeit with 
difficulty) in the 3-position. The A-oxide of pyridine (1) can also be used as an auxiliary
for promoting nucleophilic substitution at the 2- or 4-position; nucleophilic attack at the
2-position is facilitated by the formation of the O-benzoyl derivative (2 ), where 
elimination follows addition and the A-benzoate moiety becomes a leaving group. For 
example, reaction of this O-benzoyl derivative with silver phenylacetylide (as a 
carbanionic nucleophile) gives l-phenyl-2-(2-pyridyl)acetylene (3) (Scheme 1.1)^.
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Scheme 1.1
A-Oxides can also undergo 1,3-dipolar cycloadditions .^ With 1-methylbenzimidazole
3-oxide (4), the adducts with isocyanates and isothiocyanates are unstable and 
decompose to the 2-substituted benzimidazoles (5) (Scheme 1.2).
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Tautomerism is a factor to be considered when contemplating the structure of heterocyclic 
A-oxides. For example, 1-unsubstituted benzimidazole A-oxides are tautomeric with 
A-hydroxybenzimidazoles; the position of the equilibrium is solvent-dependent^. With 
benzimidazole A-oxide, the predominant tautomer in aqueous solution is the A-oxide 
form (6), but as the polarity of the solvent decreases, the predominance of the A-hydroxy 
form (7) increases’^ . The situation is similar with 2-hydroxypyridine A-oxide (8 ) 
(l-hydroxy-2-pyridone) - in this case, each tautomer is strongly intramolecularly
hydrogen bonded and the evidence (such as infra-red and ultra-violet spectroscopy) 
suggests that it exists mainly as 1-hydroxy-2-pyridone (9) in aqueous solution^. In the 
literature, the N-oxide and 7V-hydroxy forms are used more or less interchangeably, and 
the reader should be aware of the equilibria (Scheme 1.3) with the alternative tautomeric 
structures^.
N
OH
I I  I0 “ H
8
Scheme 1.3
i&2 Biological and Pharmaceutical Applications
There is much potential for the biological and therapeutic application of heterocyclic 
N-oxides - naturally-occurring examples of these include iodinin (10) and aspergillic acid 
(11) below. Iodinin  10,11 was isolated from Chromobacterium iodinum in 19381^, and 
was found to possess antibacterial activity. Aspergillic acid^^ was isolated in 1943^^, 
and although this was found to be so toxic as to preclude its therapeutic use as an 
antibiotic, it is nevertheless an example of a biologically active heterocyclic A-oxide, and 
as such is a useful model for drug (or biocide) design. In some instances, the A-oxide 
can have a far greater therapeutic effect than the parent heterocycle. For example, (13) 
has a much greater selective affinity than (12) for the AMPA (a-amino-3-hydroxy-
5-methylisoxazole-4-propionate) receptor^^, which is of great importance for the 
treatment of neurological conditions such as Parkinson's, Huntingdon's and Alzheimer's
diseases in which the excessive stimulation of excitatory amino acid receptors such as the 
AMPA receptor is involved.
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2,5,6-Trisubstituted benzimidazole A-oxides are known to be antihelmintic agents 
(helminthiasis is the infestation of the gastrointestinal tract with helmintic parasitic 
worms), and 5,6-dimethylbenzimidazole is of interest since it was discovered to be a 
constituent part of vitamin
L 2  Synthetic Strategies
The synthesis of heterocyclic A-oxides has been the target of much research for many 
decades; various synthetic strategies are considered below.
1.3.1 Direct A-oxidation
The most obvious route to such A-oxides would appear to be the direct oxidation of the 
parent heterocycles by reaction with (for example) hydrogen peroxide in warm glacial 
acetic acid, or with a peroxyacid such as peroxybenzoic acid or monoperoxyphthalic
acid^. For example, quinaldine (14) is oxidised in “very good” yield to quinaldine 
N-oxide (15) in benzene with peroxybenzoic acid at room temperature (Scheme 1.4)^^.
PhCOgH ►  I Ibenzene 
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Scheme 1.4
Peroxytrifluoroacetic acid has been used for those heterocycles which are more weakly 
nucleophilic and therefore more resistant to oxidation; for instance 2 ,6-dibromopyridine 
(16) fails to oxidise with peroxybenzoic or peroxyacetic acids (its reduced nucleophilicity 
is due to the negative inductive and steric effects of the two flanking bromine atoms), but 
the oxidation to (17) proceeds in good yield with 30% hydrogen peroxide in warm 
trifluoroacetic acid (Scheme 1.5)^^.
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However, benzimidazole (18) is resistant to oxidation by this method^^ - reaction with 
hydrogen peroxide in warm glacial acetic acid leads to cleavage of the benzene ring 
(Scheme 1.6)^k N-MethyIbenzimidazole is oxidised (with hydrogen peroxide in acetic 
acid) to N-methylbenzimidazolone^^, so again, the N-oxide is inaccessible by direct 
oxidation. Only one direct oxidation of benzimidazole (after trimethylsilylation using 
hexamethyldisilazane) has been found in the literature, utilising a molybdenum complex 
in N,N-dimethylformamide (Scheme 1.7)^^, but this gives only a 10% yield of the 
N-oxide (6), and so cannot be regarded as a viable synthetic route; no later modifications 
of this procedure have been reported to date. In fact, benzimidazole /V-oxide is even
known to be deoxygenated under apparently oxidising conditions (formic acid and 
hydrogen p erox id e)24, although this is probably due to the reducing properties of formic 
acid predominating over the oxidising power of peroxyformic acid in this instance.
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Scheme 1.7
One must therefore turn to another route in order to prepare benzimidazole N-oxides - i.e. 
cyclisation of an appropriately substituted benzene derivative (see section 1.5.2, below). 
This cyclisation strategy also has applications for the synthesis of many other benzo- 
fused heterocyclic N-oxides, and may indeed be more generally useful as a route to 
otherwise inaccessible systems. The following sections will therefore consider the 
synthetic utility of cyclisation reactions leading to heterocyclic N-oxides in general.
1.3.2 Hvdroxvlamine reactions
There are several classes of cyclisation reactions which lead to heterocyclic N-oxides. 
The cyclisations of hydroxylamine derivatives are one such class. For example, when 
glutaconic aldehyde (as its anion, 19) and hydroxylamine are heated in acidic methanol, 
pyridine N-oxide (21) is formed via the dioxime (20) (Scheme 1.8)25.
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Scheme 1.8
More simply, direct nucleophilic attack of a hydroxylamine group on a carbonyl group 
(for example, the dichloroacetanilide 22 ), followed by dehydration, will lead to an 
N-oxide (in this case, 23) (Scheme 1.9)26.
Cl - g g  ^
NOHCl
23 Ph
Scheme 1.9
The purine N-oxide (25) has been synthesised by the intramolecular nucleophilic attack 
of a hydroxylamino group on the carbonyl carbon of a formamide, which is obtained by 
the intermolecular formylation of the amine (24) with triethyl orthoformate (Scheme 
1.10)27.
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Scheme 1.10
25
LA Nitrg Group
In aromatic chemistry, the use of the nitro group as a precursor to other functional groups 
such as NO, NH2, NHOH, -N=N- etc, is well authenticated^^, as is its use both as an 
activating group^^ and as a leaving g ro u p s ® in  aromatic nucleophilic substitution. 
However, chemistry of the nitro group as a functional group in its own right is not 
particularly extensive unless the functional group transformation involves intramolecular 
interactions of the nitro group with (for example) orf/zo-substituents on a benzene ring.
There are numerous types of intramolecular transformations involving nitro groups, most 
of which lead to cyclisation. These reactions have been reviewed twice in the literature, 
in 1964^^ and 1972.33 The purpose of this section is to collect together some of the 
work in this area, with a view to a mechanistic consideration of these interactions. The 
emphasis will be mainly on the reactions of A^-substituted o-nitroanilines with base, 
although some photolytic, thermolytic and reductive processes will be considered, along 
with the transformations of some other orr/zo-substituted nitrobenzenes.
1.4.1 Reductive Transformations
The first synthesis of benzimidazole N-oxide (6) was carried out by the partial reduction 
of o-nitroform anilide (26) with ammonium sulphide (Scheme 1.11) by von 
Niementowski34. The assumption is that the reduction of the nitro group proceeds as far
10
as the hydroxylamine (27); there then follow nucleophilic attack of the latter on the 
carbonyl group, and a final dehydration.
NO
26
NH4SH
NI
6 O
27
H
NHOH
o::*e
N 
7 OH
HoO
OH
Scheme 1.11
Tricyclic benzimidazole A^-oxides (31) have also been synthesised by the reductive 
cyclisation of aromatic nitro compounds (29) using titanous chloride (TiClg) in hot acid 
solution^^. When an extra molar equivalent of reducing agent is used, the N-oxide 
undergoes deoxygenation and the parent benzimidazole (32) is recovered (Scheme 1.12). 
It was originally suggested^^ that the function of the reducing agent was to furnish the 
nitroso compound for the cyclisation to occur. However, when the corresponding amine 
is oxidised specifically to the nitroso compound (using Caro’s acid^^*^^, H2SO 5), 
cyclisation to the benzimidazole fails. The reaction is more likely to proceed through the 
7C-complexed intermediate (30), with the titanous chloride acting both as a chelating agent 
to align the interacting groups favourably, and as a reducing agent in the final step (this 
reduction was demonstrated separately to consume one mole of reducing agent).
One inherent problem with reductive cyclisations for the synthesis of N-oxides in general 
is in ensuring that reduction of the nitro group does not go beyond the level of the
11
hydroxylamine to give the primary amine, or indeed that further reduction of the A^-oxide 
does not take place. The difficulty involved in controlling the level of reduction tends to 
mean either that N-oxide yields are lower, or that mixtures of products are obtained.
TiClc
29
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cr
TiOdj
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30
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Scheme 1.12
However, various methodologies have been employed to give fairly reasonable yields^. 
Catalytic hydrogenation of an appropriate starting material over platinum or palladium in 
the presence of at least one equivalent of acid (usually HCl) gives the desired 
benzimidazole N-oxide. For example, reaction of A^-methyl-2-nitrobenzanilide (33) with
12
hydrogen over platinum oxide in ethanoiic hydrogen chloride furnishes 1-methyl- 
2-phenylbenzimidazole 3-oxide (34) (Scheme 1.13) in 50% overall yield^. Absence of 
the acid (or its presence in only catalytic amount) leads to the complete reduction of the 
nitro group to the o-aminoanilide and recovery of some of the parent benzimidazole. 
When the oxygen is protonated, attack by the hydroxylamino group on the carbonyl 
group is presumably more favourable than further reduction to the amine.
MeIN Ph H a/P tO a ^
MeI
ONO2 EtO H /H Cl
33
-
0“34
Scheme 1.13
Some examples of other heterocycles prepared by reductive processes involving nitro 
groups are outlined below. The synthesis of quinaldine AA-oxide (15) by the direct 
oxidation of quinaldine has already been referred to (Section 1,3.1); its synthesis by the 
reduction (with zinc in acetic acid) of 4-hydroxy-4-(o-nitrophenyl)butan-2-one (35) has 
also been described^^ (Scheme 1.14), although the yield is not specified, and the correct 
structure for the product was not established until later^^.
OH O
Me Zn
35
AcOH
Scheme 1.14
Because quinaldine N-oxides are accessible by direct oxidation, this type of reductive 
cyclisation is of little practical use, but for benzo-fused azole A-oxides, which are 
generally not accessible by direct oxidation, cyclisation becomes the only route possible.
13
1-Substituted benzimidazole 3-oxides (37) can be prepared by reductive cyclisation of the 
appropriate formanilide derivative (36) with hydrogen sulphide in ethanoiic aqueous 
ammonia at room temperature (Scheme 1.15)^® in a manner similar to that of von 
Niementowski34.
 H,S /E tO H  ^
H NH3 /H 2ONÜ2 I
36 37
Scheme 1.15
Sulphur-containing heterocycles are accessible by reductive cyclisation methods. 
Benzothiazole N-oxides (39) have been prepared by the reduction of o-nitrophenyl 
thiocyanate (38) with Raney nickel and 2 equivalents of hydrogen (Scheme 1.16)^^. In 
this case, the product is the 2-amino substituted heterocycle, which arises from the 
nucleophilic attack of the hydroxylamine intermediate on the thiocyanate carbon.
SCN Raney N i / 2 H9 ^
EtOH (3 atm) ^
J N U 2  I
38 39 O"
75-88%
Scheme 1.16
Benzothiazine N-oxides (42) are obtained by the catalytic transfer hydrogenation of the 
adduct (41) of the thioacetic acid derivative (40) with an aldehyde using sodium 
borohydride and palladium/charcoal (Scheme l.l?)^^.
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An example of an oxygen-containing heterocycle synthesised by reductive cyclisation is 
the 4-hydroxybenzoxazin-3-one (44) (Scheme 1.18)^^, produced from the reaction of 
ethyl o-nitrophenoxyacetate (43) with zinc and ammonium chloride.
°  B r '^ C O j E t ►82% NH^CINO2
43 88%
Scheme 1.18
Benzotriazole 1-oxides (46) are accessible from azobenzene derivatives (45) - again, by 
reduction with hydrogen sulphide in ethanoiic aqueous ammonia (Scheme 1.19)^^>^ .^
Me
H2S /E tO H  ^
N H j/H aO  L
NOa 80% ^
45 46
Scheme 1.19
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Cyclisations can also be effected between ortho-nitro groups and -substituents in an 
adjacent ring - for example in the 2-nitro-2-substituted biaryls (47) shown in Scheme 
1.20^^, in which the reduction to the pyrido[3,4-c]quinoline 6-oxide (48) is effected by 
zinc and ammonium chloride in aqueous ethanol, although the yields in most cases are 
relatively low (25-35%).
Zn/NH^Cl
47
R = C02Et, CN, H, COMe 
R' = COjEt, CN, COMe
48 O
R" = OH, Me, NH2
Scheme 1.20
1.4.2 Intramoleculai’ Redox Processes
Some examples of this type of transformation do not actually involve cyclisation, but
\
illustrate the process of simultaneous oxidation and reduction of orfAo-substituted side 
chains. For example, under alkaline conditions (potassium hydroxide) and with heat, 
o-nitrotoluene (49) is converted into anthranilic acid (50) (Scheme 1.21)47.48
Me
NO2
OH-
49
Scheme 1.21
CO2H
NH2
50
A plausible mechanism for this would appear to involve the stepwise reduction of the 
nitro group with concomitant oxidation of the methyl group, catalysed by OH” . 
Kukhtenko proved by 1^0 studies49 (using K^^OH and H2^^0 ) that one oxygen in the
16
CO2H group comes from the nitro group, and the other from the reaction medium. The 
mechanism for this transformation proposed by Scholl in 1913^® was later extended by 
Loudon and Tennant^^ and proceeds to anthranilic acid (50) via o-nitrosobenzyl alcohol 
(51) and then anthranil (52) (Scheme 1.22).
-H oO
CO2H
Scheme 1.22
The studies could also be accommodated by the mechanism outlined in Scheme 1.23, 
where the oxygen of the nitro group undergoes nucleophilic attack by the initial 
o-nitrophenylmethylene anion. The final step involves a hydride transfer. Again, in this 
mechanism, only one oxygen is derived from the nitro group, and the other from the 
reaction medium.
17
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This phenomenon of attack on the oxygen of the nitro group has been rationalised by 
Buck^i, with the claim that “the environment of the nitrogen is completely saturated with 
electrons... and nucleophilic attack is consequently no longer possible on the nitrogen, 
and should occur, if at all, on the oxygen”. An example given of this is shown in 
Scheme 1.24, with the reduction of nitroaryl groups to nitrosoaryl groups with triethyl 
phosphite. This statement, however, is curious when coupled with Buck's observation 
that “condensations of this type [i.e. with nitrogen as the electrophilic centre] are 
observed only in the case of biphenyl derivatives, where intramolecular condensation to 
form a six-membered ring is sterically favoured”. There are many examples of what 
appear to be straightforward condensations with the nitrogen as the electrophilic centre 
(see Section 1.5).
(EtO)3P :' 0 '< 3 'A t N~ Ar
(Et0 )3P= 0
+
Ar—N = 0
Scheme 1.24
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It has also been suggested^^, however, that this reaction could proceed by a mechanism 
involving radical intermediates, although a detailed mechanism was not outlined in the 
communication. This postulation was made in the light of the observation of the 
spontaneous formation of radical anions of some nitroaromatics in basic solution: for 
example, p- and o-nitrotoluene have been shown by ESR spectroscopy to form radicals 
with potassium r-butoxide in f - b u t a n o l ^ ^
o-Nitrobenzaldehyde (53) is converted, both p h o t o c h e m i c a l l y ^ ^  and chemically in the 
presence of ammonium cyanide and aqueous ammonia^^, into o-nitrosobenzoic acid (54) 
(Scheme 1.25). The reaction is claimed^^ to be general for o-nitrobenzene derivatives 
bearing an a-hydrogen; the rearrangement of the nitro compound (55) to the 
o-nitrosobenzyl alcohol (56) is one such case^^.
53 54
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Scheme 1.25
Similarly, the photolytic conversion of N-(2,6-dinitro-4-trifluoromethyl)-N-methylaniline 
(57) to the N-unsubstituted nitrosoaniline (59) is envisaged as proceeding through the 
intermediate (58) (Scheme 1.26)^^, where the methyl group has been oxidised to the 
alcohol, and the nitro group reduced to nitroso. Extrusion of formaldehyde then follows. 
The photolytic cleavage of the trinitrophenylamino acid derivatives (60) to 2,4-dinitro-
6-nitrosoaniline (61) (Scheme 1.27)^^ probably also proceeds through a similar 
intermediate derived from an intramolecular redox process. The amino acid derivatives
19
involved were those of glycine, phenylglycine, leucine, isoleucine and glutamic acid. 
That of tryptophan (R = 3-indolylmethyl) reacted only reluctantly, and gave unidentifiable 
products.
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Scheme 1.26
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Scheme 1.27
Another redox process involving interaction between a nitro group and an ortho- 
substituent is the formation of o -n itrosopheny la rsonic  acid (63)  from
o-nitrophenylarsenoxide (62) (Scheme 1.28)59.
AsO
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Scheme 1.28
Intramolecular redox processes which lead to cyclisations include the Baeyer-Drewsen 
synthesis of indigo^^ (64) (Scheme 1.29), which involves the condensation of
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o-nitrobenzaldehyde with acetone in the presence of sodium hydroxide, and then 
cyclisation by some sort of redox process to indoxyi (65). A credible mechanism is 
shown in Scheme 1.30; the dimérisation of (65) to 2,2'-bisindoxyls (66 ) is known^\ 
and the oxidation of (66) to indigo is also known to occur readily in air^2 (although this 
is impossible for 2-substituted indoxyls).
f T V
NaOH
Scheme 1.29
It was found that the reaction of the steroid (67) (5-androsten-3p-ol-17-one) with 
o -nitrobenzaldehyde in basic solution does not give the expected steroidal 
16-o-nitrobenzylidene condensation product; instead the steroidal indoxyi compound 
(68) is isolated (Scheme 1.31)^3 This reaction probably proceeds through the hydroxy 
compound (69) and follows the same mechanism (Scheme 1.32)^ "^  as that postulated for 
the Baeyer-Drewsen reaction in Scheme 1.30, although without the dimérisation step. 
This reaction is general for 17-ketosteroids; with simple ketones the reaction leads to 
more complex products.
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During an investigation of the photochemistry of trans o-nitrostilbenes (70)^’^ , it was 
found that instead of the expected isomérisation to the cw-isomers upon illumination, the 
isatogens (71) were recovered. The authors suggest that transfer of the oxygen from the 
nitro group to the carbon atom occurs as a direct result of the irradiation, and the 
subsequent oxidation/reduction occurs as a “thermal dark reaction” following the 
irradiation. Alternatively, an aci-mixo intermediate (72) can be envisaged, followed by 
cyclisation to the 5 membered ring (73) (Scheme 1.33); this cyclisation is a favoured 
process with regard to Baldwin’s rules for cyclisation^^.
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Benzimidazole A-oxides are obtained when o-nitroanilines are heated with excess of an 
aldehyde (for example, benzaldehyde). Indeed, in an attempted synthesis of 
N-benzylidene-o-nitroaniline (74), by heating o-nitroaniline with benzaldehyde as 
solvent, the heterocyclic N-oxide (75) instead may be isolated (Scheme 1.34) '^ .^ This 
seems to depend on the addition of xylene (b.p. ~140‘’C) as an inert co-solvent to aid in 
the removal of water from the reaction mixture by distillation. However, when toluene 
(b.p. 110 X )  is used as the co-solvent, the anil is obtained in satisfactory yield, 
suggesting that use of the higher boiling co-solvent favours cyclisation. The reaction has 
also been carried out in refluxing p-xylene or tetralin to give the parent benzimidazole in 
18-94% yield^S.
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This reaction is thought^^ to proceed by initial formation of the expected o-nitroanil (76) 
(Scheme 135). The anil reacts readily with another molecule of o-nitroaniline giving 
(77); the excess of aldehyde is necessary to suppress this side reaction. The aldehyde, 
however, also functions as a reducing agent, giving presumably the o-nitrosoanil (and 
benzoic acid; cf. Scheme 1.36); such anils are known to cyclise spontaneously to 
benzimidazole A/^-oxides^^. Prolonged reaction at even higher temperatures leads to 
further reduction and the production of the paient 2-phenylbenzimidazole.
PhCHO N cs^ P h PhCHO
NO-
NH2
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The iV -p icry laz irid ine  (78)  is cycUsed pho toly tica lly  to 5,7-d initro- 
2"phenylbenzimidazole 3-oxide (79) (Scheme 1.37)^^ in very high yield. The strained 
aziridine ring is presumed by the authors to cleave, giving a benzoxadiazepine 
intermediate (80), which collapses with the extrusion of benzaldehyde to the
o-nitrosoanil (81); recyclisation to the product then follows. However, Sukumaran et 
propose that this reaction occurs by an electrocyclic mechanism (Scheme 1.38). 
Electrocyclic ring opening of the aziridine ring is followed by electrocyclisation to the 
benzoxadiazine intermediate (82), which then loses benzaldehyde to give the
o-nitrosoanil; recyclisation then occurs as before. The same product is isolated if one of 
the phenyl groups is replaced by benzoyl; in this case benzoic acid is the co-product.
O2N ' NO2
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Scheme 1.37
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1.5 Condensation Reactions
There are many examples of base-induced cyclisations which appear to occur as a 
straightforward condensation of the intramolecular aldol type, whereby the nitrogen of 
the nitro group acts as the electrophilic centre in the manner of the carbon of a carbonyl 
group. A general representation of these reactions can be shown as in Scheme 1.39 
which shows three types of cyclisation. The first involves an amine as the intramolecular 
nucleophile (if the amine is secondary, then the benzenoid character of the six-membered 
ring is lost, although the heterocycle is still aromatic as a 10 7C system). The second type 
of cyclisation has as the intramolecular nucleophile a methylene group activated by a 
terminal electron-withdrawing R group, and the third a methylene group activated by a 
non-terminal carbonyl group.
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The generally accepted mechanism for this type of reaction^ is outlined in Scheme 1.40 
for the formation of benzimidazole A^-oxides, involving nucleophilic attack of the 
methylene anion, and subsequent dehydration.
% H
o '  r 'o H
Scheme 1.40
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This mechanism appears to be quite satisfactory for a substantial number of cyclisation 
reactions in which a nucleophilic centre in an ortho side chain reacts with the nitrogen of 
the nitro group to effect a cyclisation.
1.5.1 Condensations Involving Nitrogen Nucleophiles
There are several examples of condensations involving nitrogen as the internal 
nucleophile. The nitrogen can be part of several different functional groups, the simplest 
probably being hydrazino: o-nitrophenylhydrazine (83) cyclises to 1-hydroxy- 
benzotriazole (84) (Scheme 1.41). The synthesis of 1-hydroxybenzotriazole (which has 
widespread applications as a coupling reagent for peptide synthesis^^) ^^s the first 
reported hétérocyclisation of an 6>-nitrophenylamine'^4,75,76 The substituted 
(7-nitrophenylhydrazine (85) cyclises both in ethanolic hydrogen chloride^^ and with 
acetic anhydride^^ to the 2-substituted benzotriazole 1-oxide (86 ) (Scheme 1.42); 
apparently condensation of the (3—amino group with the nitro group is followed by 
removal of the a-am ino proton to effect the dehydration.
a
NHNHa
NO.
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An intriguing condensation (in aqueous sodium hydroxide) between the amino group of 
certain o-nitrophenylacetamides (87) and the nitro group leads to cinnoline N-oxides 
(88) (Scheme 1.43)7932.
NH^ OH
88 O
Scheme 1.43
The amine nucleophile can also be on an adjacent ring. Benzo[c]cinnoline A-oxides (90) 
are the result of the reaction of 2-nitro-2 '-aminobiphenyls (89)^® with sodium methoxide 
or sodium hydroxide in methanol (Scheme 1.44).
NaOMe or 
NaOH
O
89 90
Scheme 1.44
3-Aminobenzotriazine-1-oxides (92) are obtained from the reaction of o-nitrophenyl- 
guanidines (91) with aqueous sodium h y d ro x id e^ o r with potassium r-butoxide in 
t e t r a h y d r o f u r a n ^ 2  (Scheme 1.45); the corresponding 1,4-dioxides are then accessible by 
direct oxidation with hydrogen peroxide.
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An interesting variation of this reaction is the reaction of 4-nitro-3-ureidobenzoic acid 
(93) with hot potassium hydroxide^^. The expected 3-hydroxybenzo-1,2,4-triazine
1-oxide (94) is not observed; instead the benzotriazole (95) is isolated. However, this is 
considered^^ to arise from a reaiTangement of the initially formed (94) and subsequent 
hydrolysis of the rearrangement product to the observed benzotriazole (Scheme 1.46). 
Evidence for this was obtained by observing the rearrangement (Scheme 1.47) of
3-am inobenzo-1,2,4-triazine 1-oxide (96) to the 1-carboxamide (97). Subsequent 
hydrolysis of the rearrangement product leads to benzotriazole (98).
HO2C
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This rearrangement can be kept to a minimum if the conditions are chosen carefully 
(Scheme 1.48). Pyrido[2,3-e]-l,2,4-triazine 1-oxides (100) are obtained without 
rearrangement occurring by refluxing the guanidinopyridine (99) in aqueous potassium 
carbonate for several hours® .^ Similarly, pyrido[4,3-g]-1,2,4-triazine 1-oxides (101) are 
obtained from the appropriate starting materials, again in refluxing aqueous potassium 
carbonate, although this time high yields are achieved after only 5 minutes®^.
HN . N N NHj
NH;  base ^  f  T  ^
99 100 0 “
H
101 6
Scheme 1.48
A final example of an amine (secondary in this instance) as a nucleophile is the cyclisation 
in carbonate to the 2^-indazole 1-oxide (102) (Scheme 1.49)^^. Interestingly, further 
reaction of this with methoxide leads to the cinnoline A-oxide (103), by addition of 
methanol to the nitrile triple bond, ring opening and recyclisation. Similarly, reaction of 
the Schiff base (104) with cyanide in methanol gives the same product, presumably via a 
similar mechanism.
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1.5.2 Condensations Involving Carbanionic Nucleophiles
There follow examples of cyclisations which appear to involve the nucleophilic attack of a 
carbanionic centre on the nitrogen of the nitro group. These include the base-induced 
cyclisation of the glycine ester derivative (105) to the benzimidazole A-oxide (106)^^ 
(Scheme 1.50). '
^ — C02EtCOoEt
NO
105
Scheme 1.50
The unsaturated ester derivatives (107) react with base with the extrusion of an aldehyde 
to give methyl benzimidazole A-oxide-2-carboxylates (108). (Scheme 1.51)^^. 
Interestingly, the rate of cyclisation decreases as the level of substitution on the alkene 
increases; the acrylate (R = H) cyclises faster then the crotonate (R = Me), which in turn 
cyclises faster than the cinnamate (R -  Ph), This may be envisaged as an extension of
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the glycine cyclisation in Scheme 1.50 above, whereby the alkenyl side chain is lost by 
addition of water across the double bond, and then retro-aldol scission occurs with loss 
of aldehyde to give the glycine derivative, which then cyclises under the reaction 
conditions (alternatively, the scission could occur after the cyclisation step).
_ % 0  -O2N ^  NO2 O2N' ,
107 108 O
R = H ,M e, Ph
Scheme 1.51
In the benzene series, orfAo-substituents can be modified to vary the heterocyclic system 
obtained. (Arylthio)acetic acid derivatives (109) cyclise readily under basic conditions to 
the N-oxides of the benzothiazole series (Scheme 1.52)^®. Here, in the reaction of ethyl 
thiolacetate with chloro-2 ,6-dinitrobenzene derivatives, the reaction proceeds to the ethyl
4-nitrobenzothiazole 1-oxide-2-carboxylate (110), again presumably via an aldol-type 
condensation.
NO-
NO
MS
10-20“C10-20'C
Et.N NOR
109
110 o
Scheme 1.52
0-Nitrobenzamido-acetonitriles (111) react with sodium ethoxide in ethanol to give
1-hydroxyquinazoline-2,4-diones (113)^^92 The initial intermediate, however, is
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presumed to be the product (112) expected from a direct condensation between the active 
methylene and the nitrogen of the nitro group (Scheme 1.53), although this has not been 
isolated. Acetanilides (114) with electron withdrawing groups as substituents cyclise in 
basic conditions to quinoxalin-3-one 1-oxides (115)^^, again apparently as a result of a 
simple aldol-type condensation.
I l l
NR
CN
o~
112
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114
R^=COMe, COPh, etc
Scheme 1.53
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The o-nitroacetanilide derivative (116; R = CN) is cyclised to 2-cyanoquinoxalin-3-one
1-oxide (117; R = CN) in aqueous alkali (Scheme 1.54)^^. For those analogues with 
aryl groups in place of the cyano group, it is found^^ that the presence of electron- 
withdrawing groups on the aryl group facilitates formation of the anion, and so therefore 
has a profound effect on the ease of cyclisation, whereas substituents on the anilide ring 
have little effect. The mechanism was proposed^^ to proceed by formation of the
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methylene anion and its nucleophilic attack on the nitrogen of the nitro group followed by 
dehydration.
R/Ar alkali
NO2 R/Ar
116 117 Ô"
Scheme 1.54
A similar type of condensation occurs to give purine A-oxides (118) (with loss of 
benzoic acid) (Scheme 1.55)^^, although the cyclisation does not work when R = H. 
According to the authors, this is “probably due to destabilisation of the phenacyl 
carbanion by the adjacent NH group”, although this is presumably because the most 
acidic hydrogen in the molecule is the NH proton; the corresponding anion is well 
delocalised and the methylene carbanion is more unlikely to foirn.
O
NaOH
R O
Scheme 1.55
The tricyclic quinoxaline derivatives (120) are the products of the reaction of the 
acetoacetanilide (119) with sodium hydroxide in pyridine (Scheme 1.56)98.
MeNO
119
ii) H
120 O
o
Scheme 1.56
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2-Alkoxybenzimidazole A-oxides (122) are obtained by the reaction of N-phenacyl- (or 
N-acetonyl-) A-(toluene-/7-sulphonyl)-o-nitroanilines (121) with sodium alkoxides in the 
appropriate alcohol; the 2-substituent is derived from the alkoxide (Scheme 1.57)^^. 
Interestingly, when 6-methyl-2-nitroaniline derivatives (i.e. with a second group ortho to 
the amino group) are cyclised, l-hydroxy-4-methylbenzimidazoIone (123) is isolated. 
The mechanistic implications of this will be discussed in Chapter 3.
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Interactions of nitro groups with ortho substituents on an adjacent ring were described 
briefly in Section 1.4.1, in the context of reductive cyclisations. Condensation of an 
active methylene group with an o'-nitro group, for example in biphenyl derivatives, leads 
to the formation of tricyclic N-oxides. Phenanthridine N-oxides (125) can be prepared 
by reaction of the appropriately substituted biphenyl (124) with methanolic sodium 
hydroxide (Scheme 1.58)^^^. When R = COPh, w/îsubstituted phenanthridine 5-oxide 
and sodium benzoate are isolated. 6-Benzoylphenanthridine 5-oxide is appaiently formed 
initially, the benzoyl substituent being subsequently displaced by nucleophilic attack of 
hydroxide ion. Direct N-oxidation to 6-benzoylphenanthridine 5-oxide (with 
peroxyacetic acid as the oxidising agent) was also unsuccessful. When R = Ph, the
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phenyl group is presumably not sufficiently electron-withdrawing, and no cyclisation 
takes place®®.
NO
124
CH2R NaOH
MeOH
R = CN, COiMe, CONH2
Scheme 1.58
The cyclisation strategy for N-oxide synthesis has utility when a direct oxidation method 
would give uncertain results (i.e. uncertainty as to which nitrogen might be oxidised). 
The synthesis of quinoxaline 1-oxides and pyrido[3,4-^]-pyrazine 4-oxides (127) can be 
effected unambiguously by cyclisation of o-nitrophenylacetamidines (126) (Scheme 
1 59)101 with sodium ethoxide in ethanol. The adjacent acetamidine moiety is probably 
sufficient activation for the methylene group for a simple condensation mechanism to be 
considered.
NaOEt N . ^N R 2
126
Y = CH or N
EtOH
127 o
Scheme 1.59
Varying the conditions of a reaction can sometimes have a profound effect on its course. 
For instance, cyclisation of the o-nitrophenylallyl derivatives (128) (Scheme 1.60)^ ®^  
leads to quinoline 1-oxides (129) and 1-hydroxyindoIes (130 and 131). Altering the 
basicity of the reaction medium gives a mixture of products, depending on the chosen 
conditions. The more electron-withdrawing the substituents R  ^ - R^ on the benzene ring,
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the more acidic are the methyl hydrogens, and so the formation of the quinoline N-oxides 
is apparently more favoured (for example, with Cl, Br, S02Ph), Conversely, electron- 
donating substituents such as OMe and SMe increase the proportion of the
1-hydroxyindoles isolated. Indeed, the reaction of those less acidic nitriles requires the 
addition of dimethyl sulphoxide to increase the basicity of the reaction medium (by 
increasing the activity of the hydroxide ions). For a given starting material, increasing 
the basicity of the reaction medium increases the proportion of the 6-membered ring 
formed.
NaOH
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R^ Ô"
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+
130
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Scheme 1.60
The authors propose a rationalisation (Scheme 1.61) of these observations, taking into 
account the fact that no interconversion of the three products is observed. The cyclisation 
step leading to the 6-membered ring (129) could perhaps be iiTeversible under strongly 
basic conditions, whereas protonation to give the aci-nkro intermediate (132) happens 
under less basic conditions, with subsequent cyclisation leading to the 5-membered ring. 
The cyclisation step is considered by the authors to be a cycloaddition, although the 
Michael-type addition shown in the Scheme is perhaps more likely. The mechanistic 
pathway to the 2-unsubstituted indole (130) is unclear although the one-carbon unit is
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presumably lost as formaldehyde by a retro-aldol cleavage, as formaldehyde has been 
detected by trapping as its dimedone derivative.
L A
HO O
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Scheme 1.61
l-Hydroxy-2-quinolones (134) are obtained from the reaction of diethyl (a-cyano-
o-nitrobenzyl)malonate (133) with either potassium cyanide or potassium hydroxide in 
ethanoP^^. However, this requires a strongly alkaline environment: if the conditions 
employed are less basic (for example by using sodium carbonate in aqueous ethanol), or 
the starting material is less reactive (with hydrogen in place of the nitrile group), the 
course of the reaction is altered and the 1-hydroxyindoIe (135) is formed. The 
vinylogous analogue (136) of the nitrile is also cyclised with potassium cyanide to (134) 
(Scheme 1.62), although (136) probably first adds HCN across the double bond to give 
(133) as the initial intermediate.
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L i  Alternative Mechanisms?
Rationalising the foregoing reactions by invoking a straightforward aldol-type 
condensation {cf. Scheme 1.40) appears to be satisfactory in many cases. However, 
there are several classes of cyclisation which appear to involve attack on the nitro group 
by a less obviously nucleophilic centre; i.e. activation of the methylene group appears to 
be insufficient for generation of a carbanion under the reaction conditions employed.
For instance, the feeble activation of the methylene group in N-benzyl-o-nitroaniline
(137) appears to be overcome as cyclisation to 2-phenylbenzimidazole A^-oxide (75) 
occurs under alkaline conditions with sodium hydroxide (Scheme 1.63)^^. Cyclisation 
fails, however, for the N-methyl analogue, even under more drastic conditions (sodium 
hydride)^. The reason for this is unclear if a simple condensation mechanism operates.
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Attempted syntheses of ^ >-nitroanils by the elimination of toluene-p-sulphinic acid from 
A-arylmethyl-A''-(toluene-p-sulphonyl)-o-nitroanilines (138) have proved unsuccessful; 
instead the 2-arylbenzimidazoIe 1-oxide (139) is isolated (Scheme 1.64)^04 Again, 
activation of the methylene carbon is provided only by an aryl group. The co-product in 
this reaction is a l-methoxy-2-arylbenzimidazole (140). Presumably this arises from 
méthylation of the N-oxide by methyl toluene-p-sulphonate, which in turn is generated by 
nucleophilic attack on the sulphur by methoxide ion after the cyclisation has taken place 
(Scheme 1.65).
Me
NaOMeAr
MeOH
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139 O
140 OMe
Scheme 1.64
Later work by Smith et showed that cyclisation of the N-tosylated starting materials
(138) with sodium methoxide in methanol depends on the extent of methylene activation: 
for the N-benzyl derivative, no cyclisation occurs, but for the N-(p-nitrobenzyl) 
derivative, the activation is presumably sufficient for reaction to occur.
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An apparently simple condensation between an active methylene group and a nitro group 
in an adjacent ring [i.e. 2-benzyl-3-(o-nitrophenyl)quinoxaline (141) furnishes the 
tetracyclic quinolino[3,4-/?]quinoxaline 5-oxide (142) (Scheme 1.66)i^^], although here 
the acidity of the methylene protons is perhaps enhanced by the two flanking aryl groups, 
and condensation with the nitro group is sterically favoured. However, a comparison 
with the phenanthridine synthesis (Scheme 1.58) shows that in that instance, activation of 
the methylene group of (124; R = Ph) by two flanking phenyl groups was insufficient 
for cyclisation to take place. This discrepancy is intriguing in that the only difference in 
activation between (124) and (141) is that one of the aryl groups is quinoxalino instead 
of phenyl.
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Xanthine A^-oxides (144) can be obtained by cyclisation of the nitrouracil (143) with 
warm ethanolic potassium carbonate (Scheme 1.67)^07 The nitrosouracil derivative 
(146) is a presumed intermediate in the reaction of the 4-amino-5-nitrosouracil (145) by 
heating with benzaldehyde in N,N-dimethylformamide to give (144) and the parent 
xanthine (147) 1^ 8  ^ the cyclisation occurring in a fashion analogous to the spontaneous 
cyclisation of o-nitrosoanils to benzimidazole N-oxides^o.
O "  N ' g  Ph 
Me
N N
143 144
Me. NO Me
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Scheme 1.67
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1-Hydroxyindoles (149) are obtained by the reaction of an appropriately substituted 
o**(benzylcyanomethyl)nitrobenzene (148) with sodium hydroxide in dimethyl 
sulphoxide (Scheme 1.68)^® ,^ the postulated course of the reaction involving a nitroso 
intermediate (150). The crucial step is thought to involve dehydration to give (150) 
(although no mechanism is proposed for this, a plausible route is included in the 
Scheme), and then electrocyclisation to a nitrone intermediate (151) followed by 
tautomérisation. Cyclisation still occurs if there is extra substitution on the p-carbon; in 
this case [the cyclisation of (152) to (153); Scheme 1.69] the carbon at the 2-position of 
the indole (153) remains tetrahedral. This lends support to the proposed mechanism, 
which in any case is unlikely to be a simple condensation involving the nitro group.
+ OH
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Scheme 1.68
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Phenazines (155) and their N-oxides are obtained by heating 2-nitrodiphenylamines 
(154) in basic solution^^^. Relatively high reaction temperatures are required (for 
example, refluxing xylene or decalin), although the proportion of N-oxide decreases with 
increasing reaction temperature. In this case, the reaction is tantamount to electrophiiic 
aromatic substitution (Scheme 1.70). The deoxygenation appears to be a thermal 
process, which would explain the decreased proportion of N-oxide obtained at higher 
temperatures, although in decalin the deoxygenation process could also be facilitated by 
the oxidation of the solvent to tetralin or naphthalene.
(e.g.) KOH / xylene 
reflux
155 o
- H .O
Scheme 1.70
In the context of the alternative mechanisms proposed for some of these cyclisation 
reactions, it is useful now to reconsider some of the apparently simple condensation 
mechanisms proposed for some of the reactions in Sections 1,5.1 and 1.5.2.
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The mechanism of the formation of 1-hydroxybenzotriazole (84) from the cyclisation of 
o-nitrophenylhydrazine (83) (Scheme 1.41) has received considerable attention. Kinetic 
studies^ have suggested that a monoanion is formed during the reaction. The most 
stable monoanion is that of the a-NH , as this is stabilised by the ortho nitro group. The 
formation of an aci-nitro intermediate (156) is envisaged, followed by nucleophilic attack 
of the P-NH2 on the nitro group, and subsequent dehydration and tautomérisation 
(Scheme 1.71). However, formation of the p-monoanion has not been ruled out, and the 
possibility of a redox process, involv ing cyclisation of an interm ediate 
o-nitrosoazobenzene, has also been tentatively suggested^.
( o h
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Scheme 1.71
The cyclisation of the unsaturated ester derivatives (107) (Scheme 1.51)^^ is proposed 
by the authors to proceed by a concerted mechanism (Scheme 1.72) because of the fact 
that they could not detect any intermediates during the course of the reaction.
However, another mechanism which would seem to be more likely can be envisaged 
wherein a 7-membered ring intermediate (157) is formed which then collapses to the
o-nitrosoanil (158) with concomitant loss of aldehyde; the o-nitrosoanil then cyclises 
spontaneously to the benzimidazole A^-oxide (108) (Scheme 1.73).
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In conclusion, then, it is apparent that there is considerable scope for a reappraisal of the 
presumed mechanisms for some intramolecular cyclisations involving nitro groups and 
ortho side chains.
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The reseai'ch canied out for this thesis is concerned mostly with the cyclisation reactions 
of derivatives of amino acids. This type of reaction was introduced in Section 1.5.2 
(page 32), with regard to condensations involving carbanionic nucleophiles. The 
mechanism of the cyclisation of the glycine derivative in Scheme 1.50 would appear to be 
a straightforward condensation of the methylene-derived caitanion with the nitro group, 
but as explored in Chapter 1, this is open to question, as are the mechanisms of 
cyclisations of various other o-nitroanilines.
The photochemical decomposition of N-(o-nitrophenyl) derivatives of amino acids in the 
solid state has been known for quite some time^^^dis and results in decarboxylation to 
give the corresponding iV-alkyl-2,4-dinitroaniline^i'^. The N-(2 ,4-d initropheny l) 
(henceforth DNP-) derivatives of a-am ino acids (159) cyclise in aqueous solution by 
photolysis at pH<7 to give the 2-substituted benzimidazole N-oxides (160) (Scheme 
2 . 1).
/}— RpH <7NOO2N
159 160 0 “
R = CH2OH, H,
‘Bu, "Bu, Ph
Scheme 2.1
Later work by Pollitt^i^ on the photolysis of these compounds in solution showed that 
this was the case between pH 2 and pH 5, but at pH values above and below these 
values, the main product was 4-nitro-2-nitrosoaniline (164; = H)), with the amino
acid side chain having been cleaved off. Extension of this work^^^^n showed that the 
reaction is general for DNP-a-am ino acids with an a-hydrogen. The benzimidazole 
N-oxides thus formed are stable to further irradiation. N-(2,4-Dinitrophenyl)-|3-amino
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acids and DNP-peptides (also DNP-tryptophan) are decomposed only slowly by light at 
high temperatures.
Mechanistic proposals by Neadle and Pollitt^^^ to account for the apparent pH 
dependency of the reaction involve the intermediacy of the substituted /V-hydroxymethyl- 
2-nitroso-4-nitroaniline (163), arising from the decarboxylation of the photo-induced 
excited state of the starting material (162) (Scheme 2.2). Dependency on pH seems 
reasonable, because the decarboxylation is more likely to occur if the carboxy group is 
protonated. The intermediate (163) then has several possibilities for further reaction, 
depending on conditions. Direct hydrolysis would lead to the 2-nitroso-4-nitroaniline 
(164) with loss of the disubstituted a-carbon as a ketone or aldehyde. If R = H, 
reversible dehydration leading to the anil (165) would then, if R^ = H also, result in 
cyclisation to the 5-nitro-l//-benzimidazole 3-oxide (166). For sarcosine, however, this 
route is not feasible since the dehydration step could not occur. Another route could be 
envisaged whereby the carbocation (167) is formed; where R^ = H, this would then 
cyclise to the 5-nitro-l//-benzimidazole 3-oxide (166).
The authors suggest that this is probably the route which operates at very low pH. For 
the sarcosine derivative, at pH 0 in the dark after rapid photolysis, formation of 1-methyI- 
5-nitro- l//-benzimidazole 3-oxide occurs as a secondary reaction, the initial reaction 
occurring as a result of the photolysis being formation of 4-nitro-2-nitroso- 
N-methylaniline and extrusion of formaldehyde. This is presumably the same reaction as 
that described by RusselF^^, whereby reaction of 4-nitro-2-nitrosoaniline with an 
aldehyde furnishes 2-substituted-5-nitro-î//-benzimidazole 3-oxides, the 2-substitution 
depending on the aldehyde used.
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OoN
OoN
OoN
OoN
COoH
R^COR^
R^ or R  ^ = H
R
\ , R ^  R^ or R^ =
f " '  . 0 .No A A166 O
Scheme 2.2
NHR^
The authors also note that in the case of the threonine derivative (159) [where R = 
CH(Me)OH], a mixture of two benzimidazole N-oxides (160) was isolated, viz. where 
R = CH(Me)OH and where R = H. It was established that no interconversion between 
the two products occuned, which implied that cleavage of the side chain took place 
before the cyclisation step.
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Photolysis of the corresponding pyridylamino acid derivatives (168) leads as expected to 
2-substituted 3//-imidazo[4,5-Z?]pyridine 1-oxides (169)^^^ with loss of carbon dioxide 
and water (Scheme 2.3).
NO
168 169 O
Scheme 2.3
Photolysis of A^-(2,4,6-trinitrophenyl)amino acids (170) fails to yield any isolable 
heterocyclic product. In weakly basic aqueous methanol, photolysis leads only to 
isolation of 2-nitroso-4,6-dinitroaniline (171) and an aldehyde, with loss of carbon 
d i o x i d e ^ 2 0  (Scheme 2.4). Photolysis of these compounds in dilute hydrochloric acid was 
previously reported^^^ to lead to picramide (2,4,6-trinitroaniline).
NO NO
NH
NO NO170 171
+ RCHO + CO2
Scheme 2.4
On the other hand, thermolyses of the same starting materials give different mixtures of 
p ro d u c ts ^ in  no case is the benzimidazole N-oxide isolated. For example, pyrolysis of 
DNP-glycine (172) at 200 gives four isolable products, the main product being
5-nitrobenzimidazolone (173) (Scheme 2.5). A/-Methyl or N-phenyl substitution 
appears not to have a significant effect on product distribution, although a-substitution, 
for example in the case of DNP-alanine, (174) gives mostly 2-methyl-5(6)- 
nitrobenzimidazole (175), along with some of the 2,2'-bibenzimidazolyl (176) and
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2,4-dinitroaniline (Scheme 2.6). The formation of the bibenzimidazolyl demonstrates the 
loss of the two methyl groups, which is unusual; the mechanism of this cleavage is 
unclear. Thermolysis of the corresponding (a,o^-disubstituted) 2-methylalanine 
derivative (177) gives 2,4-dinitroaniline as the only identifiable product.
H HN. .CO^H A
N O ; 0 ;N  ^  g  0 ; N ^ ^ ^  NO;
172 60% X73 5%
5% 10%
Scheme 2.5
H Me ^ ^ ^ N ^ C O ; H
, X A
A
0 2 N  ^  N 0 2  0 2 N
174
OoN
0
- V/y— Me 
"N
+ 175
A ,/ /  ^'^N
176 +
NO-
OoN
Me
^  ,N H
CO;H  A. 2
0 2 N  N 0 2  0 2 N  N 0 2
177
Scheme 2.6
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Luetzow and Vercellotti reported^^ the cyclisation of DNP-glycine methyl ester (105) 
under basic conditions to the benzimidazole N-oxidt (106) in 1967 (see Section 1.5.2, 
on page 32). The same sort of cyclisation arose during the work of Ljublinskaya and 
Stepanov on peptide sequencingi^s. They demonstrated that DNP-glycylglycine (178) 
cyclised under the basic conditions employed in the sequencing process (triethylamine 
with carbonate buffer at pH 8.3) to the corresponding 2-substituted benzimidazole 
iV-oxide (179) (Scheme 2.7). It was also shown that the cyclisation only occuned when 
the N-terminal amino acid was glycine.
N O
NO
178
N CO,H base ^  ( f ' V
179 O- CO^H
Scheme 2.7
An alternative mechanism which has been proposed^^'^d25 account for the cyclisations 
in acidic media of the DNP-derivatives of a-substituted amino acids (180) to the 
2-substituted benzimidazole A-oxides (182), involves nucleophilic attack by the amine 
nitrogen on the oxygen of the nitro group with quenching of the positive charge on the 
nitrogen of the nitro group. Ring opening to give the nitroso compound (181) is 
followed by decarboxylation and re-cyclisation to the benzimidazole A-oxide (Scheme 
2.8). The mechanism is diverted when the amino acid is a,a-disubstituted - in this case, 
the product is the o-nitrosoaniline and the alkyl side chains are lost as the appropriate 
ketone.
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OoN
OoN
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L  CO2H
r ‘F k ’K  CO,H 
OH
0 ,N  ^  NO
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F
OH
NO
NHRi
H \h v i N  CO2H
J[T^]r + R^COR^
NO
R = alkyl
R^ = H
Scheme 2.8
The base-induced cyclisation reaction can be further exploited as a synthetic method 
leading to 2-unsubstituted benzimidazole N-oxides. The cyclisation of amino acid 
derivatives (including esters and nitriles) under basic conditions has been shown to be a 
viable route^^d26,i27,i28 js^  general outline of this route is shown in Scheme 2.9 below. 
The 2-substituted N-oxides (183) are hydrolysed in either acidic or basic media; it is 
presumed that the carboxy lie acid undergoes spontaneous decarboxylation. Acidic 
hydrolysis leads directly to the hydrochloride salts of the 2-unsubstituted N-oxides,
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which can be purified and then the free iV-oxide isolated by basification using aqueous 
ammonia.
It should be noted that in the starting materials, the amino nitiogen is secondary; when the 
nitrogen is tertiary, however, the reaction sequence results in a completely different set of 
products (Section 2.2).
Xî7
H
NO
base
H
R
183
IO
R = ester or CN
0 : . V c o , H
N 
OH cr
CO.
cr
x -T  I  /> H w m
N
OH
X
•nIo
Scheme 2.9
2 .2  M echanistic D iscussion
As mentioned above, the amino nitrogen of the starting material in Scheme 2.9 is 
secondary. When this is tertiary, as in the case of the nitriie (184), it was found^^^d29 
that cyclisation under basic conditions gives the A-hydroxybenzimidazolone (185) 
instead of the expected 1-methyl-1//-benzimidazole 3-oxide (Scheme 2.10). For the 
corresponding sarcosine esters (186), however, reaction with potassium carbonate 
affords the l-hydroxyquinoxaline-2,3(l//,4//)-dione (187), along with some of the
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unusual azoxybenzene derivative ( 1 8 8 ) (Scheme 2.11). The structures of both of 
these were confirmed by X-ray crystallography!^®.
K î  ,C N
Me 
I
Xtt
184 185 OH
Scheme 2.10
A/r MeMe IN v ^  C02Et O
-  - a  xNO; N O
186 187 OH
+
NHMe
N
“O188 H;N
I II 4 -X
Scheme 2.11
Apparently, the reaction proceeds via an internal redox type of mechanism, whereby the 
CH2 becomes oxidised and the nitro group becomes reduced to the hydroxylamine. This 
would imply an intermediate such as the o-hydroxylamino anilido ester (189), the ester 
carbonyl of which would then undergo nucleophilic attack by the hydroxylamine to give 
the l-hydroxyquinoxaline-2,3-dione (187).
Me O
x - ^
NH 
OH
189
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The same reaction path is apparently followed by the corresponding nitropyridyl- 
sarcosine derivative (190), which is cyclised to furnish l-hydroxy-4-methyl-
pyrido[2,3-i>]pyrazine-2,3(l//,4//)-dione^3i (191) (Scheme 2.12).
Me Me
I  IN. . N. . COjEt /  N. , OT
NO2
190 191 'OH
Scheme 2.12
Previously we have seen a deviation from the course of the “normal” cyclisation when 
glycine is replaced by sarcosine. However, it is highly significant that the reaction of 
N-(2,6-dinitrophenyl)glycine ethyl ester (192) with base (Scheme 2.13) as opposed to 
that of the A/-(2,4-dinitrophenyl) derivative does not give the expected 7-nitro- 
1//-benzimidazole 3-oxide (193). Instead l-hydroxy-5-nitroquinoxaline-2,3-dione
(194) is isolated^^^ Here we now have a deviation from the “normal” reaction with a 
glycine derivative.
CO^Et
N021 H
T
'N
193 Ô"
NO2 H
. JN:OH194
,0
O
Scheme 2.13
Evidently the difference in the course of the cyclisation is due to the presence of the 
second ortho-miro group. It is interesting to consider whether the effect of this second
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nitro group is steric, perhaps making the NH less accessible to the base, or electronic, 
perhaps affecting the acidity of the amino proton.
Whereas in Scheme 2.13, the benzimidazole iV-oxide (193) is not formed, other
6-substituted derivatives have been cyclised with base and their products i n v e s t i g a t e d ^ ^ ^  
The 6-acetamido- and 6-methyl- glycine derivatives both cyclise “normally” to the 
benzimidazole N-oxide; however, the 6-chloro and 6-trifluoromethyl analogues both give 
a mixture of the l-hydroxyquinoxaline-2,3-dione, the benzimidazole A^-oxide and the 
azoxy compound (188). So it would seem that steric factors may not be responsible for 
the deviation from the “normal” reaction pathway.
Acidity of the NH appears also to be ruled out, because A-(2,4-dinitrophenyl) and 
N-(2,6-dinitrophenyl)glycine esters are cyclised to the benzimidazole N-oxide and the 
hydroxyquinoxaline/benzimidazole A-oxide mixture respectively. One would expect the 
acidity of the NH to be similar in both these cases (both having the same electron- 
withdrawing groups ortho/ortho or ortholpara to the amino substituent), yet the two 
cyclisations proceed differently. What is clear, however, is that 6-substitution diverts the 
mechanism to a varying extent.
Nevertheless, the NH does appear to be significant in determining the course of the 
reaction. The previously accepted condensation mechanism for these cyclisations is 
shown in Scheme 1.40 (page 27). However, as represented there, the amino hydrogen is 
involved only after the cyclisation is complete, so it is unclear how A-substitution in the 
case of sarcosine derivatives could affect the course of the reaction so profoundly as to 
give the quinoxaline-2,3-dione instead of the benzimidazole A-oxide. On the basis of 
this mechanism, one might expect the product of the sarcosine cyclisation to be the
1-methylbenzimidazole 3-oxide (195), but this is not the case. It could be supposed that
(195) is an intermediate in the reaction, which reacts further to give (196) (Scheme 
2.14). In the absence of an acidic hydrogen, nucleophilic attack could occur at C-2 and
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ring opening might follow; the resultant hydroxylamine would then attack the ester 
carbonyl to give (187).
COoEt
195 O
COoEt
CiP
—  a x
196 OH 187 OH
Scheme 2.14
However, the reaction of ethyl 1-methyl-l//-benzimidazole-2-carboxylate 3-oxide (195) 
with sodium hydroxide is k n o w n t o  lead to complete loss of the ester function and not 
to ring opening, so some other explanation of the anomalous behaviour is required.
Formation of the benzimidazolone (185) could be rationalised similarly, where 
nucleophilic attack on the 2-cyano-l-methyl-l//-benzimidazole 3-oxide (197) would lead 
to (185); Scheme 2.15. The non-methylated benzimidazole oxide is not really a genuine 
A^-oxide, but a tautomeric system with an acidic hydrogen, so deprotonation occurs in 
preference to nucleophilic attack and the benzimidazolone is not observed.
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Scheme 2.15
/ ^ O H
îN  OH
185 OH
If the cyclisation mechanism involves removal of the amino hydrogen before the 
cyclisation step, then the difference in the course of the cyclisation between the glycine 
and sarcosine derivatives could be rationalised whereby a common intermediate [a
2,1,4-benzoxadiazine (198)] is formed in both cases by initial removal of the 
a-hydrogen and nucleophilic attack by the resultant carbanionic centre on the oxygen of 
the nitro group.
In the sarcosine-derived benzoxadiazine intermediate there is no amino hydrogen 
available for abstraction by base, so the second a-hydrogen may then be removed instead 
with concomitant ring-opening to give the hydroxylamine (199). This nucleophile 
would then be expected to attack the ester carbonyl carbon to form the quinoxaline-
2,3-dione (Scheme 2.16).
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O"
^  I
186
CO^Et
OH
198; R = Me
Me o
187
Scheme 2.16
Me
ON 
OH
The above mechanism can also be applied to the “normal” cyclisation of the glycine 
derivatives (ester and nitriie) (Scheme 2.17). In this case, instead of the second 
a-hydrogen being abstracted by the base, the amino hydrogen is removed to give the 
o-nitrosoanil intermediate (199), which then cyclises to the benzimidazole N-oxide 
(isolated as the hydrochloride in the work-up procedure).
H BI H 
0“
j  CO^Et
B
Co
199
198; R = H
COgEt
O
etc.
Scheme 2.17
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Alternatively, given that the a-proton of the o-nitrosoanil (199) is unlikely to be 
particularly acidic, the lone pair of electrons on the nitrogen of the nitroso group could be 
involved in an electrocyclic process breaking up the aromaticity of the benzene ring which 
would then be followed by tautomérisation to give the product (106) directly (Scheme 
2.18).
199 ^  0 “ 106 O'
Scheme 2.18
2u2— Results and Discussion
The intention of the following work was to investigate the reactions of A/-(o-nitrophenyl) 
derivatives of a-substituted amino acid esters with base, the hope being to elucidate the 
mechanism of the cyclisation reaction so that perhaps some intermediates could be 
isolated. It should be noted that either the racemic mixture (R,S) or the single 
(S)-enantiomer of the amino acids were used, depending solely on their availability 
(specified in the Experimental section). It was not considered important which of these 
was used, as the configuration of the stereogenic centre would not be retained during 
cyclisation, and the geometry was not expected to affect the course of the reaction.
Synthesis of the DNP derivatives of the amino acids was generally carried out by reacting 
the amino acid with either chloro- or fluoro-2,4-dinitrobenzene in refluxing aqueous 
ethanol; estérification of the acid was carried out by heating under reflux in the 
appropriate dry alcohol containing dry hydrogen chloride gas (Scheme 2.19). The
2-nitrophenyl derivatives were prepared similarly, although only 2-fluoronitrobenzene
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was used as the starting material since 2-chloronitrobenzene is not reactive enough 
towards these particular nucleophiles.
X
r 1  Î
Cl/F " N " ^ C 0 2 H  _ H ---------- ^
NO, NaHCOg X
? r2N ^ C O z H
NO,
R^OH
HCl
X
,
N ^ C O ^ R '
NO2
X = H, NO2
Scheme 2.19
Given the relative ease with which DNP-amino acids are prepared by the well-established 
method of Sangeri34^ and their usefulness in peptide sequencing, it is perhaps surprising 
that in fact very few of the esters prepared during the course of this work have previously 
been reported in the literature.
2.3.1 Alanine Derivatives
The alanine derivatives described below were prepared in order to probe further the 
reactions of amino acid derivatives with base - it was thought that perhaps the cyclisation 
might be intercepted at some stage because of the fact that there was one less a-hydrogen 
to be involved in the mechanism and therefore a diversion of the reaction pathway might 
occur.
Synthesis of both the DNP and A/-(2-nitrophenyl) derivatives of alanine and their ethyl 
esters (200a and b) proved straightforward. However, the melting point obtained for 
DNP-alanine ethyl ester (200b) (105 °C) was much higher than that quoted in the 
literature (60 which was curious given that all the other data were consistent with
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the proposed structure. It is possible that this discrepancy could be due to a different 
crystalline form being obtained.
Reaction of both the DNP and N-(2-nitrophenyl) derivatives of alanine ethyl ester with 
ethanolic potassium carbonate resulted in isolation of the corresponding 2-methyl- 
1//-benzimidazole 3-oxides (201a and b) (Scheme 2.20) in 30-40% yield. The ester 
group is lost in preference to the a-methyl group. The reaction of the o-nitrophenyl 
derivative also yielded some /V-(2-nitrophenyI)alanine, resulting from simple hydrolysis 
of the ester to acid.
O"
200a; X = H 201a; X = H
200b; X = NO2 201b; X= NOg
Scheme 2.20
A simple condensation mechanism now seems even more unlikely than in the case of the 
glycine derivatives, because the a-methyl group, having a positive inductive effect, will 
make formation of the methine-derived carbanion less facile - in other words, the 
carbanion would be less stable than in the glycine case. There is ample precedent for 
methyl groups attached to the carbanionic centre making compounds less acidic^ 
There is little doubt that the most acidic hydrogen in (200) should be the amino proton, 
especially given the considerable mesomeric effect of the ortho-mivo group, in addition to 
the para-m{xo group in (200b).
This result could be rationalised by a simple extension of the proposed mechanism of 
Scheme 2.17. Formation of the o-nitrosoanil (202) could be followed by ester 
hydrolysis and decarboxylation with concomitant cyclisation (Scheme 2.21).
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X- '>■202 I IO
C O ^
201
I ^  IOH in i O'
Scheme 2.21
However, it is in fact not necessaiy to invoke hydrolysis of the ester at all. Instead, 
cyclisation of the o-nitrosoanil (202) by an electrocyclic process could be envisaged {cf. 
Scheme 2.18), followed by nucleophilic attack on the ester carbonyl leading to the 
product (201) (Scheme 2.22). It is unlikely that the ester group is lost before 
cyclisation, because a carbanion would consequently have no stability - it is known that 
N-ethylo-nitroaniline does not react under these conditions^^^. The ester group is 
retained in the case of the glycine analogue because of the presence of the remaining 
acidic proton instead of the methyl group in the teU ahedral 2-position.
C02Et
202 LO
H
X ^  V X- V
OH 201 O'
Scheme 2.22
Although the yields for this process are not particularly high (30-40%), they are 
acceptable in light of the fact that this is the most useful route towards 2-alkyl
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benzimidazole iV-oxides, and is reliable. The other alternative is reductive cyclisation of 
o-nitroanilides, but as discussed in Section 1.4.1, this route is less reliable because it is 
difficult to control the extent to which the nitro group is reduced, and it is also not 
compatible with the presence of other reducible groups.
Attempted reaction of the esters with triethylamine as the base in ethanol resulted only in 
recovery of starting material.
2.3.2 Norvaline and Phenylalanine Derivatives
Similarly to the cyclisation of the alanine derivatives, both DNP-norvaline and DNP- 
phenylalanine ethyl esters (203) and (205) are cyclised to the corresponding 2-propyi- 
and 2-benzyl-1//-benzimidazole 3-oxides respectively [(204) and (206); Schemes 2.23 
and 2.24]. It is likely here that the same mechanism applies as for the alanine 
cyclisations, although again it is not entirely clear at what stage the ester group is lost, or 
indeed whether ester hydrolyis occurs. Ester hydrolysis would be expected in the basic 
conditions of the reaction if there were water present, but dry ethanol (dried by its 
reaction with magnesium and iodine) was used as the solvent for the cyclisation 
reactions, so whether there would be enough water present for this to occur is 
questionable.
Me
COoEt
NO
203
0 ,N
Scheme 2.23
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COoEt
OoNNO
205 206 O'
Scheme 2.24
2.3.3 p-Alanine Derivarives
Synthesis of the |3-alanine derivatives (207) was undertaken in order to assess whether 
separating the acidic methylene group from the amino group would lead to a six- 
membered ring being formed [i.e. giving a quinoxaline derivative (208); Scheme 2.25], 
as would be expected if the simple condensation mechanism were operating.
R
COgEt
NO, R
207
N COoEt 
208 6 -
Scheme 2.25
However, reaction of both the DNP- and N-(2-nitrophenyl) derivatives of (3-alanine ethyl 
ester with ethanolic potassium carbonate resulted only in isolation of a mixture of the 
unchanged ester and its hydrolysis product [for DNP-, 76% of the acid and 17% of the 
ester; for N-(2-nitrophenyl)-, 39% of the acid and 42% of the ester], with no cyclised 
products being found (Scheme 2.26). These results suggest that the extra methylene 
group separating the amino and ester functionalities in |3-alanine prevents any reaction 
from occurring other than hydrolysis of the ester. This in turn implies that a simple 
condensation mechanism may not be operating in these types of reactions since there is 
no obvious difference in the potential acidity of the CH% groups between (207) and its 
glycine analogue. It could be suggested, however, that cyclisation does not take place
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due to there being less of a driving force for the process as the quinoxaline derivative 
(208) would not have the extra stability of an aromatic system.
R ^  NOo 
207
R = H, NO2
COaEt K2CO3 no reaction
Scheme 2.26
Interestingly, p-alanine derivatives have been cyclised to heterocyclic products (Scheme
2.27), although this procedure involves reduction. For example, N-(o-nitrophenyl)- 
P-alanine methyl esters (209) are cyclised under dissolving metal reduction conditions 
(heating with zinc in hydrochloric acid) to give 8-substituted-1,2,3,4-tetrahydro- 
3//-l,5-benzodiazepin-2“Ones (210)1^®. The yields for this process depend on the R 
group; for R = H, 48%; R = OMe, 51%; R = NO2, 79%. Once again, no N-oxide is 
obtained by this reductive procedure.
C02Me Zn 
HCl
R = H, OMe, NO2
NO2 
209
Scheme 2.27
2.3.4 2-Methvlalanine Derivatives
Given that the cyclisation reaction is considerably diverted when the NH is not present 
(i.e. the sarcosine derivatives discussed on page 58), the 2-methylalanine derivatives
(211) were prepared and cyclisation attempted in order to see if a corresponding
71
diversion occurred when the a-position (beaiing two methyl groups) instead of the amine 
was blocked from reaction. The likelihood of there being a reaction between the amine 
and the o-nitro group was therefore probed.
The A^-(2-nitrophenyl) derivative of 2-methylalanine ethyl ester (211) was prepared in 
the usual manner, but again, no reaction with potassium carbonate occurred (Scheme
2.28), and the starting material was recovered in 90% yield, along with 10% of the acid
(212) resulting from hydrolyis of the ester. Reaction with sodium ethoxide as the base 
similarly yielded both the starting ester (40%) and the acid (60%). Cleaiiy, the presence 
of at least one a-hydrogen is required for any sort of cyclisation to take place, the only 
reaction observed in this case being simple hydrolysis of the ester, and no obvious 
reaction between the amine and the nitro group was observed.
Me MeMe Me
baseCOoEt
NO NO
211 212
Scheme 2.28
2.3.5 A^-Methvlalanine Derivatives
It was desirable to determine the effect on cyclisation of having methyl groups on both 
the nitrogen and the a-carbon. A^-Methylalanine is available commercially, but is 
prohibitively expensive, so a synthesis was undertaken from alanine itself.
Attempts were made to A-methylate directly both A-(2-nitrophenyl)alanine (213) (by 
reaction with methyl iodide and sodium hydride) and N-benzyloxycarbonylalan ine (214) 
(by the method of McDermott and Benoiton^39^ also using methyl iodide and sodium 
hydride), but no more than 20% méthylation could be achieved [in the case of the
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N-benzyloxycarbonyl-protected amino acid (214)], and no méthylation at all took place 
with N-(2-nitrophenyl)alanine (213) (Scheme 2.29). These failures were presumably 
due to the poor nucleophilicity of the amino group (because of the negative mesomeric 
effect of the o-nitro group in one case, and in the other because the amino nitrogen is part 
of a carbamate group).
NO'
N a H \
Mel / \
Me I MeN ^ C O ^ H
NO-
213
214
H Me
O
N a H \/
M e I / \
Scheme 2.29
Me I Me O ^ N ^ C O î H
o
The synthesis therefore followed the procedure of Freidinger et [substituting the 
benzyloxycarbonyl group (Z) for the fluorenylmethoxycarbonyl (Fmoc) group], outlined 
in Scheme 2.30.
Alanine was Z-protected (by reacting with benzyl chloroformate in pyridine^'^^), then 
reacted with paraformaldehyde (in refluxing toluene with a catalytic amount of 
p-toluenesulphonic acid and removal of water using Dean-Stark apparatus) to give the 
oxazolidinone (215). Reductive cleavage of this heterocycle by ionic hydrogenation 
(using triethylsilane as the hydride donor and trifluoroacetic acid as the proton donor) 
resulted in the Z-protected N-methylated amino acid (216). Deprotection to give 
A-methylalanine (217) was effected by hydrogenolysis (over palladium/charcoal).
Reaction with fluoro-2,4-dinitrobenzene was then followed by estérification, although a 
number of problems were encountered in the purification of the ester, for example
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hydrolytic loss of the amino acid side chain to give 2,4-dinitrophenol. Distillation of the 
reaction mixture residue (which was an oil) also appeared to result in hydrolysis of the 
ester, as the proportion of starting material present in the distillate was greatly increased. 
Purification was finally achieved by recrystallising the distillate from ethanol, although 
the yield by this stage was very low (6%).
Me PhCH^OCOCl ^
EtgSiH
TFA
215 O
Me
M e H N ^ C O ^ H
217
FDNB
214
216
H HCHO
O Me
MeI HrO ^ N ^ C O i H  P d /C  
O Me
Me I Me
EtOH
O^N ^  NOo 218
HCl
Me « Me
0 ,N
219
NOr
Scheme 2,30
Reaction of DNP-A-methylalanine ethyl ester (219) with ethanolic potassium carbonate 
was carried out under the noimal conditions, but unfortunately only a complex mixture of 
compounds (at least 9 spots were observed by tic) was recovered, none of the 
components of which could be identified.
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2.3.6 Proline Derivatives
These derivatives were prepared as cyclic analogues of /V-methylalanine, with a view to 
the preparation of tricyclic heterocycles. Difficulties were encountered in the purification 
of DNP-proline ethyl ester (221); the rra«5-4-hydroxyproline analogue (222) proved to 
be easier to handle. The hydroxyl group would also lend itself to the introduction of 
further functionality in any heterocyclic products formed.
However, reaction of both the DNP-proline derivatives (221) and (222) with ethanolic 
potassium carbonate (Scheme 2.31) similarly failed to yield any identifiable cyclised 
products. Compound (221) was also reacted with sodium ethoxide, but again, no 
products were isolable from the reaction mixture.
R
K2CQ3 ^
COoEt 02N^ NO2
221; R = H 
222; R = OH
Scheme 2.31
2.3.7 Histidine Derivatives
N(a)-(2,4-Dinitrophenyl)histidine ethyl ester (225) was prepared as before. The mono­
substituted product was obtained without difficulty by using one equivalent of fluoro-
2,4-dinitrobenzene; neither the bis-DNP compound (223) nor the A^(l-(2,4-dinitro- 
phenyl) compound (224) was observed. Evidently the amine nitrogen was more 
nucleophilic than the imidazole nitrogen.
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Cyclisation with potassium carbonate in ethanol produced a mixture of 5-nitro- 
l//-benzimidazole-2-carboxylic acid 3-oxide (227) and the corresponding ethyl ester 
(226) , as well as some 2-unsubstituted benzimidazole N-oxide (228, with complete 
loss of the imidazolylmethyl side chain from the products (Scheme 2.32). One 
experiment yielded 30% of the ester and 38% of the acid; another yielded 26% of the 
ester, 47% of the acid, and 6% of the 2-unsubstituted product.
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Scheme 2.32
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The imidazolyl side chain was presumed to be cleaved in a manner analogous to that of 
the serine and threonine derivatives (229a and b) described by Luetzow and 
Vercellotti^^. They propose that DNP-serine undergoes a retro-aldol cleavage under the 
basic conditions of the reaction to give the glycine derivative, which then cyclises to the 
benzimidazole A^-oxide (228) (Scheme 2.33). However, the imidazolylmethyl side chain 
in this reaction of the histidine derivative could presumably also be cleaved at some other 
stage during the cyclisation process, for example from the o-nitrosoanil intermediate
(230) by abstraction of the imidazole NH [route (i)] as shown in Scheme 2.34. 
Alternatively, nucleophilic attack by the base on the methylene carbon could displace the 
heterocycle as a leaving group [route (ii)].
/ y O H
N..OT.,
O2 N ' ^  NO2  02N ^ ^ '= = ^ '^
229a; R = H 228 O'
229b; R = Me
Scheme 2.33
COoEt
COoBtOoN
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OoN
226 ^
Scheme 2.34
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Unfortunately, however, the imidazole-containing moiety was never successfully isolated 
- its presence in a small amount of impure oil was detected, but identification proved 
elusive.
2.3.8 Trvptophan Derivatives
It was hoped that cyclisation of tryptophan derivatives would lead to benzimidazole 
A^-oxides with the indole moiety in position 2 of the heterocycle. Synthesis of DNP- 
tryptophan was straightforward, but estérification proved to be problematic, in that only 
very low yields of its hydrochloride salt could be obtained, from a complex mixture of 
products separated by chromatography. A/-(2,4-Dinitrophenyl)tryptophan methyl ester
(231) was therefore prepared directly from fluoro-2,4-dinitrobenzene and tryptophan 
methyl ester hydrochloride in 98% yield.
Reaction of DNP-tryptophan methyl ester with methanolic potassium carbonate resulted 
in isolation of methyl 5-nitro-l//-benzimidazole-2-carboxylate 3-oxide (108) in 53% 
yield (Scheme 2.35). No cyclised product containing the indole moiety could be found; 
further investigation, however, led to recovery of 3-(methoxymethyl)indole (232) (in 
69% yield) as a buff-coloured water-insoluble solid.
H
NO
OoN
j Q n , V c o . M .
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108 O
Scheme 2.35
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Cleavage of the amino acid side chain could be rationalised by a retro-aldol scission 
similar to that envisaged for the histidine (225), serine (229a) and threonine (229b) 
derivatives. The final co-product would then arise from nucleophilic Michael-like attack 
of methanol on the exocyclic double bond of (233) [if route (i) is followed |. If route (ii) 
is followed, nucleophilic attack of methanol on the CH2 of the side chain of the 
o-nitrosoanil (234) would lead to loss of the product (108) as a leaving group and 
3-(methoxymethyl)indole (232) directly (Scheme 2.37). The fact that the yields for the 
benzimidazole and indole fragments are not greatly dissimilar suggests that the 
fragmentation occurs at a late stage in the mechanism as depicted, rather than (as 
suggested by Luetzow and Vercellotti) as an initial step with the formation of the glycine 
derivative which then undergoes cyclisation.
Cleavage of the tryptophan side chain in this manner has been previously d e s c r ib e d in  
the literature. Reaction of tryptophan itself with methanolic potassium hydroxide and 
PhI(O A c)2 (a source of hypervalent iodine) to give (235) results in formation of 
3-(methoxymethyl)indole (232) and iodobenzene. This p-cleavage of the side chain was 
claimed by the authors to have been previously unobserved in chemical systems, 
although known in biological systems. The mechanism they suggest (Scheme 2.36) also 
involves the nucleophilic attack of methanol on the exocyclic double bond of (232). 
However, the authors do not describe the fate of the amino acid residue.
COoH
- P h i
OMe233 232
Scheme 2.36
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2.3.9 Glutamic Acid Derivatives
Diethyl A-(2,4-dinitrophenyl)glutamate (236) was obtained from the hygroscopic DNP- 
acid as a viscous yellow oil. Reaction with ethanolic potassium carbonate (Scheme 2.38) 
resulted in retention of the a-substituent in the cyclised product, which was almost 
entirely ethyl 3-(5-nitro-3-oxido-l//-benzimidazol-2-yl)propionate (237) and a very 
small amount of the corresponding propionic acid (238) which was detected by NMR 
spectroscopy in one of the isolated fractions. When the reaction was carried out on a
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small scale, only the ester (237) was isolated (in 70% yield). The mechanism for this 
cyclisation is again presumably similar to that postulated for the alanine derivatives in 
Scheme 2.21. However, given the high yield of the ester obtained, this would tend to 
suggest that hydrolysis of the a-ester is not in fact an important process in rationalising 
the loss of the ester group, and so presumably this makes the other mechanism proposed 
(Scheme 2.22) more likely than that requiring hydrolysis of the ester followed by 
spontaneous decarboxylation (Scheme 2.21).
COoEt
COoEt
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237 O236
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Scheme 2.38
2.3.10 Aspartic Acid Derivatives
It was expected that cyclisation of diethyl DNP-aspartate (239) would result in ethyl
3-(5-nitro-3-oxido-l//-benzimidazol-2-yl)acetate (240) (Scheme 2.39) analogously to 
the cyclisation of the corresponding glutamate derivative (236), but reaction with 
ethanolic potassium carbonate both with and without heating failed to yield any isolable 
products other than 63% recovery of the starting material from one attempt. Reaction 
with sodium ethoxide as the base was similarly unfruitful. It is unclear as to why this 
should be the case, especially in view of the fact that the glutamic acid derivative cyclises 
with relative ease.
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Scheme 2.39
It is conceivable that the amino proton is intramolecularly hydrogen bonded to the P-ester 
carbonyl oxygen in a six-membered ring (241), which could account for the lack of 
reactivity by rendering the amino proton less able to become involved in the reaction. 
The corresponding glutamyl derivative (236) would be unlikely to exhibit such strong 
hydrogen bonding because in this case it would be a less stable seven-membered ring, 
and so cyclisation therefore occurs readily.
v'Qv ,O E tH'" V
O jN ' ^
241
2.3.11 Sarcosine Derivatives
The cyclisation of DNP-sarcosine derivatives (186) has already been discussed (Section
2.2) - i.e. the anomalous cyclisation to l-hydroxy-4-methylquinoxaIine-2,3(l//,4//)- 
diones (187). The 4,5-dichloro analogue (242) has also been prepared (bearing in mind 
the work of Townsend with respect to the synthesis of antiviral compounds- see Section
4.2) and cyclised to the corresponding 6,7-dichloro-1 -hydroxy-4-methylquinoxaline- 
2 ,3 (l//,4 //)-d ione  (243) (Scheme 2.40). However, although NMR data were 
consistent with the proposed structure, not enough material was recovered to carry out a 
full characterisation.
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Scheme 2.40
2.3.12 Other Amino Acid Derivatives
Attempted syntheses of both diethyl 2,4-dinitrophenyliminodiacetate (244) and the DNP- 
and N-(o-nitrophenyl)- derivatives of diethyl aminomalonate (245) proved unsuccessful. 
Cyclisation of diethyl 2,6-dinitrophenyliminodiacetate would have been of interest in 
order to determine whether a “double” cyclisation could be effected to give the tricyclic 
heterocycle (246) in the manner of the sarcosine cyclisations to 1-hydroxy-
4-methylquinoxaline-2,3-diones (187) (Sections 2.2 and 2.3.11). Synthesis of the 
diethyl iminodiacetate derivative (244) was attempted both via the acid with subsequent 
estérification, and by direct reaction of fluoro-2,4-dinitrobenzene with diethyl 
iminodiacetate (attempted preparation of the 2,4-DNP derivative was undertaken initially 
to see if a monocyclisation would occur with the one onho-nitvo group). The acid was 
prepared successfully, but the ester could not be isolated from the estérification reaction 
mixture.
COoEt
COoEt COoEt
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Direct reaction of fluoro-2,4-dinitrobenzene with diethyl iminodiacetate presented 
difficulties. The product was isolated (in very low yield) by distillation from the reaction 
mixture residue (b.p. 210 “C/0.5 mmHg), but attempted purification of the yellow solid 
by recrystallisation from ethanol led simply to nucleophilic displacement of the 
iminodiacetate moiety by ethanol to leave 2,4-dinitrophenetole (247). Diethyl 
iminodiacetate was also recovered by distillation (b.p. 160 “C/0.5 mniHg). It has been 
noted in the literature that the imino group of such amino acids displays poor nucleophilic 
reactivity so the difficulties encountered with this reaction are perhaps not surprising, 
and evidently diethyl iminodiacetate is a particularly good leaving group (ethanol not 
being a particularly strong nucleophile).
Neither attempt at the synthesis of diethyl DNP- or diethyl N-(o-nitrophenyl)amino- 
malonate (245) led to isolation of any product - only intractable mixtures were obtained.
2.3.13 Trifluoroethvl Derivatives
Variously substituted 2-trifIuoromethylbenzimidazole V-oxides are of interest as 
acaricidal a g e n t s I t  was thought that by using the trifluoromethyl group in place of 
the ester group the methylene carbon should be activated sufficiently for cyclisation to the 
benzimidazole N-oxide to occur. The DNP-2',2',2'-ti5fluoroethyl compound (248) was 
therefore prepared by heating fluoro-2,4-dinitrobenzene with 2,2,2-trifluoroethylamine 
hydrochloride and potassium carbonate in N,N-dimethylformamide. Cyclisation took 
place when (248) was reacted with ethanolic potassium carbonate in the usual manner to
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give 5-nitro-2-trifiuoromethyl-l//-benzimidazole 3-oxide (249) in 74% yield as a buff- 
coloured solid (Scheme 2.41). This route is a simple procedure, lending itself to the 
synthesis of analogues substituted in the benzene ring, and also (9-alkylated derivatives 
(see Chapter 4).
CF.CF
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248
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Scheme 2.41
The mechanism for this cyclisation is presumably the same as that for the glycine 
analogue - i.e. a combination of Schemes 2.17 and 2.18, simply substituting the 
trifluoromethyl group for the ester group.
Attempts were made at the preparation of iV-methyl-iV-(2,4-dinitrophenyl)-2',2',2'- 
trifluoroethylamine (250) in order to see whether a diversion of the cyclisation analogous 
to that of the glycine and sarcosine ester cyclisations (pages 57-58) occurred. However, 
synthesis of this starting material in a pure enough form proved to be unsuccessful. 
A-Methyl-2,2,2-trifluoroethylamine hydrochloride (252) was prepared by the literature 
p r o c e d u r e - i.e. by reduction with lithium aluminium hydride of N-methyl-2,2,2- 
trifluoroacetamide (251) followed by bubbling hydrogen chloride gas through an ethereal 
solution of the free amine to precipitate the hydr ochloride. This was subsequently reacted 
with fluoro-2,4-dinitrobenzene in A,A-dimethylformamide with potassium carbonate 
(Scheme 2.42). Even after heating at 120 °C for 66 hours, however, starting material 
still remained and attempts at purification of the product were unsuccessful.
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Synthesis of A^-(2,6-dinitrophenyl)-2',2',2'-trifluoroethylam ine (253) was also 
attempted, again to make comparisons with the anomalous reaction of the 
correspondingly substituted glycine derivative (Section 2.2). However, again after 
heating the reactants together in N,N-dimethylformamide at 110 °C for over 140 hours, 
and after the addition of further portions of amine and carbonate, starting material (i.e. 
fluoro-2,6-dinitrobenzene) was still present as detected by thin layer chromatography.
NO
CF
NO
253
2.3.14 Pyridyl Amino Acid Derivatives
The reaction of the o-nitropyridyl glycine ester (254; R = H) with base proceeds 
analogously to that of the phenyl analogues^^^’^ '^  ^ (Scheme 2.43) to give ethyl 
3//-im idazo[4,5-^]pyridine-2-carboxylate 1-oxide (255) and its corresponding 
2-unsubstituted analogue. Similarly, the 3,5-dinitro-2-pyridylsarcosine analogue (254; 
R = Me) cyclises to give l-hydroxy-4-methylpyrido[2,3-^?]pyrazine-2,3(l//,4//)-dione 
(256). The only difference between the cyclisations of amino acid derivatives of the
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nitrophenyl and nitropyridyl series was that the 3,5-dinitro-2-pyridylglycine derivative 
(254; R = H, X = NO2) failed to yield any identifiable products.
C02Et base
R andX  = H
255 O254 *\^^^base
R = M e ^  
X = H ,NO
Me
256 OH
Scheme 2.43
The alanine analogue (257) was prepared in order to establish whether this cyclisation of 
N-(o-nitroaryl)amino acid esters was general for the pyridyl series as well as for the 
phenyl series. N-(3-Nitrù-2-pyridyl)alanine methyl ester (257) was prepared directly 
from the reaction of 2-chloro-3-nitropyridine and alanine methyl ester hydrochloride with 
methanolic triethylamine in 73% yield. Reaction of the ester with methanolic potassium 
carbonate (Scheme 2.44) led to recovery of the hydrolysis product of the starting ester 
[i.e. (258)] in 19% yield, and 2-methyl-3//-imidazo[4,5-/?]pyridine 1-oxide (259) in 
18% yield. A similar amount of material was recovered as a brown oil, along with a very 
small amount of fine yellow needles, tentatively identified as the ester (260) by iR  NMR 
spectroscopy, although not enough material was isolated to confirm this assignment. The 
brown oil was intractable.
First indications are, therefore, that the cyclisation reaction applies in the pyridyl series in 
addition to the phenyl series; work is currently under way by an Honours undergraduate 
(P. Nevin) to confirm this with the cyclisations of other pyridyl-amino acid derivatives.
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2 .4  C onclusions
There are several possible mechanisms for these types of cyclisation which have been 
mooted so far. Doubt has already been cast on the validity of the simple condensation 
mechanism of Scheme 1.40. A mechanism involving a benzoxadiazine intermediate
(198) has been proposed (Schemes 2.16 and 2.17), which can rationalise some of the 
results obtained for which the condensation mechanism appears to be insufficient (in 
addition to accounting for the simple cyclisations themselves).
Two other mechanisms can also be envisaged. In the first, initial deprotonation of the 
amine is followed either by a 1,5-sigmatropic hydrogen shift or an intramolecular hydride 
transfer on to the nitrogen of the nitro group leading to an o-nitrosoanil intermediate
(199) (Scheme 2.45). The second involves the formation of an aci-m\xo intermediate 
(261), which then undergoes deprotonation at the a-carbon (the hydrogen of which is 
now effectively allylic and therefore acidic), followed by cyclisation to (106) (Scheme 
2.46). It should be noted, however, that the o-nitrosoanil (199) could also be formed 
via the benzoxadiazine route (Scheme 2.17); its further reaction (which is known to occur 
spontaneously^®)to the benzimidazole A-oxide (106) could be as shown in Scheme 2.18 
on page 64.
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A combination of these two mechanisms shown above could involve formation of the 
acz-nitro intermediate (261) followed by re-aromatisation of the benzene ring with 
concomitant loss of water to furnish the o-nitrosoanil (199) (Scheme 2.47).
COoEt N<^^COoEt (c/. Scheme 2.18) ^
Scheme 2.47
Clearly, these mechanisms which involve abstraction of the amino proton apply only 
when the amino nitrogen is secondary - otherwise, the mechanism must be diverted 
somehow, as is observed with the (A-methylamino)acetonitriles (184) and the sarcosine 
derivatives (186). The mechanism is apparently also diverted when there is a second 
ortho-m\ïo group in the starting ester (or nitrile) which resùicts the reactivity of the amino 
hydrogen by intramolecular hydrogen bonding.
1
Certainly one a-hydrogen is required for cyclisation to occur, given that the
2-methylalanine derivative (211) failed to react with base. Those amino acid derivatives 
with an a-hydrogen and an a-substituent which is not labile towards nucleophiles or 
bases {i.e. those derivatives of alanine (200), norvaline (203), phenylalanine (205) and 
glutamic acid (236)] cyclise to give the coiTesponding 2-substituted benzimidazole 
iV-oxides directly, with loss of the ester group.
The question as to whether one or other of the previously published mechanisms is 
sufficient to explain the results of this research must now be addressed - it would be 
desirable to have a “unifying” mechanism which could account for all the types of 
cyclisation which have been observed. Whereas the simple aldol-type condensation
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mechanism (with the nitrogen of the nitro group as the electrophile) is adequate for simple 
cases, it is unlikely to account for these cyclisations of a-substituted amino acid 
derivatives, because this would require the presence of two a-hydrogens (Scheme 1.40). 
This could be modified, however, by invoking attack by base on the ester group, which 
would give the product with loss of OH“ (Scheme 2.48). When R = H, in the case of the 
glycine derivative, the ester group would be retained because the a-hydrogen is removed 
preferentially.
HO) o - IO'
R = Me, Bz, CH2CH2C02Et, 
CH2CH2CH3
Scheme 2.48
However, the amino proton of the starting material is clearly more acidic than the 
a-hydrogen, especially given the positive inductive effect of the alkyl substituent and the 
mesomeric effect of the ortho-mMo group. Intermediacy of the benzoxadiazine 
intermediate (198) and subsequent ring-opening to the o-nitrosoanil (202) is conceivable 
{cf. Scheme 2.17), followed by an electrocyclic recyclisation and loss of the ester group 
(Scheme 2.22), although again this necessitates the removal of the a-hydrogen prior to 
the more acidic amino hydrogen.
In order to avoid this apparent paradox, although the o-nitrosoanil (202) is a likely 
intermediate which then cyclises {cf. Scheme 2.22), it would seem more likely to arise 
from the ad-nitro compound (261; 2-substituted) {cf. Schemes 2.45 and 2.47) because 
the CH, being allylic, is now acidic.
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So we now have a mechanism which can account for the cyclisations of glycine and 
a-substituted amino acid derivatives to benzimidazole N-oxides, one which involves an 
aci-nitro intermediate formed by the initial removal by base of the most acidic hydrogen in 
the molecule (the amino hydrogen). This would lead to the key ^-nitrosoanil intermediate 
which then spontaneously cyclises to the observed product.
It seems that in the absence of an accessible acidic amino proton [i.e. either due to its 
absence (in the sarcosine derivatives) or to its intramolecular hydrogen bonding to a 
second ortho nitro group], the hydrogen a -  to the electron-withdrawing substituent is 
removed by base instead, being then the most acidic proton in the molecule. This leads to 
cyclisation to the proposed benzoxadiazine intermediate, then ring opening and 
recyclisation to the appropriate product, depending on the remaining substituents. As 
discussed on page 61 (Scheme 2.14), the other possibility here is that the benzimidazole 
A/-oxide is formed first, but this is known to react further with base to lead to complete 
loss of the ester functionals
If the a-substituent interacts with the amino hydrogen in such a way as to suppress its 
reactivity [for example through hydrogen bonding, as depicted for the aspartic acid 
derivative (241) (Section 2.3.10)], then cyclisation also appears to be suppressed, 
although admittedly with aspartic acid, the outcome of the reaction was not established. 
The mechanism of this suppression of cyclisation may well be the same as that proposed 
for causing diversion of the cyclisation of A-(2,6-dinitrophenyl) derivatives [i.e. 
intramolecular hydrogen bonding of the amino proton; structure (241)]. However, the 
outcome is different because there is only one a-hydrogen present, and foimation of the 
anilido ester intermediate [(189); NH for NMe) which would have led to the quinoxaline-
2,3-dione is no longer possible.
One could, however, visualise another possible cyclisation path for the aspartic acid 
derivatives, involving the formation of an a,(3-unsaturated intermediate (263) from the
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benzoxadiazine intermediate (262) (Scheme 2.49). The intermediate (263) might then 
be expected to lose the amino proton and undergo a Michael-type condensation with the 
nitroso group to form the quinoxaline (264). No such product has been observed, and 
even if (262) is formed (reversibly) from (239), it may be that the driving force of the 
stability of the aromatic quinoxaline system is not sufficient to overcome the 
intramolecular hydrogen bonding of the amino proton with the P-ester group for this 
process to occur. This would explain why no heterocyclic products were observed.
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In summary, for those cyclisations which cannot be accounted for by the aci-nitro - 
(9-nitrosoanil mechanism of Scheme 2.47, the invoking of the benzoxadiazine 
intermediate appears to be necessary. However, it is now considered unlikely that the 
benzoxadiazine mechanism is involved in the cyclisations of the glycine and other 
a-substituted amino acid derivatives because of the presence of the more acidic amino 
hydrogen in these cases.
When the side chain of the amino acid is labile to nucleophiles or bases {i.e. histidine and 
tryptophan, along with the serine and threonine derivatives of Luetzow and Vercellotti^^),
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a base-induced scission takes place, and the a-substituent is lost altogether, the ester 
group remaining in the 2-position of the benzimidazole A/-oxide product. This cleaved 
side chain was isolated as 3-methoxymethylindole (233) from the tryptophan cyclisation, 
whereas Luetzow and Vercellotti isolated the side chain in the cyclisation of DNP- 
p-phenylserine methyl ester (265) to methyl 5-nitro-l//-benzimidazole-2-carboxylate
3-oxide (108) as benzaldehyde (Scheme 2.50).
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Scheme 2.50
Presumably the serine and threonine derivatives (229) also led to loss of the side chains 
as the corresponding aldehydes, formaldehyde and acetaldehyde. Although detection of 
these was not reported, it was inferred from the cyclisation reactions of the a ,p -  
unsaturated amino acid derivatives (107) (Scheme 1.52), from which the aldehydes were 
detected, and presumed to arise from the addition of water across the double bond and 
subsequent retro-aldol cleavage.
Although the imidazole moiety could not be recovered from the histidine cyclisdtion, it 
was presumed that a similar sort of cleavage took place.
In the light of the foregoing discussion on the likely mechanisms for these cyclisations, it 
is apparent that there are several possible stages at which the labile side chain could be 
cleaved. Luetzow and Vercellotti suggest that it is cleaved initially to give the glycine
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derivative, which then cyclises. However, it is more conceivable that the reaction initially 
proceeds via the aci-nitro intermediate (due to the acidity of the amino hydrogen), 
whereafter the side chain could be cleaved at several points (two of which are depicted in 
Scheme 2.51 with the tryptophan derivative as an example).
OoN
COoMe
NO
Q -
NO
COoMe
cf. Scheme 2.18
O
Scheme 2.51
In conclusion, then, it is difficult to reconcile all the results of the various cyclisations 
under the umbrella of one unifying mechanism. It is thought that the most appropriate 
way of rationalising them is by invoking an ad-nitro intennediate [for example, (261)]
95
where there is an accessible and acidic amino nitrogen, or by invoking a benzoxadiazine 
intermediate [for example, (198)] where there is not.
This can be applied successfully to some of the cyclisations of the o-nitroarylam ines 
discussed in Chapter One. For example, the cyclisation of the acetamidine (126) 
(Scheme 1.59) could be envisaged as proceeding through the aci-nixxo intermediate 
(265a), followed by an electrocyclic re-aromatisation/cyclisation step and dehydration to 
give the product (127) (Scheme 2.52), rather than a simple methylene anion 
condensation. The nitrosoanil is not formed because of the lack of an appropriate 
removable hydrogen.
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Scheme 2.52
Similarly, the cyclisation of the nitrouracil (143) to the xanthine N-oxide (144) (Scheme 
1.67) presumably proceeds via the nitioso intermediate (146), which in turn is formed 
from the aci-nitro intermediate. This again takes account of the fact that the most acidic 
hydrogen in the molecule is clearly the amino hydrogen, and so the simple condensation 
mechanism is unlikely to be occurring.
Finally, then, as a route to 2-substituted benzimidazole N-oxides, the base-induced 
cyclisation of N-(o-nitrophenyl)am ino acid esters is particularly useful when the
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2-substituent required is non-labile, and does not interfere with the amino hydrogen of 
the starting material (for example, by intramolecular hydrogen bonding).
l i i  MentiaL IriÇYÇijç Systems
The attempted cyclisation (Scheme 2.53) of N,7V-(4,6-dinitrophenylene)bis-glycine ethyl 
ester (266)126 failed to lead to any cyclised products; unreacted starting material was all 
that was recovered. The second amino group attached to the benzene ring apparently 
deactivates the system sufficiently to prevent cyclisation from occurring.
H H
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Scheme 2.53
Other glycine derivatives with an amino group in position 5 of the benzene ring were also 
found to give largely unreacted starting material - for example, (267), where R = NH2 or 
NMe2 (Scheme 2.54). The amino derivative gives only the ester hydrolysis product, 
whereas the dimethylamino derivative gives only recovery of starting material. So 
primary, secondary and tertiary amino groups in this position all have the same negative 
effect on cyclisation. However, when the acetamido group is used instead (although with 
only one nitro group), cyclisation then proceeds to the benzimidazole iV-oxide (268) in 
67% yieldi26.
Rationalisation of this appears to be a straightforward consideration of the electrophilicity 
of the nitro group - in the cases where there is an amino (electron-donating) group in 
position para  to the nitro group, cyclisation is suppressed because of the reduced 
electrophilicity of the nitro group, whereas cyclisation succeeds with an acetamido 
(electron-withdrawing) group in the para position. With the nitro group less
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electrophilic, its condensation with the methylene anion becomes more unlikely, along 
with attack by the methylene carbanion on the oxygen of the nitro group to give the 
benzoxadiazine. This accords with the mechanism proposed in Scheme 2.47, because 
the ad-nitro intermediate would be less likely to form.
R
X ^  NOo 267
N ^ C 0 2 E t R = NH2, NMe2 
X = N02
no reaction
AcHN
R = NHAc;X = H
NIO
268
Scheme 2.54
A variety of starting materials was prepared with a view to the synthesis of tricyclic 
products, either from the “one-pot” cyclisation of two amino acid side chains on to two 
ortho nitro groups, or from the cyclisation of a monosubstituted starting material, 
subsequent reaction of another amino acid with another leaving group ortho to the second 
nitro group, and then a second cyclisation step. The 1,3-substitution pattern of the two 
amino acid residues was employed so that the disposition of the two nitro groups 
ortho!para to each of the chlorine atoms would enhance the reactivity of the chlorines 
towards the amine nucleophiles.
Firstly, l,3-dichloro-4,6-dinitrobenzene was prepared by the literature method^^^: i.e. 
nitration of w-dichlorobenzene with potassium nitrate in concentrated sulphuric acid 
(Scheme 2.55).
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Scheme 2.55
The mono-substituted N-(5-chloro-2,4-dinitrophenyl) derivatives (269) were prepared in 
the usual manner using one equivalent of the acid, and subsequent estérification. The 
acids in each case were isolated in 86-90% yield, with none of the bis-substituted 
products being formed, and the esters were cyclised to the benzimidazole N-oxide (270) 
and the l-hydroxyquinoxaline-2,3-dione (271) respectively (Scheme 2.56).
R = H 270 O"
MeNO
R = Me269
R = H, Me
271
Scheme 2.56
OH
However, attempts to gauge the reactivity of the remaining chlorine atom towards 
nucleophiles proved unsuccessful, since neither glycine nor piperidine reacted with (270) 
or (271). One attempt was made at the synthesis of 6-fluoro-l-hydroxy-4-methyl- 
7-nitroquinoxaline-2,3-dione (271; F for Cl) in order to facilitate the nucleophilic attack 
of another amino acid (fluorine being more reactive than chlorine as a leaving group in 
aromatic nucleophilic substitution). However, although the ester (269; R = Me; F for 
Cl) was successfully prepared in 60% overall yield, the quinoxalinedione could not 
prepared in sufficient purity for further reaction, although it was identified by ^H NMR
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spectroscopy. The hope was to have been able to prepare “unsymmetrical” tricyclic 
systems such as (272) by this method.
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The result of Smith et was confirmed by preparing the disubstituted glycine 
compound (266). This was carried out in 87% yield by reacting two equivalents of the 
glycine ethyl ester in dimethyl sulphoxide with sodium hydrogen carbonate with
l,3-dichloro-4,6-dinitrobenzene. Attempted cyclisation of this with ethanolic potassium 
carbonate led, as expected, only to recovery of starting material (55%) and the 
corresponding bis-acid (19%) from hydrolysis of the ester.
The disubstituted sarcosine diester (273) was similarly prepared, albeit in much lower 
yield (42%). Each attempted cyclisation of (273), however, led simply to production of 
intractable mixtures (Scheme 2.57), from which no products could be identified other 
than some starting material and the diacid thereof. It therefore would appear that 
formation of the quinoxalinedione is also inhibited by the presence of an amino group in
5-position of the starting material (although this was only attempted with another tertiary 
amino group).
It was concluded, therefore, that because no tricyclic systems could be isolated, this was 
not a viable route to such molecules. From a mechanistic point of view, the only 
rationalisation of this would appear to be the reduced electrophilicity of the nitro group, 
as already suggested previously, but otherwise, it is unconvincing as to whether this 
result is particularly informative about the mechanism.
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N . .CO^Et K9CO  ^ ►  intractable mixture
O2N ' ^  NO2 
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Scheme 2.57
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3.1 Introduction
While this research was in progress, two pieces of work appealed in the literature, both 
of which were of obvious mechanistic relevance to the work in the preceding chapter, 
and both of which also seemed to be rather difficult to account for. Firstly, an 
Argentinian group had cyclised o-nitroaniline derivatives in basic conditions to
2-substituted benzimidazole A-oxides, but significantly, the N-substituent of the
o-nitroaniline was not activated by an electron-withdrawing group^^^. This posed an 
interesting mechanistic problem, especially given the mildness of the reaction 
conditions, and that it had been found (Section 23.2) that an activating group adjacent 
to the a-carbon was required for cyclisation (Scheme 2.25). N-(2,6-Dinitrophenyl)- 
rt-butylamine (274) reacted with 0.2 M sodium hydroxide in 60% dioxan/water to give 
7-nitro-2-«-propyl-l//-benzimidazole 3-oxide (275) in almost quantitative yield 
(Scheme 3.1).
NaOH
Scheme 3.1
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The second ortho-niiro group is apparently necessary for the cyclisation to take place. 
The authors report that reaction of the /V-(2,4-dinitrophenyl) analogue under the same 
conditions (and also with 0.01 M sodium hydroxide) gives quantitative recovery of
2,4-dinitrophenol. They also report that the N-(o-nitrophenyl) analogue does not react 
at all, although a very small amount of an unidentified product was observed after 
heating under reflux for 65 hours. In the case of the picryl (2,4,6-trinitrophenyl) 
derivative, reaction with 0.2 M sodium hydroxide leads to quantitative recovery of 
picric acid, but at 0.01 M concentration, the dinitrobenzimidazole A-oxide is isolated in
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46% yield, along with 10% of picric acid. The concentration of base is therefore also 
apparently critical in determining the outcome of the reaction.
In their preliminary communication, de Vargas and Canas do not venture a mechanism 
to account for this cyclisation reaction, but they do suggest that the reason for isolation 
of the corresponding phenol in some of the reactions is due to straightforward 
nucleophilic substitution of the amino substitutent by hydroxide ion. This occurs in 
preference to cyclisation both when the base concentration is high, and when the amine 
is not sufficiently reactive for cyclisation to occur (i.e. when only one nitro group is 
present). When three nitro groups are present, the ring is activated so much towards 
nucleophilic substitution by hydroxide that the cyclisation reaction can compete with 
formation of picric acid only at low concentrations of base. However, there is no 
explanation of why the second ortho-nitro group in place of a para-nhro group should 
be critical.
Evidently the presence of the second ortho-nkro group is mechanistically significant, 
despite the fact that it remains unchanged in the final product of the reaction. This 
lends support to the hypothesis (page 67) that in the case of the cyclisation of the
2,4-dinitrophenyl norvaline derivative (203), loss of the ester group does not occur first. 
If this were the case, then no cyclisation would be expected (given the evidence above) 
to take place with the 2,4-dinitrophenyl compound.
Secondly, another group which has been working on the cyclisations of unactivated 
A-alkyl-o-nitroanilines is that of Gardiner at UMIST. They have developed a synthesis 
of 2-substituted-O-alkylated benzimidazole A-oxides (277) (for the preparation of 
potential HIV-1 inhibitors) from the tandem reactions of an o-nitroaniline with an alkyl 
halide and sodium hydride. The first step (A-alkylation) is followed by cyclisation of 
the resultant A-alkyl-o-nitroaniline (276) and then by 0 -alkylation of the ensuing 
heterocyclic A-oxide with another equivalent of the alkyl halide (Scheme 3.2)^^0,151,152
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The O-alkylation of benzimidazole A^-oxides (along with 1-hydroxyquinoxaline-
2,3-diones) will be discussed further in Chapter 4.
- I  X -  '
NOo ' NO-'2 "^*'^ 2
276
NaH ^  Y  V-RRCH^x
IO ^ R  
277
R = H,Et,Ph, vinyl
Scheme 3.2
Similarly to the cyclisation of the M-butylamine derivative (274) in Scheme 3.1, the 
cyclisation takes place even when the methylene adjacent to the amine is not 
particularly acidic (for example when R = H or ethyl), and so one must suppose that the 
mechanism is such that formation of the methylene anion (if, indeed, it is formed at all) 
is driven by the facility of the subsequent cyclisation step to give the heteroaromatic 
product.
However, Stacy et al.^ had earlier noted that reaction of N - benzy 1 -N-methy 1 -
0-nitroaniline with sodium hydride did not lead to 3-methyl-2-phenylbenzimidazole
1-oxide as desired or expected, and in fact in a variety of basic media (such as sodium 
hydroxide-methanol, sodium ethoxide-ethanol, and sodium hydroxide-dioxan-water) no 
reaction was observed. This could possibly be attributed to the presence of the tertiary, 
as opposed to secondary, nitrogen, since it has been found that various N-methylated
o-nitroanilines fail to react with bases under conditions where their secondary 
counterparts have undergone cyclisation (for example, Schemes 2.2 and 2.8 and Section 
2.3.4).
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Preparation of 2,6-dinitroanilines was undertaken by reaction of the appropriate amine 
nucleophile with ch loro-2,6-dinitrobenzene. This itse lf was prepared from 
2,6-dinitroaniline by the method of Gunstone and Tucker^^^ (Scheme 3.3): the aniline 
was diazotised with sodium nitrite in concentrated sulphuric acid and the resultant 
diazonium salt (278) then reacted in situ with cuprous chloride in concentrated 
hydrochloric acid to give the product in 80% yield.
NO NO
NaNO-
HoSO. NO
278
NO
CuCl
HCl
Scheme 3.3
Because the communication of de Vargas and Canas^^^ contained no experimental 
details, the reaction of V-(2,6-dinitrophenyl)-«-butylamine (274) (which was prepared 
in 70% yield by heating the amine with chIoro-2 ,6-dinitrobenzene in 
VJV-dimethylformamide) with sodium hydroxide in dioxan/water was repeated and 
their result [i.e. almost quantitative isolation of 7-nitro-2-i?-propyl-benzimidazole
3-oxide (275)] confirmed by and l^C NMR spectroscopy.
The y-aminobutyric acid analogue (279) was prepared and cyclisation attempted under 
the same conditions as those of de Vargas and Canas. Although no products could be 
isolated from the reaction mixture, iH NMR spectroscopy of the acetone extract did 
indicate that cyclisation had probably occurred, the most likely heterocyclic product 
being the 2-substituted benzimidazole V-oxide. This conclusion was reached because 
the three resonances in the iH NMR spectrum corresponding to the CH2CH2CH2
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moiety of the starting material (a triplet, a quartet and a quintet) had collapsed to two 
triplets at Ô = 2.92 and 3.25, the integrals of each resonance corresponding to two 
hydrogens, indicating a CH2CH2 moiety. The aromatic substitution pattern was also no 
longer symmetrical (as in the starting material), although the peaks corresponding to the 
cyclised product could not be distinguished from those of the various impurities present.
CO2H
9
NO
NO
279
NO
NaOH
In order to see whether any deviation from the reaction course would occur, the 
similarly prepared N-methyl analogue (280) was also reacted under the same conditions, 
but this time no reaction took place - the starting material was recovered quantitatively 
after heating under reflux for 2 hours (Scheme 3.4). Reaction of (280) with ethanolic 
potassium carbonate also resulted in quantitative recovery of starting material, even 
after heating the reaction mixture under reflux for 18 hours. Presumably the presence 
of the N-methyl group is responsible for blocking the cyclisation reaction, which 
implies that the NH is involved somehow in the mechanism.
Me base ^  no reaction
Scheme 3.4
In considering a plausible mechanistic explanation for these results, it is useful now to 
reconsider the cyclisations of A^-(2,6-dinitrophenyl)amino acid esters. The cyclisation 
of the glycine ester derivative (192) to l-hydroxy-5-nitroquinoxaIine-2,3-dione (194) 
has already been discussed (Section 2.2; Scheme 2.13). However, this reaction was
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initially o b se rv ed ^ to  give only a very low yield (8%) of the heterocycle along with a 
small amount of 2,2'-diamino-3,3'-dinitroazoxybenzene (281) (which was identified by 
mass spectrometry), with no other products being i s o l a t e d a n d  so it was thought that 
perhaps some other products had been missed in the course of working up the reaction. 
The cyclisation was therefore repeated, but it was found that increasing the reaction 
time (stirring at room temperature for 20 hours instead of 2.5 hours) merely increased 
the yield of l-hydroxy-5-nitroquinoxaline-2,3-dione to 37%, and again, no additional 
products were identified.
. NHn NO2
^N
N02 - 0  J w
281
One possible rationalisation of the formation of the quinoxalinedione instead of the 
benzimidazole N-oxide could be the intramolecular hydrogen bonding of one of the 
ortho-niiro groups to the NH of the glycine residue. If the 2,1,4-benzoxadiazine (282) 
is an intermediate in the reaction (as proposed in Section 2.4), then because the NH is 
hydrogen bonded to the second ortho-niiro group, removal of the second a-hydrogen by 
the base would occur in preference to removal of the amino hydrogen (Scheme 3.5). 
The anilido ester intermediate (283) thus formed [instead of the o-nitrosoanil (284), 
which would have led to the benzimidazole A^-oxide], would then lead (by 
intramolecular nucleophilic attack of the hydroxylamine on the ester carbonyl) to
l-hydroxy-5-nitroquinoxaline-2,3-dione (194).
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COoEt
NO
GEt
283
NO
COnEt
NO
284
Scheme 3.5
The sarcosine analogue (285) is cyclised to a mixture of products^^^ (Scheme 3.6), the 
major product being l-hydroxy-4-methyl-5-nitroquinoxaline-2,3-dione (286) (19%), 
along with some (presumably small amounts) l-methyl-7-nitrobenzimidazol-2-one 
(287) and 8-niti’oquinoxalin-2-one (288) in unspecified yields.
NOo Me■ ^  IN . _ 0
N " O  
286 OH
+
COoEt
NO
285
KoCO. NO2 Me
+
288
Scheme 3.6
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N-(2,6-Dinitrophenyl)alanine ethyl ester (289) was prepared and cyclisation attempted, 
but each attempt at this reaction resulted merely in intractable mixtures from which no 
products could be identified (Scheme 3.7), so no parallels w ith the 
N-(2,4-dinitiophenyl)alanine ester (200b) cyclisation could be drawn. Having said that, 
perhaps intramolecular hydrogen bonding of the NH to the second ortho-nixxo group in 
an identical fashion to that shown in Scheme 3.5 with the reaction of the 
N-(2,6-dinitrophenyl)glycine ester could prevent formation of the o-nitrosoanil (284) 
expected (cf. Scheme 2.21 on page 67) so that no cyclisation could take place as the 
second a-hydrogen is no longer present to allow formation of the alternative anilido 
ester intermediate (283).
H MeN ^ C O j E t
NO2
289
base ^-------------------inti'actable mixture
Scheme 3.7
Given the failure of this cyclisation, it is useful to note that the synthesis of 2-alkyi-
5-nitrobenzimidazole 3-oxides [for example, (201), (204) and (206)] reported in 
Chapter 2 is complemented by the method of de Vargas and Canas for the preparation 
of 2-alkyl-7-nitrobenzimidazole 3-oxides [for example, (275)], which seem to be 
inaccessible from the cyclisation of N-(2 ,6-dinitrophenyl)-a-substituted amino acid 
esters.
The cyclisation of V-(2,6-dinitrophenyl)norvaline methyl ester (290) was attempted in 
order to gauge whether the longer alkyl chain would have an effect on the cyclisation. 
However, no products could be identified from the reaction, although the ^H NMR 
spectrum of one residue (isolated in very small yield) indicates that cyclisation of some 
sort has occurred because the aromatic resonances indicate an unsymmetrically
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substituted benzene ring, and the alkyl CH resonance of the starting material has also 
disappeared.
Me
NO
Some possible reasons for the course of the glycine reaction were discussed on pages 
59-60. It seems appropriate at this stage to expand on the argument in order to attempt 
to understand the results of the cyclisation of the non-activated anilines with a second 
ortho-mXïo group.
Let it be supposed that the cyclisation of A/-(2,6-dinitrophenyl)-«-butylamine (274) 
occurs initially in the same manner as the corresponding glycine derivative. The same 
hydrogen-bonded benzoxadiazine intermediate (291) could be envisaged, where 
abstraction of the amino proton to give the o-nitrosoanil (292) is inhibited; the second 
a-hydrogen is then removed and the anilide (293) is formed. Condensation between the 
hydroxylamine and the anilide carbonyl would then follow and lead to the observed 
benzimidazole N-oxide (275) (Scheme 3.8).
However, given that in the absence of the hydrogen bonding provided by the second 
ortho-mtro group the o-nitrosoanil [(292); 4-nitro for 6-nitro] is likely to be formed 
instead, this fails to explain sufficiently the observed results because the o-nitrosoanil 
[derived from N-(2,4-dinitrophenyl)-/i-butylamine] could also be expected to cyclise to 
the benzimidazole N-oxide, for example by an electiocyclic process {cf. Scheme 2.18 on 
p. 64).
I l l
Os . 0 %
291 OH274 Q-
o>. , 0 %"N1 H16' A i fNH
293 OH
NO
Me
O'
275
292
Scheme 3.8
Going one step further back in the postulated mechanism, it is possible that the 
benzoxadiazine intermediate itself does not form unless the second ortho-nitro group is 
present. It could be supposed that the intramolecular hydrogen bonding holds the 
molecule (of the starting material) in such a configuration (294) that the a-carbon is in 
close proximity to the one of the oxygens of the “first” onho-nitro group {i.e. the one 
which will become integrated into the heterocycle). The activation energy for the 
hydrogen abstraction/cyclisation process would presumably therefore not be as high, 
and the extra activation which would be provided by an electron-withdrawing group 
such as an ester or nitrile may not be required. Cyclisation to the benzoxadiazine 
therefore occurs, whereas in the non-activated and non-hydrogen bonded case, the 
activation energy for the initial cyclisation is too high. No cyclised products are
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therefore observed without the second ortho-m\xo group. Once the benzoxadiazine 
intermediate is formed, it would seem unlikely that the o-nitrosoanil would form 
(Scheme 3.8), because of the hydrogen bonding hindering the amino hydrogen 
abstraction. Instead the hydroxylaminoanilide (293) would lead, by condensation 
between the hydroxylamine and carbonyl groups, to the observed benzimidazole 
A/-oxide.
294
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In summary, then, there is a balance between the relative acidities of the amino 
hydrogen and the a-hydrogen, the outcome of which determines the course of reaction 
with base. This balance in turn seems to depend on such factors as intramolecular 
hydrogen bonding, the presence or absence of electron-withdrawing groups, and the 
spatial relationship between the a-carbon and the onho-mivo group. If the amino 
hydrogen is in some way hindered (or indeed absent, as in the case of sarcosine 
derivatives), then formation of the o-nitrosoanil intermediate (284) or (292) [by way of 
an flc/-nitro intermediate such as (261)] is prevented. Formation of the benzimidazole 
N-oxide may also then be prevented, depending on whether or not an ester group is 
present p- to the amine. Presence of the ester group leads to formation of the 
quinoxaline-2,3-dione; absence of a leaving group such as ester [for example, in the 
/2-butylamine derivative (274)] leads to formation of the benzimidazole N-oxide.
This could also apply to the reaction of the (N-methylamino)acetonitrile (184) to give 
the benzimidazolone (185) (Scheme 2.10). The benzoxadiazine intermediate (295) can
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again be envisaged, which then ring opens to give the anilido nitrile (296). 
Intramolecular nucleophilic attack of the hydroxylamine on the carbonyl, with cyanide 
as a leaving group, would result directly in the observed benzimidazolone (Scheme 3.9).
Me
184 CN
295 OH
Me o Me
IN
O2N NHOH O2N N
296 185
Scheme 3.9
In conclusion, the combination of mechanisms proposed in Section 2.4 to rationalise the 
cyclisations of a-amino acid derivatives also seems able to account for the cyclisations 
of the non-activated o-nitroanilines described in this chapter. The different products 
arising from the cyclisations of the A/-(2,6-dinitrophenyl) derivatives of glycine ethyl 
ester (192) and w-butylamine (274) [i.e. the quinoxalinedione (194) and the 
benzimidazole N-oxide (275)] can also be rationalised in this manner.
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The potential for derivatives of benzimidazole N-oxides and 1-hydroxyquinoxaline-
2,3-diones to be biologically active is considerable. Firstly, (9-alkylated benzimidazole 
A^-oxides are acyclic analogues of nucleosides and as such are potential antiviral 
compounds.
Purine nucleoside analogues [i.e. analogues of adenosine (297) and guanosine (298)] 
such as a c y c l o v i r i 5 5  (299) and f a m c ic lo v i r ^ (300) are well known. Acyclovir 
(marketed by Glaxo-Wellcome under the brand name Zovirax) is used for the treatment 
of cold sores (caused by the herpes simplex virus, HSV), and also successfully treats 
chickenpox and shingles (which are caused by the varicellazoster virus, VZV). The 
antiviral action of acyclic nucleoside analogues like acyclovir involves incorporation of 
the drug into the growing nucleic acid chain of the virus. This causes termination of 
chain growth because of the lack of a complete sugar moiety, (chain extension normally 
occurs from the 3'-oxygen of the ribose sugar ring) and the virus is thus unable to 
replicate. Famciclovir is oxidised and deacetylated in vivo to the active form of the 
drug, which then acts in the same manner as acyclovir. 9-Alkoxypurines {i.e. with,the 
oxygen of the acyclic moiety attached directly to the nitrogen) have been prepared and 
demonstrated to be potent inhibitors of HSV-1, HSV-2 and VZV. For example, 9-(2- 
hydroxy)ethoxyguanine (301) is more potent than a c y c l o v i r ^ ^ ?
HO
HN
HO
HO OH
298
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A benzimidazole nucleoside which has been prepared and biologically tested by 
Townsend etal.^ viz. 2,5,6-trichloro-l-(p-D-ribofuranosyl)benzimidazoIe (TCRB) (302) 
has been discovered to have pronounced antiviral properties. For example, TCRB 
displays potent and selective activity against human cytomegalovirus (HCMV)^^^, a 
virus which is particularly dangerous for immunocompromised patients, such as those 
with AIDS or who are undergoing chemotherapy or radiotherapy. Previously 
mentioned^^®d5i,i52 (Section 3.1) are 2-substituted 1-alkoxybenzimidazoles (277) 
which are modest inhibitors of HIV reverse transcriptase. These results indicate that the 
pyrimidine ring of the heterocycle is not essential for biological activity, and the 
simpler benzimidazole-derived analogues are therefore viable synthetic targets.
Cl
Cl
N
a
N
HO
HO OH 
302
117
Secondly, many derivatives of quinoxaline-2,3-diones are biologically active 
compounds. Several are involved in antagonistic interactions with neurotransmitter 
receptors in the central nervous system (CNS), and as such are of interest for the 
combatting of diseases of the CNS such as Huntingdon’s, Parkinson’s and Alzheimer’s 
(for example, compound 13, Section 1.2). Other biologically active compounds include
6-ch Ioro-l-(2-hydroxyethyl)quinoxaline-2,3-dione (303) which is useful as a 
t r a n q u i l l i s e r ! 59^  6-nitro-l-/?-tolylquinoxaline-2,3-dione (304) which demonstrates 
insecticidal p r o p e r t i e s ! 60^  and 6,7-dinitroquinoxaline-2,3-dione (305) which also 
displays excitatory amino acid pharmacology! ’^! ’!^ .^ The 6,7-disubstituted 
5-nitroquinoxaline-2,3-diones (306) are efficacious in treating or preventing neuronal 
loss associated with (for example) stroke, ischaemia and hypoglycaemia, as well as the 
neurodegenerative diseases mentioned above and Down’s S y n d r o m e ! Other simple 
quinoxaline derivatives are variously active as antibacterials, fungicides and anti­
inflammatory drugs!^ , and 6,7-dimethyl-l-ribitylquinoxaline-2,3-dione has been 
shown to be a bacterial degradation product of riboflavin!^^ [vitamin B2; (307)].
N ^ O
O2N" "N'^^O O2NA ,
HO ^  H
304
306
R = haloalkyl, alkyl, alkoxy, HO OH
CN, halogen
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Quinoxalinedione derivatives have also been prepared as potential antiviral compounds, 
for example 1 -(2-acetyl)ethoxymethyIquinoxaline-2,3-dione (308), although these were 
found to be inactive against HSV-1, HSV-2, vaccinia virus and vesicular stomatitis
virus166
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The biological targets of this project were benzimidazole and quinoxaline-2,3-dione 
analogues of acyclic nucleosides such as acyclovir. It should be noted that acyclovir 
and most of the other biologically active compounds shown above are not /V-alkoxy 
heterocycles, but iV-alkoxy methyl heterocycles. In view of the proven antiviral activity 
of compounds (301) and TCRB (302), it was decided to (9-alkylate the benzimidazole 
N-oxides and l-hydroxyquinoxaline-2,3-diones {and pyrido[2,3-ib]pyrazines (191), 
prepared by the cyclisation of the pyridyl sarcosine ester (190); Scheme 4.1i3i} 
obtained from the cyclisation reactions of o-nitroanilines described in Chapter 2.
Me Me
N. / N .  .COoEt . 0^  K2CO3 ^ i
NO2 N O
190 191 OH
Scheme 4 .1
It might be supposed that in heterocycles such as benzimidazole /V-oxides and
l-hydroxyquinoxaline-2,3-diones, there are other potentially nucleophilic atoms other 
than the oxygen of the N-oxide moiety. However, it was found that alkylation occurred
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exclusively on the oxygen. This was carried out by heating the N-oxide dissolved in 
iV,A^-dimethylformamide with an alkyl halide and one equivalent of triethylamine. 
Isolation of the products (311) to (318) was generally carried out simply by dilution of 
the cooled reaction mixture with water and filtration of the resultant buff-coloured 
product. Yields were variable, but generally in the region of 40-70%.
Each heterocyclic N-oxide was first reacted with ethyl iodide as a simple model 
reaction, then the 3-hydroxypropyl derivatives were prepared as analogues of acyclovir.
3-Bromopropan-l-ol was acquired commercially, and was converted to 3-iodopropan-
l-ol in order to provide a more electrophilic reagent. The transformation was 
accomplished by heating 3-bromopropan-l-ol with sodium iodide in ace to n e^so d iu m  
bromide, being insoluble in acetone, precipitates out of the reaction mixture and drives 
the equilibrium of the displacement reaction towards the iodoalcohol.
This route towards acyclic nucleoside analogues is particularly useful, since the 
alkylation occurs with a variety of nitrogen heterocyclic N-oxides, and also 
accommodates a variety of side chains (some more of which were prepared by 
Ritchie^^^. Biological evaluation of the nucleoside analogues prepared here is still 
awaited. Assays will be undertaken initially to establish activity against HSV-1 and -2, 
and HCMV.
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5.1  Preamble
Melting points were determined on an Electi'othennal 9100 apparatus and are uncorrected; 
NMR spectra were carried out either on a Varian Gemini 200 spectrometer (iH  at 
200 MHz; at 50.31 MHz) or a Varian Gemini 300 spectrometer (^H at 300 MHz;
at 75.4 MHz) in DMSG-dg (6 values are quoted relative to DMSO at Ô = 2.49 ppm) 
unless otherwise stated (in CDCI3, Ô values are quoted relative to tetramethylsilane as an 
internal standard at Ô = 0 ppm). Mass spectra were carried out either on a VG 70-250 SE 
or a Kratos MS-50 spectrometer, and were generated under electron impact.
“Ether” refers to diethyl ether, “petrol” refers to petroleum ether of boiling point 40-60 “C 
and “HCl” refers to concentrated hydrochloric acid of specific gravity 1.18. “Dry HCl” 
refers to hydrogen chloride gas, generated as required by dropping concentrated 
hydrochloric acid into concentrated sulphuric acid, and drying the gas over glass beads 
coated in concentrated sulphuric acid. “Tic” refers to thin layer chromatography, carried 
out on silica gel coated plates.
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V -(2 -N itr o p h e n y l) - (R S )-a Ia n in e  ethyl ester (200a). A solution of 
(7?5)-alanine (5.34 g, 60 mmol) in water (80 cm^) with sodium hydiogen carbonate 
(15.12 g, 180 mmol) was added to a stirred solution of fluoro-2-nitrobenzene (7.05 g,
50 mmol) in ethanol (150 cm^) at room temperature. The mixture was heated under 
reflux for 5 h, concentrated to dryness under reduced pressure, then partitioned between 
water and ether. The aqueous layer was acidified with HCl, and the bright yellow 
crystals of V-(2-nitrophenyl)-(/?5)-alanine filtered off (6.41 g, 61%); m.p. 144-5 ”C 
(lit.122 144 »C). ÔH 1.49 (3H, d, CH3), 4.49 (IH, quintet, CH), 6.75 (IH, t, 4-H), 
7.02 (IH, d, 6-H), 7.58 (IH, t, 5-H), 8.12 (IH, dd, 3-H), 8.37 (IH, d, NH). /cHCHs 
= 7 c h n h  ^'5, 73 4 — 7^ 4 5 = 75 6 10, 73 5 = 74 5 2 Hz. m/z 210 (M+-, 43%), 165 (100),
149 (15), 118 (35), 104 (20), 91 (34), 77 (24), etc.
A solution of A-(2-nitrophenyl)-(/?5)-alanine (6.36 g, 30.3 mmol) in ethanol 
(100 cm3) containing dry HCl (3.5 g) was heated under reflux for 5 h. The solution was 
cooled to room temperature, but no precipitation occurred, so the solution was 
concentrated under reduced pressure to 50 cm^ and poured into vigorously stirred 
ice/water (100 cm^). The water/ethanol was removed under reduced pressure and the 
residue partitioned between water and ether. The ether layer was dried over MgS04  and 
concentrated under reduced pressure to give an orange oil (6.5 g, 90%); b.p.
166 "C/0.1 mmHg. (Found: C, 55.4; H, 6.3; N, 11.75. C 11H 14N2O4 requires C, 
55.5; H, 5.9; N, 11.8%.) 6^  (CDCI3) 1.30 (3H, t, CH2C/73), 1.62 (3H, d, CHC//3),
4.25 (2H, q, C % ), 4.29 (IH, quintet, CH), 6.68-6.72 (2H, m, 4- and 6-H), 7.44 (IH, 
t, 5-H), 8.20 (IH , dd, 3-H), 8.32 (IH, d, NH). 7ch2CH3 7.5, 7chcH 3 7, 73^4 10,
73,5 2.5, 74^5 7.5 Hz. ÔC 14.1 (CH2CH3), 18.5 (CHCH3), 51.4 (CH), 61.7 (CH2),
113.9 (C-6), 116.2 (C-4), 127.1 (C-3), 132.8 (C-2), 136.3 (C-5), 144.0 (C-1), 172.8 
(CO).
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2 -M e th y ï- l^ r-b en z im id azo le  3-ox ide (201a). Potassium carbonate 
(1.94 g, 14 mmol) was added to a stirred solution of V-(2-nitrophenyl)-(/?5')-alanine 
ethyl ester (2.38 g, 10 mmol) in ethanol (50 cm^) and the mixture heated under reflux for 
6 h. After cooling to room temperature, the reaction mixture was filtered, the filtrate was 
concentrated under reduced pressure to dryness, the residue taken up in water and 
acidified (HCl). The pale yellow product was filtered off (0.37 g, 25%); m.p. 
236-240 "C (lit.22 238 "C). ôy 2.50 (3H, s, CHg), 7.11-7.26 (2H, m, 5- and 6-H),
7.40-7.54 (2H, m, 4- and 7-H). 6c  12.2 (CH3), 108.6 (C-4), 118.9 (C-7), 121.4
(C-6), 122.0 (C-5), 132.4 (C-3a), 137.9 (C-7a), 148.2 (C-2).
A -(2 ,4 -D in itropheny I)-(/f5 )-a lan ine  ethyl ester (200b). A solution of 
(^5)-alanine (5.34 g, 60 mmol) in water (80 cm^) containing sodium hydrogen carbonate 
(15.12 g, 180 mmol) was added to a stirred solution of choro-2,4-dinitrobenzene 
(10.12 g, 50 mmol) in ethanol (170 cm3) at room temperature. The mixture was heated 
under reflux for 6 h, concentrated under reduced pressure to dryness, the residue 
dissolved in water and extracted with ether. The aqueous layer was acidified (HCl), and 
the resultant oil was crystallised by stirring for 1 h. A-(2,4-Dinitrophenyl)-(7?5)-alanine 
was recrystallised from propan-2-ol/water to give 11.40 g (89%), m.p. 176-7 "C 
( l i t . 1 6 9 , 1 7 0  i7 g ° c  and 180 “C respectively), ôy 1.53 (3H, d, CH3), 4.69 (IH, 
quintet, CH), 7.21 (IH, d, 6-H), 8.30 (IH, dd, 5-H), 8.88 (IH, d, 3-H), 8.99 (IH, d,
NH)' 7cHCH3 7.5, 10, ^3 5 3 Hz. 6c  18.0 (CH3), 51.1 (C-CH3), 115.9 (C-6),
116.0 (C-5), 123.8 (C-2), 130.4 (C-3), 135.7 (C-4), 147.1 (C-1), 173.4 (CO).
A solution of iV-(2,4-dinitrophenyl)-(/?5)-alanine (4.07 g, 16 mmol) in ethanol 
(60 cm^) containing dry HCl (1.5 g) was heated under reflux for 5.5 h. The solution 
was cooled to room temperature and the yellow ester filtered off and recrystallised twice 
from ethanol, giving 3.73 g (82%) of yellow crystals; m.p. 105 °C (lit. 135 60 "C). 6y 
(CDCI3) 1.25 (3H, t, CH2C //3), 1.56 (3H, d, CHC//3), 4.24 (2H, q, CH2), 4.82 (IH, 
quintet, CH), 7.23 (IH, d, 6-H), 8.31 (IH, dd, 5-H), 8.90 (IH, d, 3-H), 8.93 (IH, s, 
NH). 7cHzCH3 7.5, 7cHCH3 7.5, 73,5 2.5, 7^,6 10 Hz. 6c  14.3 (CH2C H 3), 17.9
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(CHCHg), 51.2 (CH), 61.9 (CH2), 116.0 (C-6), 123.8 (C-5), 130.4 (C-2), 130.5 
(C-3), 135.9 (C-4), 147.1 (C-1), 171.8 (CO).
2 -M e th y I -5 -n i tro - lH -b e n z im id a z o le  3-oxide (201b). P o ta s s iu m  
carbonate (1.10 g, 8 mmol) was added to a suspension of A-(2,4-dinitrophenyl)- 
(/?5)-alanine ethyl ester (1.42 g, 5 mmol) in ethanol (50 cm^), and the mixture stined at 
room temperature overnight. Mostly starting material remained (by tic), so the reaction 
mixture was heated under reflux for 5 h, then filtered. The filtrate was concentiated 
under reduced pressure to dryness, partitioned between water and ethyl acetate, and the 
aqueous layer acidified (HCl) to furnish 2-methyl-5-niti'o-l//-benzimidazole 3-oxide 
(0.32 g; 33%); m.p. 277-9 "C (dec.; from ethanol) (lit.H6 290-4 "C). 6y 2.60 (3H, s, 
CH3), 7.74 (IH, d, 7-H), 8.10 (IH, dd, 6-H), 8.31 (IH, d, 4-H). 9, g 2 Hz.
8c  12.5 (CH3), 105.4 (C-4), 117.5 (C-7), 119.1 (C-6), 131.5 (C-3a), 142.2 (C-5),
142.6 (C-7a), 154.1 (C-2). m/z 193 (M+-, 100%), 177 (42), 147 (17), 131 (20) etc.
Reaction of V -(2 ,4 -d in itro p h en y I)-(/?5 )-a lan in e  ethyl ester (200b) 
with triethylam ine. /V-(2,4-Dinitrophenyl)-(/?5)-alanine ethyl ester (2.83 g, 
10 mmol) and triethylamine (1.1 g, 11 mmol) in ethanol (50 cm^) were heated under 
reflux for 7 h. The mixture was cooled to room temperature, and the yellow precipitate 
filtered off (1.67 g, 59% of starting material; confirmed by m.p., ^H NMR spectroscopy 
and tic). The mother liquor was concentrated under reduced pressure and the residue 
partitioned between water and ether. The ether layer afforded 0.24 g of a yellow solid; 
m.p. 107-108 "C, also identified as starting material. The aqueous layer was acidified 
(HCl), but no precipitation occurred, and no residue remained after removing the water 
under reduced pressure.
A -(2 ,4 -D in itro p h en y l)-(i?5 )-n o rv a lin e  ethyl ester (203). A solution 
of chloro-2,4-dinitrobenzene (4.66 g, 23 mmol) and (/?5)-norvaline (2.93 g, 25 mmol) 
in ethanol (80 cm^) had added to it a solution of sodium hydrogen carbonate (6.30 g,
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75 mmol) in water (40 cm^) and the mixture heated under reflux for 10 h, concentrated 
under reduced pressure to dryness and taken up as much as possible in water. The 
water-insoluble yellow solid was filtered off and dried in vacuo to give 3.66 g (56%) of 
V-(2,4-dinitrophenyl)-(/?5)-norvaline. 6y  0.80 (3H, t, CH3), 1.25 (2H, C //2CH3),
1.75 (2H, m, CHCH2I  3.97 (IH, q, CH), 7.07 (IH, d, 6-H), 8.17 (IH , dd, 5-H), 
8.86 (IH, d, 3-H), 9.78 (IH, d, NH). /cHzCHs 7, 7chcH 2 5, 7nHCH 6 , 7 5 6
73,5 3 Hz. ÔC 14.2 (CH3), 17.7 (CH2CH3), 33.7 (CHCH2), 57.4 (CH), 116.1 (C-5),
124.1 (C-3), 129.3 (C-6), 130.0 (C-2), 134.0 (C-4), 146.7 (C-1), 172.1 (CO).
7/-(2,4-Diniti'ophenyl)-(/?5)-norvaline (2.26 g, 8 mmol) in ethanol (40 cm^) had 
dry HCl bubbled through it for 40 min. The mixture was heated under reflux for 6 h, 
cooled to room temperature, filtered, and the filtrate concentrated under reduced pressure 
to dryness. The oil was triturated with petrol and the yellow ester filtered off and 
recrystallised from ethanol/water (stiiring was needed to crystallise the oil). Yield 1.73 g 
(69%); m.p. 58-59 "C. 6y  (CDCI3) 1.00 (3H, t,CH2CH2C //3), 1.31 (3H, t, ester 
CH 3), 1.49 (2H, sextet, CH2C //2CH 3), 1.99 (2H, m, CH C//2), 4.27 (2H, q, ester 
CH2), 4.32 (IH, q, CH), 6.81 (IH, d, 6-H), 8.28 (IH, dd, 5-H), 8.89 (IH, d, NH), 
9.18 (IH, d, 3-H). 7c h 2CH3 7, 7 ch n h  6 , 73 5 3,7$ g 9 Hz. Ôq 13.5 (ester CH3), 14.0 
(CH2CH2CH3), 18.5 (CH2CH2CH3), 34.2 (CHCH2), 56.0 (CH), 62.1 (ester CH2),
114.0 (C-5), 124.3 (C-3), 130.4 (C-6), 131.1 (C-2), 136.7 (C-4), 147.4 (C-1), 171.0 
(CO). The ester was cyclised without further purification.
2 -P ro p y l-5 -n itro -lff-b en z im id azo le  3-oxide (204). A suspension of 
A/-(2,4-dinitrophenyl)-(/?5')-norvaline ethyl ester (0.62 g, 2 mmol) and potassium 
carbonate (0.35 g, 2.5 mmol) in dry ethanol (20 cm^) was stirred at room temperature for 
2 h, then heated under reflux for 2.5 h, filtered, and the filtrate concentrated under 
reduced pressure to dryness. The residue was dissolved in water, extracted with ethyl 
acetate, and the aqueous phase acidified (HCl). The acidic solution was extracted into 
ethyl acetate, dried (MgSO^) and concentrated under reduced pressure to a pale buff- 
coloured solid (0.15 g, 34%); m.p. 161-162 "C. ôy 0.97 (3H, t, CH3), 1.83 (2H, sex.
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C //2CH3), 2.89 (2H, t, CCH2), 7.73 (IH, d, 7-H), 8.06 (IH, dd, 6-H), 8.29 (IH, d,
4-H). 7cmCH3 = ./CH2CH2 = 7, 76,7 9, 74,6 2 Hz. 6c  13.7 (CH3), 19.8 (CH2CH3),
27.4 (CCH3), 105.3 (C-4), 117.3 (C-7), 119.2 (C-6), 131.5 (C-3a), 142.3 (C-5), 142.6 
(C-7a), 157.0 (C-2). Attempts at further purification for microanalysis were 
unsuccessful.
V -(2 ,4 -D in itrop h en yI)-(S )-p h en y laIan in e  ethyl ester (205). A
warmed solution of (5)-phenylalanine (3.63 g, 22 mmol) and sodium hydrogen 
carbonate (5.04 g, 60 mmol) in water (60 cm^) was added to a stined solution of fluoro-
2,4-dinitrobenzene (3.72 g, 20 mmol) in ethanol (80 cm^) and the mixture heated under 
reflux for 5 h. The reaction mixture was concentrated under reduced pressure to diyness, 
partitioned between water and ether, and the aqueous layer acidified (HCl). The resultant 
oil was extiacted into ether, dried (MgS0 4 ) ^nd concentrated under reduced pressure to 
yield 5.79 g (87%) of N -(2,4-dinitrophenyl)-(5)-phenylalanine; m.p. 50-2 "C 
( l i t . 186 "C) [this discrepancy was overlooked, given the consistency of the NMR 
data, and the correct analysis for the ester (205) below]. 6y 3.26 (IH, dd, CH2^), 3.45 
(IH, dd, CH2^), 4.62 (IH, dt, NCH), 6.70 (IH, d, 6-H), 12 -1 A  (5H, m, Ph-H), 8.19 
(IH , dd, 5-H), 8.89 (IH , d, NH), 9.12 (IH , d, 3-H). 7ch2  14, 7cHCH2= 7.5, 
'7cHCH2' 5 , 73,6 2 , 75,6 9H z. 6c  38.3 (CH2), 57.1 (CH), 113.9 (C-6), 124.1 (C-3),
127.9 (C-4’), 129.1 and 129.2 (C-2’ and -6 '; and C-3' and -5'), 130.2 (C-5), 131.1 
(C-P), 134.4 (C-2), 136.8 (C-4), 147.0 (C-1), 174.7 (CO).
A solution of A-(2,4-dinitrophenyl)-(5)-phenylalanine (3.97 g, 12 mmol) in 
ethanol (50 cm^) containing dry HCl (6 g) was heated under reflux for 7 h. The solution 
was cooled to room temperature and the yellow crystals filtered off; 3.71 g (86%); m.p. 
115 “C (from ethanol) [lit.^^^ 105-7 "C (from benzene)]. (Found: C, 56.8; H, 5.0; N,
11.7. C 17H 17N3O6 requires C, 56.8; H, 4.8; N, 11.7%.) 6y  (CDCI3) 1.24 (3H, t, 
CH3), 3.21 (IH, dd, CHC//2^), 3.35 (IH, dd, CHC/fg^), 4.25 (2H, q, C //2CH3), 4.57 
(IH , dt, CH), 6.69 (IH , d, 6-H), 7.2-7.S (5H, m, Ph-H), 8.18 (IH, dd, 5-H), 8.90 
(IH, d, NH), 9.10 (IH, d, 3-H). 7ch2CH3 7, 7ch2 14, 7chcH 2 ' 7.5, 7chcH2'' 5,
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75,6 10, 73,5 3 Hz. Ôc 14.0 (CH3), 38.5 (CHCH2), 57.5 (CH), 62.3 (CH2C H 3),
114.0 (C-6), 124.2 (C-3), 127.8 (C-4'), 129.1 and 129.3 (C-2 ,6 ' and C-3',5'), 130.2 
(C-5), 131.1 (C-1'). 134.8 (C-2), 136.8 (C-4), 147.2 (C-1), 170.2 (CO).
2 -B e n z y l-5 -n itrO “ l£ r-benziin ldazo Ie  3-oxide (206). A mixture of 
V-(2,4-dinitrophenyl)-(5)-phenylaianine ethyl ester (0.72 g, 2 mmol) and potassium 
caî'bonate (0.30 g, 2.2 mmol) in dry ethanol (25 cm3) was stirred at room temperature for 
19 h, then under reflux for 1.5 h. The mixture was cooled to room temperature, filtered, 
and the filtrate concentrated under reduced pressure to dryness. The residue was 
partitioned between water and ethyl acetate and the aqueous layer acidified (HCl), 
extracted with ethyl acetate and the organic layer dried (MgSO^) and concentrated under 
reduced pressure to give 0.27 g (50%) of product; m.p. 240-243 °C. ôy 4.30 (2H, s, 
CH2), 7.Z-7.4 (5H, m, Ph-H), 7.73 (IH , d, 7-H), 8.05 (IH, dd, 6-H), 8.28 (IH, d,
4-H), 12.43 (IH, br s, NH). ^H NMR data are consistent with the proposed structure; 
however, attempts at further purification of the title compound were unsuccessful and a 
fuller characterisation was not achieved.
V -(2-N itrophenyl)-P-alanine ethyl ester (207a). A solution of p-alanine 
(2.23 g, 25 mmol) and sodium hydrogen carbonate (3.86 g, 46 mmol) in water (40 cm3) 
was added to a stirred solution of fluoro-2-nitrobenzene (2.82 g, 20 mmol) in ethanol 
(80 cm3) at room temperature. The reaction mixture was heated under reflux for 5.5 h, 
then concentrated under reduced pressure to dryness and partitioned between water and 
ether. The aqueous layer was acidified (HCl) and the yellow A/-(2-nitrophenyl)-(3-alanine 
filtered off; 3.28 g (78%); m.p. 145-6 "C (lit. 1^ 3 144-5 "C). 8y 2.60 (2H, t, CH2CO), 
3.55 (2H, br q, C //2NH), 6.68 (IH, t, 4-H), 7.08 (IH, d, 6-H), 7.54 (IH, t, 5-H),
8.05 (IH, dd, 3-H), 8.20 (IH, br s, NH). Jq\{2Q}{2 5.5, 7g 4 = ./g ^ “  8.5, ^3 5 1.5 Hz. 
ÔC 33.5 (NCH2), 38.5 (CH2CO), 114.6 (C-6), 115.6 (C-4), 126.5 (C-3), 131.3 (C-2),
136.9 (C-5), 145.1 (C-1), 173.3 (CO).
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A solution of A/-(2-nitrophenyl)-p-alanine (1.47 g, 7 mmol) in ethanol (40 cm^) 
containing dry HCl (2.4 g) was heated under reflux for 6.5 h, then concentrated under 
reduced pressure to dryness. The residue was recrystallised from ethanol to give 1.52 g 
(91%) of product; m.p. 69-70 "C (lit.i74 66-68.5 ”C). ôy (CDCI3) 1.28 (3H, t, CH3), 
2.71 (2H, t, CH2CO), 3.65 (2H, q, C //2NH), 6.67 (IH, t, 4-H), 6.87 (IH, d, 6-H), 
7.42 (IH, t, 5-H), 8.18 (IH, d, 3-H). /CH2CH3 7.1, /CH2CH2 6.7, ^3,4 = 1^,6 = 8.5 Hz. 
ÔC 14.1 (CH2CH 3), 33.8 (NCH2), 38.4 (CH2CO), 61.0 (CH2CH 3), 113.3 (C-6),
115.5 (C-4), 126.9 (C-3), 132.0 (C-2), 136.2 (C-5), 144.9 (C-1), 171.3 (CO).
Reaction of A -(2-n itrophenyl)-P -aIanine  ethyl ester (207a) with 
potassium carbonate. A-(2-Nitrophenyl)-p-alanine ethyl ester (0.95 g, 4 mmol) and 
potassium carbonate (0.83 g, 6 mmol) in ethanol (40 cm^) were heated under reflux for 
8 h, then cooled and filtered. The filtrate was concentrated under reduced pressure to 
dryness and partitioned between water and ethyl acetate. The aqueous layer was acidified 
(HCl) and the yellow precipitate was collected (0.33 g, 39%) and identified by ^H NMR 
spectroscopy as N-(2-nitrophenyl)-p-alanine; m.p. 145-7 “C. The ethyl acetate layer was 
dried (MgS0 4 ) and concentrated under reduced pessure to give 0.40 g (42%) of the 
starting material; m.p. 69-70 "C.
A -(2 ,4-D initrophenyi)-p-alanine ethyl ester (207b). A solution of 
p-alanine (4.01 g, 45 mmol) and sodium hydrogen carbonate (7.56 g, 90 mmol) in water 
(80 cm3) was added to a stirred solution of chloro-2,4-dinitrobenzene (8.10 g, 40 mmol) 
in ethanol (160 cm3) at room temperature. The mixture was heated under reflux for
6.5 h, concentrated under reduced pressure to dryness, and partitioned between water 
and ether. The aqueous layer was acidified (HCl) and the yellow A-(2,4-dinitrophenyl)- 
P-alanine filtered off (10.14 g, 99%); m.p. 146-7 “C (from ethanol) (lit.^^s.ns 144.5 
and 142-3 "C respectively). 5y 2.67 (2H, t, CH2CO), 3.71 (2H, q, NHCH2), 7.28 
(IH, d, 6-H), 8.26 (IH, dd, 5-H), 8.84 (IH, d, 3-H), 8.92 (IH, t, NH). 7cH2CH2 7,
75,6 10, 73 5 3 Hz.
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A solution of A/-(2,4-dinitrophenyl)-p-alanine (3.83 g, 15 mmol) in ethanol 
(70 cm3) containing dry HCl (2.4 g) was heated under reflux for 7 h. The solution was 
cooled to room temperature, and the resultant oil crystallised by stirring in ethanol; yield:
4.08 g (96%); m.p. 72-3 “C (from ethanol). (Found: C, 46.2; H, 4.4; N, 14.5. 
C 11H 13N3O6 requires C, 46.6; H, 4.6; N, 14.8%.) ôy (CDCI3) 1.29 (3H, t, CH3),
2.78 (2H, t, CH2CO), 3.76 (2H, q, NHC//2), 4.21 (2H, q, C //2CH3), 6.98 (IH, d, 
6-H), 8.29 (IH , dd, 5-H), 8.80 (IH, br s, NH), 9.13 (IH, d, 3-H). /CH2CH3 7.1, 
7cH2CH2 6.4, / 5,6 9.5, 73,5 2.8 Hz. ôc 14.2 (CH3), 33.5 (CH2CO), 39.0 (NHCH2),
61.4 (CH2CH3), 113.6 (C-3), 124.4 (C-6), 130.4 (C-5), 130.7 (C-2), 136.2 (C-4),
148.0 (C-1), 170.9 (CO).
Reaction of A-(2,4-dinitrophenyl)-P-alanine ethyl ester (207b) with 
potassium carbonate. Potassium carbonate (1.10 g, 8 mmol) was added to a 
suspension of A-(2,4-dinitrophenyl)-p-aIanine ethyl ester (1.42 g, 5 mmol) in ethanol 
(50 cm^), and the mixture heated under reflux for 11.5 h then filtered. The solid was 
taken up in water, acidified (HCl), and the yellow precipitate filtered off (0.70 g, 55%) 
and identified by ^H NMR spectroscopy as N-(2,4-dinitrophenyl)-p-alanine; m.p. 
138-43 “C. The reaction mixture filtrate was concentrated under reduced pressure to 
dryness, partitioned between water and ethyl acetate, the aqueous layer acidified (HCl) 
and a further crop (0.27 g, 21%) of the acid collected; m.p. 145-7 "C (overall yield 
76%). The ethyl acetate layer was dried (MgSO^) and concentrated under reduced 
pressure to give a residue which was crystallised from ethanol and identified as starting 
material (0.24 g) by ^H NMR spectroscopy.
A -(2-N itrophenyl)-2-m ethylalanine ethyl ester (211). A suspension of
2-aminoisobutyric acid (4.12 g, 40 mmol) and sodium hydrogen carbonate (10.08 g, 
120 mmol) in water (70 cm^) was added to a stirred solution of fIuoro-2-nitrobenzene 
(4.94 g, 35 mmol) in ethanol (100 cm^) at room temperature. The mixture was heated 
under reflux for 6.5 h, concentrated under reduced pressure to dryness, then partitioned
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between water and ether. The aqueous layer was acidified with HCl and the yellow 
A/-(2-nitrophenyl)-2-methylalanine filtered off; m.p. 140-1 °C (lit.^^^ 142 "C). 5y 1.59 
(6H, s, 2 X CHg), 6.76 (2H, m, 4- and 6-H), 7.56 (IH, t, 5-H), 8.13 (IH, d, 3-H), 
8.39 (IH, s, NH). 73 4  10, 74 5 10, 75 g  8  Hz.
A solution of A-(2-nitrophenyl)-2-methylalanine (1.70 g, 7.6 mmol) in ethanol 
(20 cm3) containing dry HCl (2.3 g) was heated under reflux for 5.5 h. The reaction 
mixture was cooled, evaporated to dryness under reduced pressure, the residue 
partitioned between water and ether, and the ether layer dried over MgS0 4  and 
concentrated under reduced pressure to an oil (1.40 g, 73%); b.p. 141 "C/0.1 mmHg. 
(Found: C, 56.8; H, 6.6 ; N, 11.35. C 12H 15N 2O 4 requires C, 57.1; H, 6.4; N, 
11.1%.) ÔH 1.20 (3H, t, CH2C //3), 1.68 (6H, s, 2 x CH3), 4.19 (2H, q, C //2CH3), 
6.59 (IH, d, 6-H), 6.68 (IH, t, 4-H), 7.38 (IH, t, 5-H), 8.23 (IH , d, 3-H), 8.41 (IH, 
s, NH). 7c h 2CH3 6 .8, 73 4 = 75 g = 7.4, 74 5 7.3 Hz. Ôc 14.0 (CH2C //3), 26.2 (2 x 
CCH3), 57.2 [C(CH3)2], 61.8 (CH2), 115.2 (C-6), 116.0 (C-4), 127.3 (C-3), 133.0 
(C-2), 135.7 (C-5), 143.6 (C-1), 175.0 (CO).
Reaction of A -(2 -n itro p h en y I)-2 -m eth y Ia lan in e  e thyl e s te r (211) 
with potassium carbonate. Potassium carbonate (0.34 g, 2.5 mmol) was added to a 
stirred solution of A-(2-nitrophenyl)-2-methylalanine ethyl ester (0.50 g, 2 mmol) in 
ethanol (20 cm^) and the mixture stirred at room temperature for 1.5 h. No reaction 
occurred, so the mixture was heated under reflux for 12 h, concentrated under reduced 
pressure to dryness, partitioned between water and ether, and the aqueous layer acidified 
with HCl. The aqueous layer was extracted into ethyl acetate, washed with water, dried 
over MgS04  and concentrated under reduced pressure to give 70 mg of a yellow solid, 
which was identified by ^H NMR spectroscopy as the acid resulting from hydrolysis of 
the starting material. The ether layer was concentrated under reduced pressure to yield 
starting material (0.45 g, 90%) (identified by ^H NMR spectroscopy).
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Reaction of V-(2-nitrophenyl)-2-methylalanine ethyl ester (211) 
with sodium ethoxide. A solution of N-(2-nitrophenyl)-2-methylalanine ethyl ester 
(0.50 g, 2 mmol) in ethanol (15 cm3) had added to it sodium ethoxide [from Na 
(0.058 g, 2.5 mmol) in ethanol (6 cm^)], and the solution heated under reflux for 6.5 h. 
The reaction mixture was concentrated under reduced pressure to dryness and partitioned 
between water and ether. The ether layer afforded 0.20 g of an orange oil which was 
identified as starting material, and the aqueous layer, upon acidification (HCl) and 
extraction into ethyl acetate, yielded 0.27 g of the starting acid (m.p. 140-1 "C, and by 
iR  NMR spectroscopy).
V-Benzyloxycarbonyl-(/?5)-alanine (214). To a solution of (/?5)-alanine 
(8.9 g, 100 mmol) in 4 M sodium hydroxide solution (4 g, 100 mmol in 25 cm^ of 
water) cooled to 0 °C was added benzyl chloroformate (17.9 g, 105 mmol) and 4 M 
sodium hydroxide solution (25 cm3) alternately and portionwise over 30 min with stirring 
and cooling. The mixture was warmed to room temperature, stirred for 2 h, then 
extracted with ether. The aqueous phase was acidified (HCl) and extracted with ether; the 
ether was dried (MgSO^) and concentrated under reduced pressure to a white solid 
(14.55 g, 65%) which was recrystallised from ether/petrol; m.p. 113-4 "C (lit.^^^ 
112-3 "C). ÔH (CDCI3) 1.46 (3H, d, CH3), 4.43 (IH, m, CH), 5.15 (2H, br s, CH2), 
5.34 (IH, d, NH), 7.35 (5H, s, 5 x ArH), 10.29 (IH, br s, CO2H). /cHNH 7 Hz. 6^
18.9 (CH3), 50.0 (CH), 67.7 (CH2), 128.7, 128.8, 129.1 (C-2 and -6; C-3 and -5; and 
C-4), 136.5, (C-1), 156.4 (CON), 178.3 (CO).
Attempted direct synthesis of A-benzyIoxycarbony!-A-methyl-(/?5)- 
alanine (216). A/-Benzyloxycarbonyl-(/?5)-alanine (1.12 g, 5 mmol) and methyl 
iodide (2.5 cm^, 40 mmol)) were dissolved in tetrahydrofuran (20 cm^) and cooled to 
0 °C (under nitrogen). Sodium hydride (80% dispersion in oil; 0.45 g, 15 mmol) was 
added cautiously with gentle stirring, then the suspension stirred at room temperature for 
24 h. Ethyl acetate (25 cm^) was added followed by water dropwise to consume the
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excess sodium hydride. The solution was evaporated to dryness and the residue 
partitioned between water and ether. The ether layer was washed with aqueous sodium 
hydrogen carbonate, the combined aqueous extracts acidified (HCl) and the product 
extracted into ethyl acetate. The ethyl acetate was washed with water, aqueous sodium 
thiosulphate (5% solution) then water, dried (MgSO^) and concentrated under reduced 
pressure to an oil which was further dried at the oil pump to yield a white solid which 
was recrystallised from ether/petrol. iH NMR spectroscopy showed that only 20% 
méthylation had taked place.
A ttem pted synthesis of V -(2 -n itro p h e n y l) -V -m e th y l- (R 5 )-a la n tn e .
N-(2-Nitrophenyl)-(/?S)-alanine (0.42 g, 2 mmol) and methyl iodide (1,0 cm^, 2.27 g, 
16 mmol) were dissolved in dry tetrahydrofuran (20 cm^) and cooled to 0 °C. Sodium 
hydride (80% dispersion in oil; 0.18 g, 6 mmol) was added cautiously with gentle 
stirring, then the suspension was stirred at room temperature for 5 days. Ethyl acetate 
was added, followed by water dropwise to destroy excess sodium hydride. The solution 
was evaporated to dryness, the residue partitioned between water and ether, the ether 
washed with aqueous 5% sodium hydrogen carbonate, then the combined aqueous 
extracts acidified (HCl) and extracted into ethyl acetate. The ethyl acetate was washed 
with water, aqueous 5% sodium thiosulphate. At this stage, the product moved into the 
aqueous layer, so this was acidified (HCl), extracted into ethyl acetate, washed with 
water, dried (MgSO^) and concentrated under reduced pressure to a yellow solid, which 
by ^H NMR spectroscopy was entirely starting material.
3 -(B enzy Ioxycarbonyl)-4-m ethyI-5-oxazolid inone (215). V -B enzyl- 
oxycarbonyl-(/?5')-alanine (14.50 g, 65 mmol) suspended in toluene (600 cm^) had 
added to it paraformaldehyde (13.5 g) and p-toluenesulphonic acid (1.35 g). The mixture 
was heated under reflux for 30 min [with azeotropic water removal (Dean-Stark 
apparatus)], then cooled, washed with 1 M aqueous sodium hydrogen carbonate 
solution, dried (MgSO^) and concentrated under reduced pressure. Recrystallisation of
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the residue from propan-2-ol gave 13.60 g (89%) of white crystals; m.p. 63-4 °C. 
(CDCI3) 1.58 (3H, d, CH3), 4.32 (IH, q, C //CH 3), 5.20-5.30 (2H, m, CZ/gPh), 5.50 
(2H, s, NCH2O), 7.41 (5H, s, aromatics). /chCHs 7 Hz. ôc 16.6 (CH3), 50.6 (ox- 
C-4), 67.8 (CH2Ph), 77.3 (ox-C-2), 128.3, 128.6 and 128.7 (C-2' and 6 '; C-3' and 5'; 
and C-4'), 135.5 (C-1'), 172.9 (2 x CO).
A-(Benzyloxycarbonyl)-V-methyl-(i?5)-alanine (216). 3-(Benzyloxy- 
carbonyl)-4-m ethyl-5-oxazolidinone (9.40 g, 40 mmol) was dissolved in 
dichloromethane (200 cm^), then trifluoroacetic acid (200 cm^) and triethylsilane 
(13.92 g, 120 mmol) were added. The solution was stirred at room temperature for 
22 h, then concentrated under reduced pressure to an oil. The triethylsilyl residues were 
removed by azeotroping the oil with toluene, and the toluene by azeotroping with petrol; 
the title compound persisted as an oil (9.48 g; 100%), which was not further purified. 
ÔH (CDCI3) 1.47 (3H, d, CHC//3), 2.93 (3H, s, NCH3), 4.7-4.9 (IH, m, CH), 5.17 
(2H, s, CH2), 7.37 (5H, s, ArH), 6.6-6.9 (IH, br s, CO2H). /chcH b 7 Hz.
A-M ethyl-(/?5)-alanine (217). A solution of A -benzy loxycarbony l- 
A-methyl-(/?5)-alanine (9.48 g, 40 mmol) in ethanol (130 cm^) containing 10% 
palladium on charcoal (0.82 g) was stirred under an atmosphere of hydrogen gas 
overnight. The catalyst was filtered off and washed with water, the filtrate concentrated 
under reduced pressure to dryness and the white solid recrystallised from ethanol 
(2.44 g, 59%); m.p. 257-8 "C ( I i t . i 7 7 , i 7 8  315.7 «c and 260 °C respectively), ôy (D2O)
1.33 (3H, d, CHC//3), 2.55 (3H, s, NCH3), 3.47 (IH, q, CH). /cHCHa 7 Hz.
A “M ethyI-A-(2,4-dinitrophenyl)-(/?5)-alanine (218). A solution of 
A/-methyl-(/?5)-alanine (2.62 g, 22 mmol) in water (40 cm^) containing sodium 
hydrogen carbonate (3.78 g, 44 mmol) was added to a stirred solution of fluoro-2,4- 
dinitrobenzene (3.91 g, 21 mmol) in ethanol (80 cm^) at room temperature. The mixture 
was heated under reflux for 6 h, concentrated under reduced pressure to dryness.
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redissolved in water and extracted with ether. The aqueous layer was acidified (HCl) and 
the yellow product (4.92 g, 87%) filtered off and recrystallised from ethanol; m.p. 
162 "C (from ethanol). (Found: C, 44.9; H, 4.0; N, 15.7. C ioHnN^Og requires C, 
44.6; H, 4.1; N, 15.6%.) ôg 1.47 (3H, d, CHC//3), 2.79 (3H, s, NCH3), 4.60 (IH, 
q, CH), 7.31 (IH , d, 6 -H), 8.26 (IH, dd, 5-H), 8.60 (IH, d, 3-H). JcHCHs 7,
75.6 9.5, 73 5 1.5 Hz. ôc  15.0 (CHCH3), 36.4 (NCH3), 59.0 (CH), 119.5 (C-6),
123.6 (C-3), 127.8 (C-5), 136,2 and 136.6 (C-2 and -4), 149.4 (C-1), 172.2 (CO).
V-M ethyl-V-(2,4-dinitrophenyl)-(^*5)-alanine ethyl ester (219). A 
solution of A-(2,4 dinitrophenyl)-(7?5)-alanine (4.84 g, 18 mmol) in dry ethanol 
(80 cm^) containing dry HCl was heated under reflux for 6.5 h, then cooled to room 
temperature and concentrated under reduced pressure to an oil; b.p. 200 "C/0.8 mmHg 
(Kugelrohr). The distillate was dissolved in ethyl acetate, washed with aqueous sodium 
hydrogen carbonate to remove remaining V-methyl-A-(2,4-dinitrophenyl)-(/?5)-aIanine, 
dried (MgS0 4 ) and concentrated under reduced pressure. The residue was recrystallised 
from ethanol; m.p. 82-83 "C. ôy (CDCI3) 1.34 (3H, t, CH2C //3), 1.74 (3H, d, 
C H CH 3), 2.79 (3H, s, NMe), 3.90 (IH, q, CH), 4.31 (2H, q, CH2), 7.34 (IH , d, 
6-H), 8.48 (IH, dd, 5-H), 9,09 (IH, d, 3-H). 7c h 2CH3 7, ./cHCHs 7, 9, 3 Hz.
The ester was not purified sufficiently for microanalysis.
Reaction of A -m eth y l-A -(2 ,4 -d in itro p h en y l) - ( /? 5 )-a la n in e  ethyl 
ester (219) with potassium carbonate. A solution of 7V-(2,4 dinitrophenyl)-(/?5)- 
alanine ethyl ester (0.15 g, 0.5 mmol) in dry ethanol (5 cm^) containing potassium 
carbonate (0.08 g, 0.6 mmol) was heated under reflux for 4.5 h, then cooled to room 
temperature and partitioned between water and ethyl acetate. The aqueous layer was 
acidified (HCl) and extracted with ethyl acetate, but nothing was isolated. The original 
ethyl acetate layer was a complex mixture, showing at least 9 spots by tic.
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V -(2 ,4 -D in itropheny I)-(S )-proIine ethyl ester (221), A suspension of 
(S)-proline (2.88 g, 25 mmol) and sodium hydrogen carbonate (6.3 g, 75 mmol) in water 
(40 cm3) was added to a stiired solution of fiuoro-2,4-dinitrobenzene (3.72 g, 20 mmol) 
in ethanol (80 cm^) at room temperature. The mixture was heated under reflux for 6.5 h, 
concentrated under reduced pressure to 50 cm^, then extracted with ether and the aqueous 
layer acidified with HCl. The brown precipitate was recrystallised from ethanol twice 
(the brown oil crystallised upon stirring for 30 min) to give 5.5 g (98%) of A-(2,4- 
dinitrophenyl)-(5)-proline; m.p. 133-6 “C (dec.) ( I i t . i 7 9  i 3g “C). Sy 1.88-2.11 (2H, m, 
CH2C //2CH2), 2.45-2.52 (2H, m, CHC//2), 3.15-19 (IH, m, NCH2^), 3.38-3.48 (IH, 
m, NCUJ^), 4.68 (IH, t, CH), 7.02 (IH , d, 6 -H), 8.25 (IH, dd, 5-H), 8.60 (IH, d,
3-H). /5  g 9.5, 73 5 2.5 Hz.
A solution of A-(2,4-dinitrophenyl)-(5)-proline (5.30 g, 18.9 mmol) in ethanol 
(80 cm3) containing dry HCl (2 g) was heated under reflux for 6 h. The excess ethanol 
was removed under reduced pressure and the residue taken up in dichloromethane, 
washed with water, dried over MgSO^ and concentrated under reduced pressure. 
Crystallisation of the brown oil was attempted from ether/petrol, but the product persisted 
as an oil (5.49 g, 94%). 0 ^  (CDCI3) 1.20 (3H, t, CH3), 1.95-2.02 (2H, m, 
CH2C //2CH2), 2.45 (2H, m, CHC//2), 3.30 (2H, m, NCH2), 4.14 (2H, q, C //2CH3), 
4.70 (IH, t, CH), 7.00 (IH, d, 6-H), 8.21 (IH, dd, 5-H), 8.63 (IH, d, 3-H). 7ch2CH3 
9.5, 72,3 9.5, 73 5 2.5 Hz. 5c 14.2 (CH3), 24.5 (CH2CH2CH2), 30.5 (CHCH2), 52.3 
(NCH2), 61.6 (CH2CH3), 62.3 (CH), 117.5 ( C-3), 123.5 (C-6), 127.7 (C-5), 135.5 
(C-2), 135.7 (C-4), 145.3 (C-1), 171.0 (CO), m/z 309 (M+-, 5%), 279 (5), 236 (100), 
149 (45) etc. Microanalytical purity was not obtained, although no impurities could be 
detected by NMR spectroscopy.
R eaction of /V -(2 ,4 -d in itro p h e n y l)- (5 )-p ro lin e  ethyl e ste r (221 ) 
with potassium  carbonate. A solution of A-(2,4-dinitrophenyl)-(5)-proline ethyl 
ester (0.23 g, 0.75 mmol) in dry ethanol (10 cm^) containing potassium carbonate 
(0.11 g, 0.8 mmol) was stirred at room temperature for 24 h (no reaction). The mixture
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was heated under reflux for 2 h, then cooled to room temperature, concentrated under 
reduced pressure to dryness and partitioned between water and ethyl acetate. The 
aqueous layer, upon acidification (HCl) and extraction with ethyl acetate, yielded an 
intractable brown oil. The original ethyl acetate layer was dried (MgS0 4 ) and 
concentrated under reduced pressure to an intractable red solid.
Reaction of A -(2 ,4 -d in itro p h en y I)-(5 )-p ro lin e  ethyl ester (221) 
with sodium ethoxide. A solution of A/-(2,4-dinitrophenyl)-(5)-proline (0.15 g, 
0.5 mmol) in dry ethanol (10 cm3) and N,N-dimethylformamide (2 cm^) had added to it 
sodium ethoxide [from Na (0.012 g, 0.5 mmol) in ethanol (1 cm^)] at room temperature. 
The solution was stirred at room temperature for 4 h, then the ethanol removed under 
reduced pressure and the residue diluted with water. Again, however, no products could 
be isolated from the reaction mixture, either from the precipitate (after dilution with water) 
or from the filtrate (which was partitioned between water and ethyl acetate, etc.).
N -(2 ,4 -D in itro p h en y l)-< ra / is -4 -h y d ro x y -(S )-p ro lin e  ethyl ester 
(222). A solution of franj-4-hydroxy-(^)-proline (3.28 g, 25 mmol) in water (40 cm^) 
with sodium hydrogen carbonate (6.3 g, 75 mmol) was added to a stirred solution of 
fluoro-2,4“dinitrobenzene (3.72 g, 20 mmol) in ethanol (80 cm^) at room temperature. 
The yellow mixture was heated under reflux for 6.5 h (solution turned red), concentrated 
under reduced pressure to -50  cm^, then extracted with ether and the aqueous layer 
acidified with HCl. The oil was extracted with ether, dried over MgS04  and concentrated 
under reduced pressure; 4.81 g (81%). Attempted recrystallisations from propan-
2-ol/water and ether/petrol were both unsuccessful - removal of the solvent under reduced 
pressure resulted in a brown solid [A/-(2 ,4-dinitrophenyl)-rran5'-4-hydroxy-(5 )-proline]; 
m.p. 165-168 "C (lit.^*® m.p. 174-5 ”C), which was esterified without further 
purification. Ôpj 2.40 (IH, m, pro-3-H), 2.66 (IH, d, pro-3-H), 3.62 (IH, dd, pro-
5-H), 4.40 (IH, br s, pro-5-H), 4.73 (IH, dd, pro-2-H), 5.20 (IH , br s, OH; absent
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after addition of D2O), 7.11 (IH , d, 6-H), 8.27 (IH, dd, 5-H), 8.61 (IH, d, 3-H). 
7$,6 9, 7g g 2.5 Hz.
A solution of A/-(2 ,4 -dinitrophenyl)-fr<2/î.y-4 -hydroxy-(5 )-proline (4.57 g, 
15 mmol) in ethanol (100 cm^) containing dry HCl (2.5 g) was heated under reflux for 
7 h. The solution was cooled to room temperature, the solvent removed under reduced 
pressure and the residue partitioned between water and dichloromethane. The organic 
layer was dried over MgSO^ and concentrated to yield a brown solid (3.20 g, 66%); m.p. 
-90  "C, which could not be recrystallised under a range of different solvent conditions. 
ÔH (CDCI3) 1.24 (3H, t, CH2C //3), 2.00 (IH, br s, OH; exchangeable with D2O), 2.25 
(IH, m, pro-4-H), 2.55 (IH, m, pro-3-H), 2.96 (IH, d, pro-3-H), 3.87 (IH, dd, pro-
5-H), 4.20 (2H, q, C //2CH3), 4.65 (IH, br s, pro-5-H), 4.79 (IH , dd, pro-2-H), 6.90 
(IH , d, 6-H), 8.21 (IH , dd, 5-H), 8.69 (IH, d, 3-H). 7g g 9, 73 5 2.5 Hz. ôc 14.1 
(CH3), 38.7 (pro-C-3), 60.8 and 60.9 (pro-C-2 and -5), 62.4 (CH2CH3), 69.9 (pro- 
C-4), 116,3 (C-6), 123.9 (C-3), 128.0 (C-5), 136.4 (C-2), 137.2 (C-4), 146.2 (C-1),
171.3 (CO).
Reaction of A -(2 ,4 -d in i tr o p h e n y l) - /r a n s -4 -h y d r o x y - (S ) -p r o l in e  
ethyl ester (222) with potassium carbonate. A solution of V -(2 ,4 -  
dinitrophenyl)-rran.s-4-hydroxy-(5')-proline ethyl ester (0.65 g, 2 mmol) in dry ethanol 
(15 cm^) containing potassium carbonate (0.30 g, 2.2 mmol) was heated under reflux for
3.5 h, then cooled to room temperature and filtered (inorganic). The filtrate was 
concentrated under reduced pressure to an intractable dark red solid.
A -(2 ,4-D initrophenyl)-(S)“histidine ethyl ester (225). A suspension 
of (5)-histidine (3.88 g, 25 mmol) and sodium hydrogen carbonate (6.3 g, 75 mmol) in 
water (40 cm^) was added to a stirred solution of fluoro-2,4-dinitrobenzene (4.28 g, 
20 mmol) in ethanol (80 cm^) at room temperature. The mixture was heated under reflux 
for 6 h, concentrated under reduced pressure to dryness, dissolved in water then 
extracted with ether and the aqueous layer acidified with HCl to yield a yellow precipitate
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of iV -(2 ,4-d initropheny l)-(S)-histidine (7.13 g, 97%); m.p. 218-220 "C (lit.^^i 
250-280 "C). ÔH 3.20 (2H, d, CH2), 4.79 (IH, q, CH), 7.00 (IH, s, 5’-H), 7.12 
(IH, d, 6-H), 7.88 (IH, s, 2'-H), 8.24 (IH, dd, 5-H), 8.88 (IH, d, 3-H), 9.35 (IH, d, 
NH). / C H 2 C H  7 , / 3,5 3 , / 5,6 9 Hz.
A solution of A/-(2,4-dinitrophenyl)-(5)-histidine in ethanol (250 cm^) containing 
dry HCl (6 g) was heated under reflux for 6.5 h. The solution was evaporated to dryness 
under reduced pressure and the residue taken up in dichloromethane, washed with water, 
dried over MgSO^ and the dichloromethane removed under reduced pressure to yield a 
yellow solid which was recrystallised from ethanol (2.85 g, 41% from fluoro-2,4- 
dinitrobenzene); m.p. 170 "C (from ethanol/water). (Found: C, 48.1; H, 4.1; N, 20.2. 
C14H 15N5O6 requires C, 48.1; H, 4.3; N, 20.05%.) ôy (CDCI3 + 2 drops DMSO-dg)
1.28 (3H, t, CH2C //3), 3.29 (2H, m, CHC//2), 4.24 (2H, q, C //2CH3), 4.72 (IH, m, 
CH), 6.81 (IH, d, 6-H), 6.83 (IH , s, im-5-H), 7.59 (IH, s, im-2-H), 8.19 (IH, dd,
5-H), 9.09 (IH, s, 3-H), 9.22 (IH , d, exocyclic NH). 7cH 2CH3 9.5, 7 cHCH2 7, 
7 n h c h  7. 75,6 9.5, 73,5 2.5 Hz. ôc 14.2 (CH2CH3), 31.0 (CHCH2), 56.4 (CH), 62.2 
(CH2CH3), 114.7 (C-6), 115.5 (im-C-2), 124.2 (C-3), 130.2 (C-5), 131.1 (im-C-4),
134.0 (C-2), 135.8 (im-C-5), 136.6 (C-4), 147.8 (C-1), 170.7 (CO), m/z 349 (M+-, 
37%), 317 (9), 285 (10), 276 (12), 191 (11), 91 (100) gfc.
R eaction of A -(2 ,4 -d in itro p h e iiy l) -(5 )-h is tid in e  ethyl e ste r (225) 
with potassium carbonate, a) Potassium carbonate (1.10 g, 8 mmol) was added to 
a suspension of V-(2,4-dinitrophenyl)-(5)-histidine ethyl ester (1.75 g, 5 mmol) in 
ethanol (50 cm^) and the mixture heated under reflux for 4 h. The reaction mixture was 
filtered, the solid dissolved in water and the solution taken to pH 7 (HCl); 5-nitro- 
1//-benzimidazole-2-carboxylic acid 3-oxide (227) was filtered off (0.52 g, 47%); m.p. 
258-60 "C (dec.), ôy 7.81 (IH, d, 7-H), 8.05 (IH, dd, 6-H), 8.39 (IH, d, 4-H). 
4 ,7 9 , 74 ,6 :^  Hz. ÔC 107.8 (C-4), 117.3 (C-7), 121.7 (C-6), 129.3 (C-3a), 141.7 
(C-5), 142.6 (C-7a), 143.1 (C-2), 162.2 (CO) The filtrate was taken to pH 1 (HCl) and
5-nitro-l//-benzimidazole 3-oxide (228) (0.05 g, 6%) collected; m.p. 265 "C (lit.^82
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274 "C). ÔH 7.86 (IH, d, 7-H), 8.11 (IH, dd, 6-H), 8.38 (IH, d, 4-H), 8.78 (IH, s,
2-H). /g  7 9, /4  6 2 Hz. The original reaction mixture filtrate was concentrated under 
reduced pressure to dryness, partitioned between water and ethyl acetate, the aqueous 
phase acidified (HCl) and the precipitate [ethyl 5-nitro-l//-benzimidazole-2-carboxylate
3-oxide (226)] filtered off and dried; 0.32 g (26%), m.p. 209-10 “C (lit.8 8 
209-210 "C). ÔH 1.41 (3H, t, CH3), 4.49 (2H, q, CH2), 8.01 (IH, d, 7-H), 8.21 
(IH, dd, 6-H), 8.46 (IH, d, 4-H). /chzCHs 7, / g j  9, / 4,6 2 Hz. ôc 14.2 (Me), 62.4 
(CH2), 107.4 (C-4), 118.9 (C-7), 122.3 (C-6), 132.2 (C-3a), 140.9 (C-5), 142.2 
(C-7a), 144.9 (C-2), 157.6 (CO).
b) V-2,4-(Dinitrophenyl)-(5)-histidine ethyl ester (0.70 g, 2 mmol) and potassium 
carbonate (0.41 g, 3 mmol) in ethanol (25 cm3) were heated under reflux for 5 h. The 
reaction mixture was filtered, the solid taken up in water, acidified and the yellow 
precipitate [5-nitro-l//-benzimidazole-2-carboxylic acid 3-oxide (227)] filtered off 
(0.17 g, 38%). The reaction mixture filtrate was concentrated under reduced pressure to 
dryness, partitioned between water and ethyl acetate, the aqueous phase acidified (HCl) 
and ethyl-5-nitrobenzimidazole-2-carboxylate 3-oxide (226) (0.15 g, 30%) filtered off 
(confirmed by m.p.).
1
A-(2,4-Dinitrophenyl)-(S)-tryptophan ethyl ester. (With M. Parsons.) 
A solution of fluoro-2,4-dinitrobenzene (1.87 g, 10 mmol) in ethanol (20 cm3) was 
added to a stirred solution of (5)-tryptophan (2.15 g, 10.5 mmol) and sodium hydrogen 
carbonate (1.77 g, 10 mmol) in water (20 cm^), and the mixture heated under reflux for 
12 h. The mixture was concentrated under reduced pressure to dryness, and the residue 
dissolved in water, extracted with ethyl acetate and the aqueous layer acidified to give 
N-(2,4-dinitrophenyl)-(5)-tryptophan which was recrystallised from acetone/ether; 
2.41 g (61%); m.p. 193-4 “C (lit.183 196-8 "C). Ôh 3.37-3.51 (2H, symm. m, CH2), 
4.96-5.10 (IH, symm. m, CH), 6.92 (IH, t, indole 5-H), 7.06 (IH, t, indole 6-H), 
7,16 (IH, s, indole 2-H), 7.20 (IH, d, 6-H), 7.29 (IH, d, indole 7-H), 7.36 (IH, d,
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indole 4-H), 8.20 (IH , dd, 5-H), 8.83 (IH, d, 3-H), 8.85 (IH, d, NH), 10.95 (IH, s, 
indole NH). /s , 5 3 ,75,5 10, 7nhCH 7 ,7indole 4,5 ~ ^indole 5,6 ~ 7indole 6,7 7 Hz.
A solution of N-(2,4-dinitrophenyl)-(5)-tryptophan (0.35 g, 0.95 mmol) in 
ethanol (15 cm^) containing dry HCl (3.1 g) was heated under reflux for 5 h. The 
reaction mixture was concentrated under reduced pressure to dryness, and the resultant 
oil purified by column chromatography on silica gel with dichloromethane/petrol as 
eluent. Triturating the orange oil in petrol yielded the product as a solid (0.14 g, 24%) 
which was recrystallised from acetic acid to give orange needles; m .p.113-5 "C. 
(Found: C, 42.5; FI, 4.3; N, 12.7. C19H 18N4O6.HCI requires C, 42.5; H, 4.4; N, 
12.9%.) ÔH (CDCI3) 1.18 (3H, t, CH2C //3). 3.39-3.53 (2H, symm. m, C H C//2), 
4.12 (2H, q, C //2CH3), 4.97-5.11 (IH, symm. m, CH), 6.94 (IH, t, indole 5-H), 7.07 
(IH, t, indole 6-H), 7.18 (IH, s, indole 2-H), 7.23 (IH, d, 6-H), 7.30 (IH, d, indole 7- 
H), 7.34 (IH, d, indole 4-H), 8.21 (IH, dd, 5-H), 8.81 (IH , d, 3-H), 8.83 (IH , d, 
NH), 10.99 (IH, s, indole NH). 7c h 2CH37, 73,5 3, 7g,6 10, 7 n h c h  7, 7mdole 4,5 ~ 
/indole 5,6 -  /indole 6.7 -  7 Hz. 5 c  13.9 (CH3), 27.0 (CHCH2), 55.9 (CH), 61.7 
(CH2CH3), 107.6 (indole C-3), 111.6 (indole C-7), 116.0 (C-6), 118.0 (indole C-5),
118.7 (indole C-6), 121.3 (indole C-4), 123.6 and 124.6 (C-3 and indole C-2), 127.3 
(indole C-7a), 130.1 (C-5), 130.3 (C-2), 135.8 (indole C-3a), 136.2 (C-4), 147.2 
(C-1), 170.8 (CO), m/z 398 (M+-, 7%), 266 (5), 235 (6), 224 (7), 192 (25), 162 (7), 
130 (100) etc.
A -(2 ,4 -D in itro p h en y l)-(5 )" try p to p h an  m ethyl ester (231). (With M. 
Parsons.) Fluoro-2,4-dinitrobenzene (1.86 g, 10 mmol), (S)-tryptophan methyl ester 
hydrochloride (2.55 g, 10 mmol) and sodium hydrogen carbonate (1.68 g, 20 mmol) in 
dry methanol (40 cm^) were heated together under reflux for 13 h, cooled, poured into 
ice/water and filtered. The product was recrystallised from acetic acid; yield 3.75 g 
(98%); m.p. 157-8 "C. (Found: C, 56.0; H, 4.0; N, 14.4. C18H 16N4O6 requires C, 
56.0; H, 4.2; N, 14.6%.) Ôh 3.38 (2H, symm. m, CH2), 3.69 (3H, s, CH3), 5.06-
5.19 (IH, symm. m, CH), 6.95 (IH, t, indole 7-H), 7.04 (IH, t, indole 6-H), 7.17
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(IH, s, indole 2-H), 7.21 (IH, d, 6-H), 7.28 (IH, d, indole 7-H), 7.34 (IH, d, indole
4-H), 8.22 (IH, dd, 5-H), 8.79 (IH, d, NH), 8.82 (IH, d, 3-H), 10.99 (IH, s, indole 
NH). 6c  27.1 (CH2), 52.6 (CH3), 55,7 (CH), 107.5 (indole C-3), 111.5 (indole C-7),
115.8 (C-6), 117.8 (indole C-5), 118.6 (indole C-6), 121.9 (indole C-4), 123.4 and
124.6 (indole C-2 and C-3), 127.0 (indole C-7a), 129.9 (C-5), 130.1 (C-2), 135.6 
(indole C-3a), 136.1 (C-4), 147.0 (C-1), 171.0 (CO), w/z 384 (M+-, 5%), 130 (100), 
84 (8), etc.
Reaction o f  A ^ -(2 ,4 -D in itro p h en y l) - (5 )- try p to p h a n  m ethyl ester  
(231) with potassium carbonate. (With M. Parsons.) N -(2,4-D initrophenyl)- 
(5)-tryptophan methyl ester (0.77 g, 2 mmol) and potassium carbonate (0.28 g, 2 mmol) 
in dry methanol (20 cm^) were heated together under reflux for 2 h, then cooled to room 
temperature and filtered. The methanol filtrate was concentrated under reduced pressure 
to dryness and the residue stirred in water; the insoluble buff-coloured solid 
[3-(methoxymethyl)indole (232)] was filtered off and dried in vacuo; 0.22 g (69%); 
m.p. 94-6 “C [lit.184.185,186 96_7 »c, 99-100 “C and 98-99 °C respectively], ô r  3.20
(3H, s, CH3), 4.53 (2H, s, CH%), 6.98 (IH , t, 5-H), 7.08 (IH , t, 6-H), 7.29 (IH, s,
2-H), 7.35 (IH , d, 7-H), 7.54 (IH, d, 4-H), 10.99 (IH, br s, NH). The aqueous 
filtrate was acidified (HCl) to precipitate methyl 5-nitro-l//-benzimidazole-2-carboxylate
3-oxide (108) (0.25 g; 53%); m.p. 194-5 T  (lit.i87 205-6 T ) .  Ôr 3.97 (3H, s, CH3), 
7.97 (IH , d, 7-H), 8.18 (IH , dd, 6-H), 8.43 (IH, d, 4-H). Je,i 9, 74,6 2 Hz. The 
original reaction mixture precipitate was dissolved in water, extracted with ethyl acetate 
and the aqueous layer acidified (HCl); 80 mg of a buff-coloured solid was isolated as a 
mixture of methyl 7-nitrobenzimidazole-2-carboxylate 3-oxide and another, unidentified 
compound.
Diethyl A ^ -(2 ,4 -d in itr o p h e n y I ) - (5 ) -g I u ta m a te  (236). (With M. 
Parsons.) A solution of fluoro-2,4-dinitrobenzene (11.16 g, 60 mmol) in ethanol 
(120 cm^) was added to a stirred solution of (5)-glutamic acid (11.79 g, 63 mmol) and
143
sodium hydrogen carbonate (10.59 g, 126 mmol) in water (120 cm^), and the mixture 
heated under reflux for 7 h. The mixture was concentrated under reduced pressure to 
dryness, and the residual oil crystallised to give N-(2,4-diniti'ophenyl)-(5)-glutamic acid, 
which was a yellow hygroscopic solid (m.p. 115-6 °C; lit.^^  ^ 155-162 °C) from ethyl 
acetate/petrol (13.33 g; 71%). Ôr 2.10-2.20 (2H, symm. m, CHC//2CH2), 2.30-2.41 
(2H, m, CHCH2C/72), 4.68-4.76 (IH, symm. m, CH), 7.25 (IH , d, 6-H), 8.26 (IH, 
dd, 5-H), 8.86 (IH, d, 3-H), 8.93 (IH, d, NH). /cHNH 7,73,5 3, 7s ,6 10 Hz.
A solution of /V-(2,4-dinitrophenyl)-(5)-glutamic acid (6.00 g, 19.17 mmol) in 
dry ethanol (36 cm3) containing dry HCl (about 9 g) was heated under reflux for 5.5 h, 
then cooled to room temperature and concentrated under reduced pressure to a yellow- 
brown oil. This was chromatographed on silica gel with ether-petrol (6:5) as eluent to 
give the ester as a yellow oil; 4.53 g (75%); b.p. 200 °C/0.5 mmHg. (Found: C, 49.0; 
H, 5.3; N, 11.0. C 15H 19N3O8 requires C, 48.8; H, 5.2; N, H.4%.) Ôr (CDCI3) 1.28 
(3H, t, CH2C//3  of a -  or y-ester), 1.34 (3H, t, CH2C//3  of a -  or y-ester), 2.24-2.34 
(2H, symm. m, CHC//2CH2), 2.52 (2H, t, CHCH2C //2), 4.19 (2H, q, C //2 of a -  or 
y-ester), 4.31 (2H, q, C //2 of a - or y-ester), 4.45-4.53 (IH, symm. m, CH), 6.99 (IH, 
d, 6-H), 8.33 (IH , dd, 5-H), 8.95 (IH, d, NH), 9.18 (IH , d, 3-H). 7ch2CH3 = 
7cH2CH2 = 7, 7cr2  14, 7 c r n h  7 ,73^5 2 ,75,6 9.5 Hz. 5c 13.9 (CHCH3 of both a -  and 
y-esters), 26.8 (CHCH2), 29.6 (CH2C0 2 Et), 54.7 (CH), 60.7 (CH2CH 3 of a -  or 
y-ester), 62.2 (CH2CH3 of a - or y-ester), 114.5 (C-6), 123.8 (C-3), 130.2 (C-5), 130.8 
(C-2), 136.4 (C-4), 146.8 (C-1), 170.1 (y-CO), 172.0 (a-CO). m/z 369 (M+-, 5%), 
324 (55), 296 (82), 262 (16), 250 (100). 222 (42) etc.
Reaction of diethyl A -(2 ,4 -d in itro p h en y l)-(5 )-g lu tam a te  (236) with 
potassium  carbonate . (With M. Parsons.) A solution of diethyl N-(2,4-dinitro- 
phenyl)-(5)-glutamate (1.52 g, 4.1 mmol) in dry ethanol (35 cm^) containing potassium 
carbonate (0.57 g, 4.1 mmol) was heated under reflux for 2 h. The cooled reaction 
mixture was filtered and the brown precipitate dissolved in water. The aqueous solution 
yielded (on acidification with HCl) ethyl 3-(5-nitro-3-oxido-17/-benzimidazol-
144
2-yl)propionate (237) which was recrystallised from acetone/petrol; 0.41 g (39%); 
m.p. 79-83 "C. 6h  1.15 (3H, t, CH2C //3), 2.88 (2H, t, C C //2CH2), 3.18 (2H, t, 
C CH 2C //2), 4.02 (2H, q, C //2C H 3), 7.70 (IH. d, 4-H), 8.03 (IH , dd, 6-H), 8.24 
(IH , d, 7-H). 7 CH2CH3 = 7CH2CH2 = 7, 74,6 2, 76,7 9 Hz. 6c  14.0 (Me), 21.1 
(CH2CH2CO2), 29.8 (CH2CO2), 60.1 (CH2CH3), 105.2 (C-4), 116.9 (C-7), 119.3 
(C-6), 131.8 (C-3a), 142.4 (C-2 and C-5), 155.9 (C-7a), 172.0 (CO). Although (237) 
was not obtained in sufficient purity for microanalysis, the NMR data are consistent with 
the proposed structure. Extiaction with ether of the original reaction mixture filtrate 
yielded a mixture (0,1 g) of the above ester and the corresponding carboxylic acid (238).
D iethyl A - ( 2 ,4 - D in i t r o p h e n y l ) - ( S ) - a s p a r ta te  (239). (With M. 
Parsons.) A solution of fluoro-2,4-dinitrobenzene (3.72 g, 20 mmol) in ethanol 
(40 cm3) was added to a stirred solution of (5)-aspartic acid (2.80 g, 21 mmol) and 
sodium hydrogen carbonate (5.29 g, 63 mmol) in water (40 cm^), and the mixture heated 
under reflux for 5 h. The mixture was concentrated under reduced pressure to dryness 
and the residue dissolved in water and extracted with ether. The aqueous layer was 
acidified (HCl) and N-(2,4-dinitrophenyl)-(5)-aspartic acid filtered off and recrystallised 
from ethyl acetate/petrol to give yellow needles, 5.13 g (86%); m.p. 185-6 °C (lit.^79 
186-7 °C). ÔH 2.70 and 2.91 (each IH, dd, CH2), 4.94-5.07 (IH , symm. m, CH), 
7.30 (IH, d, 6-H), 8.30 (IH , dd, 5-H), 8.85 (IH, d, 3-H), 9.20 (IH , d, NH). 
7 c h n h  8, 7c h 2 16, 7chCH2 8, 73,5 3 ,7g,6 10 Hz.
A solution of A-(2,4-dinitrophenyl)-(5)-aspartic acid (2.50 g, 8.4 mmol) in dry 
ethanol (35 cm3) containing dry HCl (5.1 g) was heated under reflux for 7 h, then cooled 
to room temperature and concentrated under reduced pressure to a yellow-brown oil. 
Trituration in petrol yielded a yellow solid which was recrystallised from aqueous 
ethanol; 2.19 g (74%); m.p. 58-9 "C. (Found: C, 47.3; H, 4.8; N, 11.8. C14H 17N3O8 
requires C, 47.4; H, 4.8; N, 11.8%). Ôr (CDCI3) 1.28 (3H, t, a -  or (3- CH2C //3),
1.33 (3H, t, a -  or (3- CH2C //3), 2.95 and 3.04 (each IH, dd, CH2), 4.18 (2H, q, a - or 
p- C //2CH3), 4.29 (2H, q, a- or p- C //2CH3), 4.73 (IH, symm. m, CH), 6.96 (IH, d,
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6-H), 8.32 (IH, dd, 5-H), 9.13 (IH, d, 3-H), 9.20 (IH, d, NH). /cHzCHa 7, J e m  16, 
7CHCH2 5 , 7cH N H & /3,5 3 , / 5,6 9H z. 6c  14.0 (2 xCHg), 36.6 (CHCH2), 52.4 (CH),
61.7 and 62.7 (CHg of a - and p-ester), 113.9 (C-6), 124.2 (C-3), 130.3 (C-5), 131.3 
(C-2), 136.8 (C-4), 147.0 (C-1), 169.3 and 169.5 (CO of a -  and p-ester). m/z 355 
(M+-, 13%), 282 (100), 268 (10), 236 (55), etc.
Reaction o f  diethyl A -(2 ,4 -d in itrop h en y l)-(5 )-a sp ar ta te  (239) with  
potassium carbonate. (With M. Parsons.) Potassium carbonate (0.22 g, 1.8 mmol) 
was added to a solution of diethyl N-(2,4-dinitrophenyl)-(5)-aspartate (0.6 g, 1.7 mmol) 
in ethanol (40 cm3). After stirring for 40 min at room temperature, the solution was 
filtered, and the brown solid dissolved in water and the solution acidified (HCl). No 
identifiable product was isolated. The reaction mixture was concentrated under reduced 
pressure to dryness and the residue dissolved in water. The aqueous solution was 
acidifed (HCl) and the yellow solid (0.38 g, 63%) filtered off and identified as starting 
material.
Reaction of diethyl A -(2 ,4 -d in itrop h en yI)-(5 )-a sp arta te  (239) with 
sodium ethoxide. (With M. Parsons.) Sodium ethoxide [1.13 mmol, from Na 
(0.059 g) in ethanol (3 cm^)] was added to a stirred solution of diethyl 
N-(2,4-dinitrophenyl)-(5')-aspartate (0.40 g, 1.13 mmol) in ethanol (1 cm^) at 0-5 “C. 
After stirring for 19 h at room temperature, excess solvent was remove under reduced 
pressure, and the residual solid dissolved in water. Acidification of this solution (HCl) 
again failed to yield any identifiable product.
A -(4 ,5 -D ic h lo ro -2 -n itro p h e n y l)sa rc o s in e  e th y l e s te r  (242). A
suspension of sarcosine (1.07 g, 12 mmol) and sodium hydrogen carbonate (3.02 g, 
36 mmol) in water (20 cm^) was added to a stirred solution of 1,2-dichloro-4-fluoro-
5-nitrobenzene (2.10 g, 10 mmol) in ethanol (40 cm^) at room temperature. The mixture 
was heated under reflux for 6 h, concentrated under reduced pressure to dryness.
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dissolved in water then extracted with ether and the aqueous layer acidified with HCl, 
giving a yellow precipitate of N-(4 ,5-dichloro-2-nitrophenyl)sarcosine, which was 
filtered off and recrystallised from ethanol (2.64 g, 95%); m.p. 139-40 “C. Ôr 2.82 
(3H, s, CHg), 4.02 (2H, s, CH2), 7.33 (IH , s, 6-H), 8.09 (IH , s, 3-H). ôc  41.2 
(CH3), 54,9 (CH2), 119.6 (C-4), 120.7 (C-6), 127.6 (C-3), 136.2 (C-2), 137.3 (C-5),
144.2 (C-1), 170.9 (CO). The acid was esterified without further purification for 
microanalysis.
A solution of A-(4,5-dichloro-2-nitrophenyl)sarcosine (2.64 g, 9.46 mmol) in 
ethanol (30 cm^) containing dry HCl (1.2 g) was heated under reflux for 5 h. The excess 
ethanol was removed under reduced pressure, the residue taken up in ether, filtered, and 
the filtrate concentrated under reduced pressure to leave a yellow solid on cooling which 
was recrystallised twice from ethanol (1.87 g, 64%); m.p. 66-7 “C. (Found: C, 42.8;
H, 4.3; N, 9.0. C11H12CI2N2O4 requires C, 43.0; H, 3.9; N, 9.1%.). 6r  (CDCI3)
I.32 (3H, t, CH2C //3), 3.00 (3H, s, NCH3), 4.21 (2H, s, NCH2), 4.25 (2H, q, 
C //2CH3), 7.50 (IH, s, 6-H), 8.20 (IH, s, 3-H). ./CR2CH3 8 Hz. ôc 14.0 (CH2CH3),
40.8 (NCH3), 54.9 (NCH2), 60.6 (CH2CH3), 120.1 (C-4), 121.0 (C-6), 127.2 (C-3),
136.0 (C-2), 137.7 (C-5), 143.8 (C-1), 169.1 (CO), m/z 306 (M+-, 7%), 233 (100), 
200 (37), 187 (10), 174 (9), 159 (21).
6 ,7 -D ic h Io ro -l-h y d ro x y -4 -m e th y lq u in o x a lin e -2 ,3 -d io n e  (243). A
solution of iV-(4,5-dichloro-2-nitrophenyl)sarcosine ethyl ester (0.92 g, 3 mmol) and 
potassium carbonate (0.41 g, 3 mmol) in /V,/V-dimethylfomiamide (13 cm^) and ethanol 
(25 cm^) was stirred at room temperature for 5 h. The solid product was filtered off, 
dissolved in water and acidified with HCl to furnish 90 mg (11%) of product. The 
mother liquor was stirred for a further 9 days, then concentrated under reduced pressure 
and the residue partitioned between water and ether. The aqueous layer was acidified 
with HCl, but no further precipitation occurred. The crude material melted between 
260 "C and 280 °C, with decomposition. Ôr 3.62 (3H, s, CH3), 7.65 (IH, s, 5-H),
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7.75 (IH, s, 8-H). Further purification proved impossible on the small amount of 
material available.
A/^-(2,4-Dinitrophenyl)iminodiacetic acid. A solution of iminodiacetic 
acid disodium salt monohydrate (3.90 g, 20 mmol) in water (30 cm^) was added to a 
stirred solution of 2,4-dinitrochlorobenzene (3.65 g, 18 mmol) in ethanol (60 cm3), and 
the mixture heated under reflux for 15 h, during which another portion of the disodium 
salt (0.39 g, 2 mmol) was added. The solution was concentrated under reduced pressure 
to dryness and the residue partitioned between water and ether. The aqueous layer was 
acidifed (HCl), extracted with ethyl acetate, and the ethyl acetate dried (MgS0 4 ) and 
concentrated under reduced pressure to a yellow solid, which was treated with ether to 
remove traces of starting material to furnish 3.08 g (57%) of product, which was not 
further purified. Ôr 4.19 (4H, s, 2 x CHg), 7.14 (IH, d, 6-H), 8.28 (IH, dd, 5-H), 
8.61 (IH, d, 3-H). 6 9 ,73,5 2 Hz.
Attempted estérification of A -(2,4-dinitrophenyI)im inodiacetic acid.
A solution of iV-(2,4-dinitrophenyl)iminodiacetic acid (0.58 g. 1.9 mmol) in dry ethanol 
(30 cm3) containing dry HCl (2 g) was heated under reflux for 12 h, but only an 
inseparable mixture (by tic and ^H NMR spectroscopy) of products was obtained.
Attempted direct synthesis o f  diethyl A -(2 ,4 -d in itr o p h e n y I ) im in o -  
diacetate (244). A solution of diethyl iminodiacetate (2.27 g, 12 mmol) and fluoro-
2,4-dinitrobenzene (1.86 g, 10 mmol) in dry ethanol (25 cm^) with triethylamine 
(1.74 cm^, 12.5 mmol) was heated under reflux for 11 h, cooled to room temperature 
and concentrated under reduced pressure to ~5 cm^. The yellow crystals were filtered off 
and washed with a little ethanol to give 2,4-dinitrophenetole (247) (0.75 g, 35%); m.p. 
83-85 “C (lit.188 87 °C). Ô r  (CDCI3) 1.55 (3H, t, CH2C //3), 4.33 (2H, q, C //2CH3),
7.20 (IH, d, 6-H), 8.44 (IH , dd, 5-H), 8.75 (IH, d, 3-H). 73,5  3, Js,6 9 Hz. The 
ethanol filtrate was concentrated under reduced pressure to a brown oil, which was
. , ,  -.-I»;.--
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distilled (b.p. 160“C/0.5 mmHg) to give the starting material (diethyliminodiacetate;
1.29 g, 57%). The d istillation residue yielded a yellow product (b.p. 
210 X /0 .5  mmHg; 0.82 g, 23%), tentatively identified as the desired product. 
Attempted recrystallisation from ethanol, however, led to complete recovery of
2,4-dinitrophenetole (247).
Attempted synthesis of diethyl A - ( 2 -n i t r o p h e n y l)a m in o m a !o n a te  
(245). Fluoro-2-nitrobenzene (1.41 g, 10 mmol), diethyl aminomalonate hydrochloride 
(2.96 g, 14 mmol) and potassium carbonate (4.15 g, 30 mmol) were heated together 
under reflux in acetonitrile (50 cm^) for 4 h. Only an intractable mixture was obtained. 
The same result occurred with the attempted synthesis of diethyl iV-(2,4-dinitrophenyl)- 
aminomalonate.
A - ( 2 ,4 - D in i t r o p h e n y I ) - 2 ' ,2 ’,2 ' - t r i f lu o r o e th y la m in e  (2 4 8 ) .  A
solution of fluoro-2,4-dinitrobenzene (1.58 g, 8.5 mmol) and 2,2,2-trifluoroethylamine 
hydrochloride (1.22 g, 9 mmol) in dry N,A-dimethylformamide (5 cm3) with potassium 
carbonate (2.48 g, 18 mmol) was heated to 100 °C for 5 h with stirring, then cooled and 
poured into ice/water. The precipitate was filtered off, washed with water, dried and 
recrystallised from propan-2-ol; 1.37 g (61%), m.p. 116 "C (lit.^^^ 115-6 “C). 5 r  4.48 
(2H, quintet, CH2), 7.48 (IH , d, 6 -H), 8.34 (IH, dd, 5-H), 8.86 (IH, d, 3-H), 8.94 
(IH , t, NH). 7 c H 2CF ~ 7, 73  5 3, 7^ 6 9.5 Hz. 0^ 43.3 (CH2 , q,
7 c ,p 3 3 H z ) ,  115.7 (C-6 ), 123.3 (C-3), 124.9 (CF3 , q , 7 c,p 281 Hz), 130.0 (C-5),
131.1 (C-2), 136.3 (C-4), 147.8 (C-1).
2 -T r i f I u o r o m e th y l-5 -n i tr o - l /7 -b e n z im id a z o le  3-oxide (249). A
suspension of N-(2,4-dinitrophenyl)-2',2',2'-trifluoroethylamine (0.53 g, 2 mmol) and 
potassium carbonate (0.35 g, 2.5 mmol) in diy ethanol (20 cm^) was heated under reflux 
for 7 h, cooled to room temperature and filtered. The filtrate was concentrated under 
reduced pressure to dryness, dissolved in water, extracted with ethyl acetate and the
4%
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aqueous phase acidified (HCl). The buff-coloured precipitate was filtered and washed 
with water to furnish 0.35 g (71%) of product; m.p. 218 “C . (Found: C, 39.1; H, 1.4; 
N, 16.9. C8H4F3N3O3 requires C, 38.9; H, 1.6; N, 17.0%.) Ôr 8.04 (IH, d, 7-H),
8.22 (IH , dd, 6-H), 8.51 (IH , d, 4-H). /g  7 9, 2 Hz. 5c  107.4 (C-4), 118.1
(CFg, 7c,F 271 Hz), 118.8 (C-7), 122.5 (C-6), 132.0 (C-3a), 140.3 (C-5), 140.3 (C-2, 
7c,F 32 Hz), 145.2 (C-7a). m/z 247 (M+-, 37%), 234 (68), 205 (20), 201 (16), 191 
(35), 184 (13), 173 (13), 133 (12), 118 (43), 91 (100) etc.
A -M eth y l-2 ,2 ,2 -tr if lu o ro eth y la in in e  h yd roch lor ide  (252). Under 
nitrogen, a solution of N-methyl-2,2,2-trifluoroacetanilide (3.17 g, 25 mmol) in sodium- 
dried ether (12 cm3) was added at between -10 to -20 "C over 1 h to a stirred suspension 
of lithium aluminium hydride (1.90 g, 50 mmol) in ether (25 cm^). After stirring at this 
temperature for 1 h, then at room temperature overnight, the reaction mixture was cooled 
to 0 ”C and the excess lithium aluminium hydride decomposed by cautious addition of 
water (25 cm^). After stirring at room temperature for 1 h, the volatile portion was 
distilled off, dried (MgS0 4 ), filtered, and dry HCl bubbled through the solution. The 
white hydrochloride salt of the product was filtered off and dried in vacuo, yielding 
1.65 g (44%); m.p. 168-9 “C [lit.i90 >200 T  (dec.)]. Ô r  (D2O) 2.79 (3H, s, NCH3), 
3.90 (2H, q, CH2). 7c h 2CF3 8.5 Hz. 5c 36.3 (Me), 51.3 (CH2, 7c,CF3 35 Hz), 125.1 
(C F3,7c,f 277 Hz).
/V -(2 ,4 -D in itrophenyl)-A /-m ethyl-2’,2 ',2 ’- tr if lu o r o e th y lam ine (250).
A solution of fluoro-2,4-dinitrobenzene (0.93 g, 5 mmol) and A -m ethyl-2,2,2- 
trifluoroethylamine hydrochloride (0.80 g, 5.4 mmol) in dry N,A/-dimethylformamide 
(3 cm3) containing potassium carbonate (1.52 g, 11 mmol) was stirred at 120 °C for 
66 h, then cooled to room temperature and poured into ice/water with stirring. The 
brown precipitate was filtered off, washed with water and dried in vacuo. The product 
was distilled (Kugelrohr) as a yellow oil; b.p. 160 “C/0.2 mmHg. ô r  (CDCI3) 3.12 
(3H, s, CH3), 3.94 (2H, q, CH2), 7.25 (IH, d, 6-H), 8.31 (IH, dd, 5-H), 8.69 (IH, d,
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3-H). /C H 2CF3 8.5, 75,6 8, 73,5 2 Hz. Further attempts at purification were 
unsuccessful.
Attempted synthesis of A - ( 2 ,6 - d in i t r o p h e n y l ) - 2 ' ,2 ' ,2 ' - t r i f lu o r o -  
ethylamine (253). A solution of chloro-2,6-dinitrobenzene (1.62 g, 8 mmol) and 
2,2,2-trifluoroethylamine hydrochloride (1.15 g, 8.5 mmol) in dry N ,N-dimethyl- 
formamide (5 cm^) containing potassium carbonate (2.35 g, 17 mmol) was heated at 
110 °C for 6 days, during which time extra portions of the amine (0.41 g, 3 mmol) and 
potassium carbonate (0.83 g, 6 mmol) were added. The reaction mixture still contained 
mainly starting material by tic.
A -(3 -N itr o -2 -p y r id y l) - (5 ) -a Ia n in e  methyl ester (257). 2 -C h lo ro -
3-nitropyridine (1.58 g, 10 mmol) and (5)-alanine methyl ester hydrochloride (2.51 g, 
17 mmol) in dry methanol (15 cm^) containing triethylamine (4.6 cm^, 34 mmol) were 
heated under reflux for 8.5 h, cooled and concentrated under reduced pressure to 
dryness. The residue was partitioned between water and ethyl acetate, the organic layer 
washed with water then saturated brine, dried (MgSO^) and concentrated under reduced 
pressure to dryness. Yield 1.64 g (73%); b.p. 172 “C/0.9 mmHg [lit.i^i (for the 
R-enantiomer) m.p. 39-40 “C]. Ôr (CDCI3) 1.59 (3H, d, C H C //3), 3.76 (3H, s, 
CO2CH3), 4.88 (IH, quintet, C //CH3), 6.70 (IH, dd, 5-H), 8.40 (2H, m, 4- and 6-H). 
7cRCR3 7, 75,6 4.5, 74,5 8 Hz. 6^ 18.1 (CHCH3), 49.7 (CH), 52.3 (CO2CH3), 112.6 
(C-5), 123.0 (C-3), 135.2 (C-4), 152.5 (C-2), 155.3 (C-6), 173.7 (CO).
2-M ethyI-37f-im idazo[4,5-^>]pyridine 1-oxide (259). A solution of 
A/-(3-nitro-2-pyridyl)-(5)-alanine methyl ester (0.34 g, 1.5 mmol) in dry methanol 
(10 cm3) containing potassium carbonate (0.25 g, 1.8 mmol) was heated under reflux 
for 2 h, cooled to room temperature and concentrated under reduced pressure to dryness. 
The residue was partitioned between water and ethyl acetate, and the aqueous layer 
acidified (HCl) and extracted with ethyl acetate to furnish N-(3-nitro-2-pyridyl)-
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(S)-alanine (0.06 g, 19%). The remaining aqueous layer was taken to pH 8 with sodium 
hydroxide solution to give a reddish solution, which was concentrated under reduced 
pressure to dryness and the residue extracted with acetone to give 2-methyl- 
3//-imidazo[4,5-/)]pyridine 1-oxide (0.04 g, 18%). ô r  2.28 (3H, s, CH3), 6.94 (IH, 
dd, 6-H), 7.45 (IH, dd, 7-H), 8.14 (IH, dd, 5-H). 1.5, 76,7 8, 7g,6 4.5 Hz. The
original ethyl acetate extract from the reaction mixture residue was dried (MgS0 4 ) and 
concentrated under reduced pressure to a brown oil which yielded a very small amount of 
yellow needles, tentatively identified as ethyl 3//-imidazo[4,5-^]pyridine-2-carboxylate 
1-oxide (260); ô r  (CDCI3) 4.12 (CH3), 7.05 (IH, dd, 6-H), 8.28 (IH, dd, 7-H), 8.41 
(IH, dd, 5-H). 75 7 1.5, 76 7 8,7^ 6 4.5 Hz.
l,3-D ichIoro-4,6-dinitrobenzene. m-Dichlorobenzene (29.4 g, 200 mmol) 
was added to a solution of potassium nitrate (40.4 g, 400 mmol) in concentrated 
sulphuric acid (150 cm^) at 50 “C with stirring. The temperature was maintained at 
130 “C for 2 h, cooled to room temperature and poured on to crushed ice. The pale 
yellow product was washed with water, filtered off, dried in vacuo and recrystallised 
from ethanol to give 29.9 g (63%); m.p. 99-101 “C (lit.i92 103-4 “C). Ôr 7.85 (IH, s,
6-H), 8.58 (IH, s, 3-H).
A -(5-Chloro-2,4-dinitrophenyl)glycine ethyl este r (269; R = H). A
solution of glycine (3.0 g, 40 mmol) and sodium hydrogen carbonate (6.72 g, 80 mmol) 
in water (80 cm^) was added to a suspension of l,3-dichloro-4,6-dinitrobenzene (9.48 g, 
40 mmol) in ethanol (150 cm3), and the mixture heated under reflux for 6 h. After 
cooling to room temperature, the precipitate was filtered off, dissolved in water then 
N-(5-chloro-2,4-dinitrophenyl)glycine reprecipitated by acidification (HCl); the product 
was filtered and dried in vacuo; 9.80 g (89%), m.p. 197-8 °C (lit. ^ 93 200-1 °C). 5 r
4.33 (2H, d, CH2), 7.29 (IH, s, 6-H), 8.87 (IH, s, 3-H), 8.93 (IH, t, NH). J^uCHi 
6 Hz.
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A suspension of N-(5-chloro-2,4-dinitrophenyl)glycine (9.80 g, 35.6 mmol) in 
ethanol (120 cm^) had dry HCl (about 7 g) bubbled through it. As soon as the acid 
dissolved, the ester precipitated, was filtered off, washed with ethanol and dried in vacuo 
to give 7.98 g (74%) of product; m.p. 154 “C (lit.i94 150-1 “C). Ôr (CDCI3) 1.36 (3H, 
t, CH3), 4.15 (2H, d, NCH2), 4.36 (2H, q, CH2CH 3), 6.82 (IH , s, 6-H), 8.85 (IH, 
br s, NH), 9.09 (IH , s, 3-H). /C H 2CH3 7, 7n h c H 2 5 Hz. 5 c  14.0 (CH3), 44.8 
(NCH2), 62.5 (CH2CH3), 116.3 (C-6), 126.8 (C-3), 129.4 (C-2), 129.7 (C-5), 136.0 
(C-4), 145.7 (C-1), 167.9 (CO).
6 -C h io ro -5 -n itrO “liy -benzim idazole 3-oxide (270). a) A solution of 
N-(5-chloro-2,4-dinitrophenyl)glycine ethyl ester (0.61 g, 2 mmol) in boiling ethanol 
(40 cm^) had added to it potassium carbonate (0.28 g, 2 mmol). The mixture was heated 
under reflux for 22 h, then filtered and the precipitate extracted with boiling acetone. The 
acetone-insoluble residue was dissolved in water, acidified (HCl); the precipitate was 
washed with water and dried in vacuo to give 0.21 g (49%) of the title compound. Ôr
8.05 (IH , s, 4-H), 8.33 (IH, s, 7-H), 8.78 (IH, s, 2-H). ôc  107.7 (C-4), 117.9 
(C-3a), 122.0 (C-7), 129.3 (C-6), 141.3 (C-5), 143.1 (C-7a), 145.2 (C-2).
b) A solution of the ester (7.71 g, 28 mmol) in boiling ethanol (400 cm^) had 
added to it potassium carbonate (3.86 g, 28 mmol). The mixture was heated under reflux 
for 12.5 h, filtered, and the precipitate extracted with boiling acetone, dissolved in water 
and acidified (HCl). The brown precipitate was filtered off and dried in vacuo to give 
0.87 g (15%) of the 2-unsubstituted benzimidazole 3-oxide. The reaction mixture filtrate 
was concentrated under reduced pressure to dryness, dissolved in water, acidified (HCl) 
and the yellow precipitate filtered off and recrystallised from ethanol to furnish ethyl
6-chloro-5-nitro-lH-benzimidazole-2-carboxylate 3-oxide (1.62 g, 20%); m.p. 215-6 °C. 
ÔR 1.35 (3H, t, CH3), 4.42 (2H, q, CH2), 8.20 (IH , s, 4-H), 8.42 (IH , s, 6-H).
7 Hz. Ô C  14.0 (CH3), 62.3 (CH^), 108.8 (C-4), 119.1 (C-3a), 123.4 (C-7),
130.7 (C-6), 138.4 (C-5), 142.1 (C-7a), 145.1 (C-2), 157.1 (CO). Further purification 
for microanalysis was not achieved.
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c) Ethyl 6-chloro-5-nitro-l//-benzimidazole-2-carboxylate 3-oxide (1.00 g,
3.5 mmol) in concentrated hydrochloric acid (20 cm^) was heated under reflux for 6 h, 
the solution cooled to room temperature and concentrated under reduced pressure to 
dryness. The residue was dissolved in concentrated ammonia (50 cm^) and concentrated 
under reduced pressure again to dryness; the residue was stirred in boiling water and the 
water-insoluble solid filtered off and dried in vacuo to give the 2-unsubstituted 
benzimidazole N-oxide (0.45 g, 60%). 5 r  as in (a).
N -(5-C h Ioro-2,4-dinitrophenyl)sarcosine ethyl ester (269; R = Me).
A suspension of l,3-dichloro-4,6-dinitrobenzene (4.74 g, 20 mmol) in ethanol (80 cm^) 
had added to it at room temperature a solution of sarcosine (1.78 g, 20 mmol) and 
sodium hydrogen carbonate (3.36 g, 40 mmol) in water (40 cm^). The mixture was 
heated under reflux for 7 h, concentrated under reduced pressure to dryness and 
partitioned between water and ether. The aqueous layer was acidified (HCl), and the 
yellow precipitate filtered, washed with water and dried in vacuo ; recrystallisation from 
propan-2-ol furnished 5.00 g (86%) of A/-(5-chloro-2,4-dinitrophenyl)sarcosine; 
m.p. 188 “C. (Found: C, 37.5; H, 2.8; N, 14.5. CgHgClNgO^ requires C, 37.3; H, 
2.8; N, 14.5%.) Ôr 2.90 (3H, s, CH3), 4.27 (2H, s, CH2), 7.30 (IH, s, 6-H), 8.62 
(IH, s, 3-H). 7cH2CH3 7 Hz. 0^ 41.7 (CH2), 54.7 (CH3), 120.2 (C-6), 126.7 (C-3),
131.2 (C-2), 134.2 (C-5), 134.8 (C-4), 147.2 (C-1), 170.0 (CO), m/z 289 (M+., 8%), 
244 (100), 241 (26), 211 (52), 198 (37), 181 (19), 165 (20), 152 (34) gfc.
A/-(5-Chloro-2,4-dinitrophenyl)sarcosine (3.76 g, 13 mmol) in ethanol (40 cm^) 
containing dry HCl (3 g) was heated under reflux for 7 h, then cooled to room 
temperature and concentrated under reduced pressure to an oil which solidified upon 
standing. The solid was recrystallised from propan-2-ol to yield 3.66 g (89%) of 
product; m.p. 102-3 “C. (Found: C, 41.8; H, 3.9; N, 13.2. C11H 12CIN3O6 requires 
C, 41.6; H, 3.9; N, 13.3%.) Ôr (CDCI3) 1.33 (3H, t, CH2C //3), 3.05 (3H, s, NCH3),
4.02 (2H, s, NCH2), 4.29 (2H, q, C //2CH 3), 7.01 (IH, s, 6-H), 8,62 (IH, s, 3-H). 
7cH2CH3 7 Hz. ÔC 14.0 (CH2CH3), 41.5 (NCH2), 55.3 (NCH3), 62.1 (CH2CH3),
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120.7 (C-6), 126.4 (C-3), 133.3 (C-2), 135.4 (C-5), 136.5 (C-4), 147.4 (C-1), 168.2 
(CO).
6-C h loro-l-hyd roxy-4-m ethyl-7-n itroq uin oxaline-2 ,3-d ione (271).
A solution of A-(5-chloro-2,4-dintrophenyl)sarcosine ethyl ester (1.27 g, 4 mmol) in 
ethanol (20 cm^) and A ,A-dimethylformam ide (14 cm3) with potassium carbonate 
(0.55 g, 4 mmol) was stirred at room temperature for 72 h, then filtered. The solid was 
extracted exhaustively with boiling acetone, dissolved in water, acidified (HCl) and the 
brown precipitate filtered off and dried in vacuo; 0.38 g (35%). Ôr 3.54 (3H, s, CHg),
7.78 (IH, s, 5-H), 8.12 (IH, s, 8-H), 12.15 (IH, br s, OH). 5c 30.7 (CH3), 110.2 
(C-8), 117.4 (C-5), 120.8 (C-8a), 126.9 (C-6), 129.8 (C-4a), 141.7 (C-7), 150.1 
(C-3), 155.2 (C-2).
A/-(5-Fluoro-2,4-dinitrophenyl)sarcosine ethyl ester (269; R = Me;
F for Cl). A mixture of l,3-difluoro-4,6-dinitrobenzene (2.04 g, 10 mmol), sarcosine 
(0.89 g, 10 mmol), sodium hydrogen carbonate (1.68 g, 20 mmol), ethanol (40 cm3) and 
water (20 cm3) was heated under reflux for 5 h, concentrated under reduced pressure to 
dryness and partitioned between water and ether. The aqueous layer was acidified (HCl) 
and the yellow A-(5-fluoro-2,4-dinitrophenyl)sarcosine filtered and dried in vacuo; 
1.86 g (68%); m.p. 174 “C (from ethanol). (Found: C, 39.8; H, 2.8; N, 15.2. 
C9H8FN3O6 requires C, 39.6; H, 2.95; N, 15.4%.) 5 r  2.90 (3H, s, CH3), 4.25 (2H, 
s, CH2), 7.17 (IH, d, 6-H), 8.61 (IH, d, 3-H). 73,p 8, 76,? 15 Hz. 5c 41.8 (CH3),
54.9 (CH2), 105.8 (C-6), 125.5 (C-3), 126.9 (C-4), 132.1 (C-2), 149.5 (C-1), 157.1 
(C-5), 169.6 (CO). 75,F 265, 76,f  27, 7r f  13, 73,? 9 Hz.
A solution of/V-(5-fluoro-2,4-dinitrophenyl)sarcosine (1.65 g, 6 mmol) in 
ethanol (40 cm^) containing dry HCl was heated under reflux for 6 h, then cooled and 
concentrated under reduced pressure to dryness; the residue was stirred in water and the 
the product filtered and dried in vacuo; 1.53 g (85%); m.p. 71-4 “C (from ethanol/water). 
(Found: C, 43.0; H, 3.7; N, 13.7. CnHi2FN3O6.0.25 H2O requires C, 43.2; H, 4.1;
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N, 13.7%.) 6h (CDCI3) 1.33 (3H, t, CH2C //3), 3.05 (3H, s, NCH3), 4.02 (2H, s, 
NCH2), 4.29 (2H, q, C //2CH 3), 6.68 (IH, d, 6-H), 8.70 (IH, d, 3-H). JcHzCHa 7, 
73,F 8,76,F 13 Hz. m/z 301 (M+-, 6%), 228 (100), 202 (50), 182 (23), 172 (28) etc. 
Further attempts at purification were unsuccessful.
6-FIuoro-l-hydroxy-4-m ethy!-7-nitroquinoxaline“2,3-dione (271; F 
for Cl). A solution of A-(5-fluoro-2,4-dinitrophenyl)sarcosine ethyl ester (0.30 g, 
1 mmol) in dry ethanol (15 cm^) containing potassium carbonate (0.15 g, 1.1 mmol) 
was heated under reflux for 6 h, cooled, concentrated under reduced pressure to dryness 
and the residue dissolved in water. The aqueous solution was acidified (HCl), filtered, 
and the filtrate extracted with ethyl acetate. The organic extract was dried (MgSO^), 
concentrated under reduced pressure and recrystallised from water to give 0.14 g (54%) 
of product. ÔH 3.52 (3H, s, CH3), 7.73 (IH, d, 5-H), 8.10 (IH, d, 8-H), 12.12 (IH, 
br s, OH). 75.R f  13,7g_R F 7 Hz. Attempts at purification were unsuccessful.
A,/V -(4,6-D initro-l,3-phenylene)bis-gIycine diethyl ester (266). A
solution of l,3-dichloro-4,6-diniti*obenzene (2.37 g, 10 mmol) and glycine ethyl ester 
hydrochloride (2.79 g, 20 mmol) in dimethyl sulphoxide (15 cm3) containing sodium 
hydrogen carbonate (3.36 g, 40 mmol) was heated to 90 “C with stirring, until 
effervescence ceased, then cooled to room temperature and diluted with water; the 
yellow-brown precipitate was filtered off, washed with water and dried in vacuo to give
3.23 g (87%); m.p. 190-2 “C (dec.) (lit. 1^ 6 190-1“C). Ôr 1.23 (6H, t, 2 x CH3), 4.18 
(4H, q, 2 X C //2CH3), 4.30 (4H, d, 2 x NCH2), 5.73 (IH , s, 2-H), 8.68 (2H, t, 2 x 
NH), 8.98 (IH, s, 5-H). 7c r 2CH3 7, 7c r 2NH 7 Hz. ôc 14.3 (CH3), 44.9 (NCH2),
61.5 (CH2CH 3), 92.7 (C-2), 124.0 (C-4 and -6), 128.6 (C-5), 147.8 (C-1 and -3),
169.4 (CO).
Reaction of A /,A /-(4 ,6 -D in itro -l,3 -p h en y len e)b is-g lycin e  diethyl 
ester (266) with potassium carbonate. A mixture of the diester (0.74 g, 2 mmol)
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and potassium carbonate (0.55 g, 4 mmol) in dry ethanol (15 cm^) was heated under 
reflux for 6 h, cooled to room temperature and the brown solid filtered off. The solid 
wsa dissolved as much as possible in water; the insoluble product (0.41 g, 55%) was 
identified as unchanged starting material. The aqueous solution was acidified (HCl), 
ethyl acetate added, and the mixture stined until the ethyl acetate had evaporated; the 
brown solid was filtered off and identified by ^H NMR spectroscopy as the acid resulting 
from hydrolysis of the starting material Ôr 4.22 (4H, d, 2 x CH%), 5.78 (IH, s, 2-H),
8.69 (2H, t, 2 X NH), 9.00 (IH, s, 5-H).
Sarcosine ethyl ester hydrochloride. A suspension of sarcosine (5.34 g, 
60 mmol) in ethanol (40 cm^) was saturated with dry HCl, then the solution heated under 
reflux for 2.5 h, cooled to room temperature, concentrated under reduced pressure to 
dryness and the residue recrystallised from ethanol; 6.02 g (65%), m.p. 127 “C (lit.^95 
127-8 “C). ÔR (D2O) 1.22 (3H, t, CH2C H 3), 2.72 (3H, s, NCH3), 3.92 (2H, s, 
NCH2), 4.23 (2H, q, C //2CH3), ./CH2CH3 Hz.
A /,A -(4 ,6 -D in itro -3 ,5 -phenyIene)b is-sarcosine d ie thy l e ste r (273).
A solution of l,3-dichloro-4,6-dinitrobenzene (4.74 g, 20 mmol) and sarcosine ethyl 
ester hydiochloride (6.45 g, 42 mmol) in dimethyl sulphoxide (20 cm^) had added to it 
sodium hydrogen carbonate (7.06 g, 84 mmol), and the mixture heated to 90 °C with 
stirring, until effervescence ceased. The solution was cooled to room temperature, 
diluted with water, and the brown solid filtered off and recrystallised from acetic acid; 
3.32 g (42%), m.p. I l l  “C. (Found: C, 48.25; H, 5.7; N, 14.0. C 16H 22N 4O 8 
requires C, 48.2; H, 5.6; N, 14.1%.) Ôr 1.21 (6H, t, 2 x CH2C //3), 2.88 (6H, s, 2 x 
NCH3), 4.15 (4H, q, 2 X C //2CH3), 4.17 (4H, s, 2 x NCH2), 6.11 (IH, s, 2-H), 8.43 
(IH, s, 5-H). /CH2CH3 7 Hz. ÔC 14.1 (CH2CH3), 40.9 (NCH3), 54.8 (NCH2), 60.7 
(CH2CH3), 104.5 (C-2), 128.6 (C-4,6), 129.3 (C-5), 148.4 (C-1,3), 169.0 (CO), m/z 
398 (M+-, 6%), 381 (5), 325 (100), 291 (7) gfc.
157
Reaction of A ,A -(4 ,6 -d in itro-3 ,5 -p h en ylen e)b is-sarcosine diethyl 
ester (273) with potassium carbonate. A solution of the diester (0.80 g, 2 mmol) 
in dry ethanol (15 cm^) containing potassium carbonate (0.62 g, 4.5 mmol) was heated 
under reflux for 7 h, then cooled to room temperature and the dark red solid filtered off. 
Exhaustive extraction (Soxhlet) with acetone, and dissolution of the residue in water and 
acidification (HCl) both failed to yield any identifiable products.
Reaction of A ^,A -(4,6-d initro-3,5-phenylene)bis-sarcosine diethyl 
ester (273) with sodium ethoxide. A solution of the diester (0.80 g, 2 mmol) in 
dry ethanol (15 cm^) and dry A7/-dimethylformamide (12 cm^) had added to it sodium 
ethoxide [from Na (0.10 g, 4.3 mmol) in ethanol (4 cm^)] dropwise at 0-5 “C with 
stirring. The solution was warmed to room temperature and stirred for 72 h, then 
concentrated under reduce pressure to dryness. Again, no identifiable products could be 
isolated.
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C hloro-2,6 -d initrobenzene. Sodium nitrite (4.56 g, 66 mmol) was added 
over 15 min to concentrated sulphuric acid (50 cm^) with stirring, then heated to -60  “C 
until all the sodium nitrite dissolved. The mixture was cooled in an ice bath, then a 
solution of 2,6-dinitroaniline (10.98 g, 60 mmol) in hot acetic acid (120 cm^) was added 
slowly with stirring, such that the temperature remained below 40 “C. The mixture was 
then stirred at 40 “C for 30 min. The diazonium salt solution was added to a solution of 
cuprous chloride (13.2 g, 132 mmol) in concentrated HCl (120 cm^) over 20 min with 
stirring and cooling in an ice bath. The reaction mixture was then heated to 80 “C and 
stirred at that temperature for 20 min, until effervescence ceased. An equal volume of 
water was added and the mixture cooled in an ice bath. After 1.5 h the yellow crystals 
(10.03 g, 83%) were collected and dried; m.p. 85-6 “C (lit.^^^ 86-7 “C). Ôr (CDCI3) 
7.62 (IH, t, 4-H), 8.01 (2H, d, 3- and 5-H). 7 3 4 = 7 4 5  8 Hz.
A “(w -B u ty l) -2 ,6 -d in itro a n ilin e  (274). A solution of chloro-
2,6-dinitrobenzene (0.41 g, 2 mmol) and «-butylamine (0.29 g, 4 mmol) in dry 
A,A-dimethylformamide (2 cm^) was left at room temperature for 72 h, then heated to 
130 °C for 30 min, cooled to room temperature and poured into ice/water. The yellow 
precipitate was filtered off, washed with water and ethanol and dried in vacuo to give 
0.33 g (69%) of product; m.p. 29-30 “C (lit.i96 39.40 °c). Ôr 0.84 (3H, t, CH3), 1.27 
(2H, sex, CA2CH3), 1.56 (2H, quin, CH2C //2CH2), 2.89 (2H, dt, NCH2), 6.88 (IH, 
t, 4-H), 8.05 (IH , br t, NH), 8.26 (2H, d, 3- and 5-H). 7CR2CH3 — 7CR2CH2 7, 
•7n h c H2 5, 73 4 = 75 4 = 8 Hz.
2 -« -P ro p y l-7 -n itro -lJ7 -b en z im id azo Ie  3-oxide (275). A solution of 
A-(«-butyl)-2,4-dinitroaniline (0.20 g, 0.8 mmol) in 60% dioxan/water (50 cm^) with 
0.5 M sodium hydroxide (i.e. 1.6 g NaOH) was heated under reflux for 45 min. The red 
solution was cooled to room temperature and 1 M aqueous sodium dihydrogen
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orthophosphate was added to bring the pH down to 6 . The white precipitate was filtered 
off (inorganic). The solution was concentrated under reduced pressure to dryness and 
the residue extracted exhaustively (Soxhlet) into acetone, which was removed under 
reduced pressure to give 0.15 g (83%) of the title compound. Ôr 0.97 (3H, t, CH3), 
1.80 (2H, sex, C //2C H 3), 2.89 (2H, t, C //2CH 2), 7.39 (IH, t, 5-H), 7.87 (IH , d, 
4-H), 8.00 (IH, d, 6-H). /cHzCHz ~ '^ cm cm  ~ 7, 7^ 5 = 7g ^ 8 Hz. 13.6 (CH3),
20.0 (C-2'), 27.4 (C-1'), 115.3 (C-4), 118.1 (C-6), 121.1 (C-5), 131.2 (C-7a), 135.0 
(C-7), 137.8 (C-3a), 155.1 (CO). NMR data compare favourably with those of 
de Vargas and Cahas^"^9  ^ who also further characterised the title compound by high 
resolution mass spectrometry.
A -(2 ,6-D in itrophenyl)-'y-am inobutyric acid (279). A solution of 
y-aminobutyric acid (0.54 g, 5.2 mmol) and sodium hydrogen carbonate (0.87 g,
10.4 mmol) in water (10 cm3) was added to a stirred suspension of chloro-
2,6-dinitrobenzene (1.01 g, 5 mmol) in ethanol (20 cm3) at room temperature. The 
mixture was heated under reflux for 5 h, concentrated under reduced pressure to dryness, 
dissolved in water and extracted with ether. The aqueous phase was acidified (HCl) and 
the yellow precipitate filtered off, washed with water and dried in vacuo to give 1.14 g 
(85%) of the title compound; m.p. 173-4 “C. Ôr 1,80 (2H, quin, CH2C //2CH2), 2.24 
(2H, t, C //2CO2H), 2.91 (2H, q, NCH2), 6.88 (IH, t, 4-H), 8.02 (IH, t, NH), 8.25 
(2H, d, 3- and 5-H), 12.15 (IH, br s, CO). 7c r 2CH2 7, 73 4 = 74,5 = 8 Hz. 5c 24.8 
(CH2CH2CH2), 30.8 (CH2CO), 45.7 (NCH2), 114.9 (C-4), 132.3 (C-3 and -5), 137.9 
(C-2 and -6), 139.2 (C-1), 173.9 (CO). Although no impurities were detected by NMR 
spectroscopy, the sample was insufficiently pure for microanalysis.
Reaction of A -(2,6-dinU rophenyl)-y-am inobutyric acid (279) with 
sodium hydroxide. A solution of A-(2,6-dinitrophenyl)-y-aminobutyric acid (0.22 g, 
0.8 mmol) in dioxan (48 cm3) and water (32 cm^) containing sodium hydroxide (1.6 g) 
(i.e. 0.5 M NaOH) was heated under reflux for 60 min, cooled to room temperature and
160
acidified (HCl). The solution was concentrated under reduced pressure to dryness and 
the residue extracted exhaustively with acetone (Soxhlet); the acetone was removed under 
reduced pressure to leave a very small amount of impure residue, tentatively identified as 
3-(7-nitro-3-oxido-l//-benzimidazol-2-yl)propionic acid. Ôr 2.92 (2H, t, C //2CO2H),
3.25 (2H, t, CCH2), etc. (see Discussion, pages 105-106). ^cHzCHz 7 Hz.
A -(2 ,6 -D in itro p h en y l)-A -m e th y !-« -b u ty lam in e  (280). A solution of 
chloro-2,6-dinitrobenzene (0.61 g, 3 mmol) and A-methyl-«-butylam ine (0.52 g, 
6 mmol) in dry A,A-dimethylformamide (2 cm^) was stirred at room temperature for 
72 h, then poured into ice/water and the orange solid (0.76 g, 100%) filtered off and 
dried in vacuo; m.p. 52-53 “C. Ôr (CDCI3) 0.88 (3H, t, CH2C //3), 1.28 (2H, sex, 
C //2CH3), 1.53 (2H, quin, CH2CA2CH2 ), 2.83 (3H, s, NCH3), 2.91 (2H, t, NCHg),
7.14 (IH, t, 4-H), 7.81 (2H, d, 3- and 5-H). /cHzCHz = /cHzCHa = 7, 734  7 Hz. ôc
13.6 (CH3), 19.7 (CH2CH3), 29.9 (CH2CH2CH2), 40.1 (NCH3), 54.9 (NCH2), 121.4 
(C-6), 128.8 (C-3 and -5), 139.9 (C-2 and -4), 147.3 (C-1). m/z 253 (M+-, 9%), 210 
(100), 194 (10), 105 (9), 79 (9) etc. Further purification for microanalysis was 
unsuccessful.
R eaction of A -(2 ,6 -d in itro p h e n y I)-A -m e th y I-r t"b u ty la m in e  (280) 
with NaOH. A solution of A-(2,6-dinitrophenyl)-A-methylbutylamine (0.25 g, 
1 mmol) in dioxan (150 cm^) and water (100 cm^) containing sodium hydroxide (2.0 g) 
(i.e. 0.2 M NaOH) was heated under reflux for 2 h. The solution was cooled to room 
temperature, taken to pH 6 with HCl, then concentrated under reduced pressure to 
dryness and the residue extracted exhaustively with acetone (Soxhlet) to give 100% 
recovery of starting material.
Reaction of A -(2 ,6 -d in itro p h en y l)-A -m eth y lb u ty lam in e  (280) with 
potassium  carbonate . A solution of A-(2,6-dinitrophenyl)-A-methylbutylamine 
(0.25 g, 1 mmol) in dry ethanol (10 cm^) containing potassium carbonate (0.14 g.
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1 mmol) was heated under reflux for 18 h, concentrated under reduced pressure to 
dryness, and the residue partitioned between water and ethyl acetate. The organic layer 
was dried (MgS0 4 ) and concentrated under reduced pressure to give 0.23 g (92%) of 
starting material.
A -(2,6-D initropheny l)gIycine ethyl ester (192). A solution of glycine 
(1.35 g, 18 mmol) in water (20 cm^) with sodium hydrogen carbonate (3.02 g, 36 mmol) 
was added to a stirred solution of chloro-2,6-dinitrobenzene (3.04 g, 15 mmol) in 
methanol (30 cm^) at room temperature. The mixture was heated under reflux for 2 h and 
concentrated under reduced pressure to dryness. Water was added to the residue, and the 
insoluble copper-coloured solid was filtered off and treated with 2 M HCl until it turned 
yellow, whereupon it was filtered off and recrystallised from methanol, giving 
A-(2,6-dinitrophenyl)glycine; 3.05 g (84%), m.p. 173-4 “C (lit. 9^7 173 'Q  3.71 
(2H, d, CH2), 6.86  (IH , t, 4-H), 8.21 (2H, d, 3- and 5-H), 9.06 (IH, br s, NH). 
7cH2,NH 4.5, 73 4 8 Hz.
A solution of A-(2,6-dinitrophenyl)glycine (2.29 g, 9.5 mmol) in ethanol 
(60 cm^) containing concentrated sulphuric acid (1.30 g) was heated under reflux for 
4 h, concentrated under reduced pressure to dryness, and the yellow crystals (2.55 g, 
100%) were collected and washed with water; m.p. 86 “C (lit.i98 86 "C). Ôr (CDCI3)
1.31 (3H, t, CH3), 3.78 (2H, s, NCH2), 4.28 (2H, q, C //2C H 3), 6.85 (IH, t, 4-H), 
8.22 (2H, d, 3- and 5-H), 9.05 (IH, br s, NH). 7c r 2,cH3 7, 73 4 8 Hz.
l-H ydroxy-5-n itroquinoxaline-2 ,3-d ione (194). A solution of A -(2 ,6 - 
dinitrophenyl)glycine ethyl ester (0.54 g, 2 mmol) in ethanol (20 cm3) and 
A,A-dimethylformamide (2.5 cm^) with potassium carbonate (0.30 g, 2.2 mmol) was 
stirred at room temperature for 20 h, filtered, and the solid dissolved in water. The 
aqueous solution was acidified (HCl) and filtered. The filtrate precipitated on standing 
for 3 days; the red crystals (0.055 g)were identified as the title compound, and the filtrate 
was concentrated under reduced pressure to a small volume, extracted into ethyl acetate.
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dried (MgSO^) and concentrated under reduced pressure to dryness; 0.11 g (also 
identified as the title compound) (total yield 37%), m.p. 232 °C (lit.^32 231-2 °C). Ôr 
7.39 (IH, t, 7-H), 7.82 (IH, dd, 6- or 8-H), 7.98 (IH, dd, 6- or 8-H), 11.3-12.0 (2H, 
2 X br s, NH and OH), ^ 9, 76,8 2 Hz. 6c  119.4 (C-6), 119.8 (C-4a), 121.0 (C-8),
123.6 (C-7), 130.3 (C-8a), 135.3 (C-5), 151.3 (C-3), 154.9 (C-2).
A -(2 ,6 -D in itro p h en y l)-(i?5 )-a lan in e  ethyl ester (289). A solution of 
(/?5)-alanine (1.07 g, 12 mmol) in water (20 cm3) containing sodium hydrogen carbonate 
(2.94 g, 35 mmol) was added to a stirred solution of chloro-2 ,6-dinitrobenzene (2.03 g, 
10 mmol) in ethanol (30 cm^), and the mixture heated under reflux for 5.5 h, then 
concentrated under reduced pressure to dryness. The residue was partitioned between 
ether and water, the aqueous layer acidified (HCl), extracted with ethyl acetate, dried 
(M gSO ^) and concentrated under reduced pressure to give 1.66 g (65%) of 
A-(2,6-dinitrophenyl)-(/?5)-alanine m.p. 136-7 “C (lit. 195 136 “C). Ôr 1.36 (3H, d, 
CHg), 3.84 (IH, br quintet, CH), 7.06 (IH, t, 4-H), 8.33 (2H, d, 3- and 5-H). 7c r c r 3 
6 .4 , 73,5 8.0. 6c  18.6 (CH3), 53.5 (CH), 117.1 (C-4), 132.5 (C-3 and -5), 137.7 (C-2 
and -6), 139.5 (C-1), 173.6 (CO).
A solution of A-(2,6-dinitrophenyl)-(/?5)-alanine (1.62 g, 6.4 mmol) in ethanol 
(50 cm^) containing dry HCl (2.0 g) was heated under reflux for 4.5 h, then concentrated 
under reduced pressure to an oil (1.51 g, 83%); b.p. 180 “C/0.05 mmHg. (Found: C, 
46.5; H, 4.8; N, 15.1. C n H i 3N 306  requires C, 46.65; H, 4.6; N, 14.8%.) Ôr 
(CDCI3) 1.25 (3H, t, CH2C //3), 1.49 (3H, d, CHC//3), 4.02 (IH, quintet, CH), 4.18 
(2H, q, CH2), 6.90 (IH , t, 4-H), 8.20 (2H, d, 3- and 5-H), 8.58 (IH , d, NH). 
7cH2CH3 7 .1, 7c r c r 3 6.9, 73,4 8.1. 6c  14.0 (CH2CH3), 19.0 (CHCH3), 53.7 (CH), 
62.1 (CH2), 116.2 (C-4), 132.0 (C-3 and -5), 138.5 (C-2 and -6), 139.6 (C-1), 172.1 
(CO).
Reaction of A -(2 ,6 -d in itro p h e n y l)- ( i? 5 )-a Ia n in e  ethyl e ste r (289) 
with potassium carbonate. A solution of A-(2,6-dinitrophenyl)-(/?5)-alanine ethyl
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ester (0.42 g, 1.5 mmol) in dry ethanol (12 cm^) and A,A-dimethylformaniide (2 cm^) 
containing potassium carbonate (0.23 g, 1.7 mmol) was stirred at room temperature for 
21 h, then heated under reflux for 4.5 h. The reaction mixture was concentrated under 
reduced pressure to dryness, dissolved in water and exracted into ethyl acetate. Only an 
intractable mixture (by tic and NMR spectroscopy) of products was obtained.
A -(2 ,6 -D in itropheny l)-(R 5)-norvaH ne methyl es ter (290). A solution 
of chloro-2,6-dinitrobenzene (0.81 g, 4 mmol) and (/?5)-norvaline (0.49 g, 4.2 mmol) in 
ethanol (15 cm^) with sodium hydrogen carbonate (1.06 g, 12.6 mmol) in water 
(10 cm3) was heated under reflux for 5 h, concentrated under reduced pressure to 
dryness, dissolved in water, extracted with ether and the aqueous phase acidified (HCl) 
to give a yellow precipitate of A-(2,6-dinitrophenyl)-(/?5)-norvaline (0.96 g, 85%), 
which was filtered off and dried in vacuo; m.p. 156-7 °C. Ôr 0.81 (3H, t, CHg), 1.24 
(2H, sex, C //2C H 3), 1.68 (2H, m, CH C//2), 3.76 (IH, m, CH), 7.04 (IH, t, 4-H),
8.14 (IH, d, NH), 8.30 (2H, d, 3- and 5-H). /cHzCHz -  ^cR^cRg = 7, /cHCHz 7, 
./NHCHz 8 ,73,4 = 4 ,5  = 8 Hz. ÔC 13.4 (CH3), 17.8 (CH2CH3), 34.1 (CHCH2), 57.3 
(CH), 117.2 (C-4), 132.2 (C-3 and -5), 137.5 (C-2 and -6), 139.3 (C-1), 172.6 (CO). 
The acid was esterified without further purification.
A solution of A-(2,6-dinitrophenyl)-(/?5)-norvaline (0.85 g, 3 mmol) in dry 
methanol (20 cm^) containing dry HCl was heated under reflux for 3 h, then cooled to 
room temperature, concentrated under reduced pressure to -1 0  cm^ and the yellow 
crystals filtered off and dried in vacuo. Yield 0.58 g (65%); m.p. 76 “C (from 
methanol). (Found: C, 48.7; H, 4.95; N, 14.1. C 12H 15N3O6 requires C, 48.5; H, 5.1; 
N, 14.1%.) 5 r  0.92 (3H, t, CH3), 1.39 (2H, sex, C //2CH3), 1.80 (2H, m, CHCA2), 
3.73 (3H, s, COCH3), 3.97 (IH, m, CH), 6.89 (IH, t, 4-H), 8.18 (2H, d, 3- and 5-H), 
8.47 (IH , d, NH). 7 c r 2 C H 3  = 7n r c h  = 7, 73,4 8  Hz. ô c  13.6 (CH3), 18.4 
(CH2CH3), 35.2 (CHCH2), 52.7 (COCH3), 58.1 (CH), 116.2 (C-4), 132.0 (C-3 and 
-5), 138.7 (C-2 and -6), 139.4 (C-1), 172.0 (CO).
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R eac tion of A - (2 ,6 -d in i tro p h e n y l) - (R S )-n o rv a l in e  m ethy l e s te r  
(290) with po tassium  carbonate . A solution of A “(2,6-dinitrophenyl)-(/?<S)- 
norvaline methyl ester (0.30 g, 1 mmol) in dry methanol (10 cm^) and 
A,A-dimethylformamide (1 cm^) containing potassium carbonate (0.15 g, 1.1 mmol) 
was stirred at room temperature for 26 h. No product could be identified from the 
reaction mixture, which was (by tic and NMR spectroscopy) a complex mixture.
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 C hanter Four Experim ental
3-Iodopropan-l-ol. 3-Bromopropan-l-ol (10.43 g, 75 mmol) and sodium 
iodide (22.8 g, 150 mmol) in anhydrous acetone (75 cm^) were heated under reflux for 
6 h. The sodium bromide precipitate was filtered off and most of the acetone removed 
under reduced pressure. The residue was diluted with water, and extracted with ether.
The ether layer was dried over MgSO^ and concentrated under reduced pressure to an oil; 
12.89 g (92%); b.p. 68-70 “C/30 mmHg (lit.i6V 105 “C/25 mmHg). Ôr 2.05 (2H, 
quin, CH2C / /2C H 2), 3.31 (2H, t, CH2I), 3.78 (2H, t, CA 2OH). /C R 2CH2 7, 
4 h 2CH2 6 Hz. ÔC 3.01 (CH2I), 35.5 (CH2CH2CH2), 62.3 (CH2OH).
A-(2,4-D initrophenyI)sarcosine ethyl ester (186; X= 4 -NO2 ). A
solution of sarcosine (4.45 g, 50 mmol) in water (150 cm3) with sodium hydrogen 
carbonate (12.6 g, 150 mmol) was added to a stirred solution of fluoro- 
2,4-dinitrobenzene (7.44 g, 40 mmol) in ethanol (160 cm3) at room temperature. The 
mixture was heated under reflux for 6 h, concentrated under reduced pressure to about 
100 cm^, then extracted with ether and the aqueous layer acidified with HCl. The brown 
precipitate was filtered off, washed with water and recrystallised from ethanol to, give
10.8 g (85%) of A-(2,4-dinitrophenyl)sarcosine; m.p. 175 “C (lit.i^9 175 °C). Ôr 2.92 
(3H, s, CH3), 4.33 (2H, s, CH2), 7.19 (IH, d, 6-H), 8.25 (IH, dd, 5-H), 8.60 (IH, d,
3-H). 75 6 8,73 5 2.5 Hz.
A solution of A-(2,4-dinitrophenyl)sarcosine (11.71 g, 46 mmol) in ethanol 
(150 cm3) containing dry HCl (7.3 g) was heated under reflux for 6 h. The solution was 
then cooled to room temperature and the yellow-gieen precipitate filtered off, affording 
12.71 g (98%) of product; m.p. 103-4 “C (lit.i^o 103 “C). Ô r  (CDCI3) 1.25 (3H, t, 
CH2C //3), 2.95 (3H, s, NCH3), 4.20 (2H, q, C //2CH3), 4.38 (2H, s, NCH2), 7.20 
(IH , d, 6 -H), 8.25 (IH, dd, 5-H), 8.60 (IH , d, 3-H); 7cr2CH3 7.5, 73,5 2 .5 ,
75,6 10 Hz. ÔC 14.3 (CH2CH3), 41.8 (NCH3), 54.9 (CH2CO 2), 61.3 (CH2CH 3),
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118.7 (C-3), 123.7 (C-6), 127.8 (C-5), 135.7 (C-2), 135.6 (C-4), 148.6 (C-1), 168.8 
(CO).
l-H y d ro x y -4 -m e th y l-7 -n itro q u in o x a lin e -2 ,3 -d io n e  (187; X = 7- 
NO2). A solution of A-(2,4-dinitrophenyl)sarcosine ethyl ester (12.45 g, 44 mmol) and 
potassium carbonate (6.23 g, 45 mmol) in ethanol (250 cm^) was stirred at room 
temperature for 24 h. The solid product was filtered off and extracted exhaustively with 
boiling acetone to give an acetone-insoluble solid which was dissolved in water - this was 
acidified with HCl to give a precipitate which was recrystallised from acetic acid to give 
4.28 g (41%) of yellow-green crystals; m.p. 245 “C (lit.^^^ 243 “C). 6r  3.60 (3H, s, 
NCH3), 7.67 (IH, d, 5-H), 8.15 (IH, dd, 6-H), 8.25 (IH, d, 8-H); 9» 76,8 3 Hz.
ÔC 30.8 (CH3), 107.4 (C-8), 116.0 (C-5), 119.5 (C-6), 128.2 (C-8a), 131.1 (C-4a),
142.9 ( C-7), 150.4 (C-3), 155.4 (C-2).
l-E thoxy-4-m ethyI-7-n itroqu inoxaIine-2 ,3 -d ione (312). Ethyl iodide 
(0.34 g, 2.2 mmol) and l-hydroxy-4-methyl-quinoxaline-2,3-dione (0.47 g, 2 mmol) 
were dissolved in dry A,A-dimethylformamide, and triethylamine (0.22 g, 2.2 mmol) 
was added with stirring at room temperature. After 48 h at room temperature, the 
reaction mixture was filtered, the filtrate diluted with water and the buff-coloured 
precipitate filtered off, washed with water and recrystallised from water; 0.22 g (42%), 
m.p. 210-11 ”C. (Found: C, 49.5; H, 4.0; N, 15.6. C nH nN sO g requires C, 49.8; H, 
4.2; N, 15.8%.) Ôr 1.41 (3H, t, CH2CA3), 3.58 (3H, s, NCH3), 4.30 (2H, q, CH2),
7.69 (IH, d, 5-H), 8.12 (IH , d, 8-H), 8.18 (IH, dd, 6-H). 7cr2CH3 7 ,7 ^  6 9,
76,8 2 Hz. 8c  13.2 (CH2CH3), 30.6 (NCH3), 71.3 (CH2), 107.2 (C-8), 116.2 (C-5),
119.7 (C-6), 127.1 (C-8a), 131.2 (C-4a), 142.9 (C-7), 150.0 (C-3), 155.5 (C-2). m/z 
265 (M+., 52%), 237 (12), 221 (10), 209 (65), 192 (100), 160 (14), 146 (35) gfc.
l-(3 -H y d ro x y p ro p o x y )-4 -m e th y l-7 -n itro q u in o x an n e-2 ,3 -d io n e  (314). 
A solution of l-hydroxy-4-methyl-7-nitroquinoxaline-2,3-dione (0.43 g, 1.8 mmol) in
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dry N,iV-dimethylformamide had added to it triethylamine (0.20 g, 2 mmol). The 
resultant precipitate dissolved when 3-iodopropanol (0.37 g, 2 mmol) was added at 
120 "C. The red solution was stirred at room temperature for 24 h, then concentrated 
under reduced pressure (Kugelrohr) to dryness. The residue was stirred in boiling water 
and filtered to give a brown solid which was recrystallised from water; 0.23 g (43%), 
m.p. 101-3 “C. The filtrate yielded a further crop of crystals; 0.21 g (40%). Total yield 
83%. (Found: C, 48.4; H, 4.3; N, 14.0. C 12H 13N3O5 requires C, 48.8; H, 4.4; N, 
14.2%). 6h  1.93 (2H, quin, CH2C //2C H 2), 3.55 (3H, s, NCH3), 3.82 (2H, q, 
C //2OH), 4.28 (2H, t, OCH2), 4.67 (IH , t, OH), 7.66 (IH, d, 5-H), 8.15 (IH, dd,
6-H), 8.17 (IH, d, 8-H). Js,e 8, /6 ,8  2 , /CH2CH2 6.5, /CH2OH 4.5 Hz. 0^ 31.0 and 
31.3 (CH3 and CH2CH 2CH 2), 57,8 (CH2OH), 73.4 (OCH2), 107.7 (C-8), 116.6 
(C-5), 120.1 (C-6), 127.5 (C-8a), 131.7 (C-4a), 143.4 (C-7), 150.3 (C-3), 156.0 
(C-2). miz 295 (M+-, 38%), 237 (58), 222 (35), 221 (36), 209 (72), 192 (100), etc.
A^-(2-Nitrophenyl)sarcosine ethyl ester (186; X = H). A solution of 
sarcosine (4.45 g, 50 mmol) in water (80 cm^) containing sodium hydrogen carbonate 
(12.60 g, 150 mmol) was added to a stirred solution of fluoro-2-nitrobenzene (6.35 g, 
45 mmol) in ethanol (140 cm^) at room temperature. The mixture was heated under 
reflux for 6.5 h, concentrated under reduced pressure to dryness and dissolved in water. 
This was extracted with ether, the aqueous layer acidified (HCl), extracted with ethyl 
acetate and the organic phase dried (MgSO^) and concentrated under reduced pressure to 
a red oil [A-(o-nitrophenyl)sarcosine] which crystallised on standing. Yield 7.66 g 
(81%); m.p. 93-5 T  ( I i t . i 2 2 . i 3 i  g8-92 “C and 75 “C respectively), ôy 2.84 (3H, s, 
CH 3), 3.99 (2H, s, CH2), 6.93 (IH, t, 4-H), 7.08 (IH , d, 6-H), 7.51 (IH , t, 5-H), 
7.76 (IH, d, 3-H). 6.5 Hz.
A solution of N-(o-nitrophenyl)sarcosine (6.20 g, 30 mmol) in ethanol (125 cm^) 
conatining dry HCl (5.8 g) was heated under reflux for 6 h. The solution was then 
concentrated under reduced pressure to 5.00 g (70%) of an oil, b.p. 160 “C/O.l mmHg 
(lit. 131 170 “C/0.2 mmHg). dy (CDCI3) 1.29 (3H, t, CH2C //3), 2.99 (3H, s, NCH3),
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3.91 (2H, s, NCH2), 4.23 (2H, q, C //2CH 3), 6.93 (IH, t, 4-H), 7.06 (IH , d, 6-H), 
7.43 (IH, t, 5-H), 7.78 (IH, d, 3-H). 73 4 =74  5 =7^ 6 = 8 Hz. 14.0 (CH2CH3),
40.7 (NCH3), 55.9 (NCH2), 61.0 (CH2CH 3), 119.8 and 120.0 (C-4 and -6), 126.5 
(C-3), 133.4 (C-5), 136.3 (C-2), 145.0 (C-1), 170.1 (CO).
l-H ydroxy-4-m ethy lqu inoxâline-2 ,3 -d ione  (187; X = H). Sodium 
ethoxide [11 mmol; from sodium (0.25 g) in ethanol (12 cm^)] was added to a stirred 
solution of N-(2-nitrophenyl)sarcosine ethyl ester (2.38 g, 10 mmol) in ethanol (12 cm^) 
at 0-5 “C. StiiTing was continued at room temperature for 3 days, then the brown 
precipitate filtered off and recrystallised from acetic acid. Yield 0.59 g (31%); 
m.p. 239-240 “C (lit.i99. 253 °C). 5h 3.58 (3H, s, CH3), 7.29-7.34 (2H, m, 6- and
7-H), 7.44-7.50 (IH , m, 5-H), 7.55-7.60 (IH, m, 8-H). (These assignments are 
provisional.)
I-E thoxy-4-m ethy lqu inoxaline-2 ,3 -d ione  (311). Ethyl iodide (0.09 g, 
0.6 mmol) and l-hydroxy-4-methylquinoxaline-2,3-dione (0.10 g, 0.5 mmol) in dry 
N,A/-dimethylformamide (2 cm^) were heated to 75 “C, then triethylamine (0.06 g, 
0.6 mmol) was added with stirring. The temperature was maintained at 80 “C for 5 h, 
then cooled to room temperature, diluted with water and the very small amount of yellow 
precipitate filtered off and discarded . The filtrate was concentrated under reduced 
pressure (Kugelrohr) to dryness, and the residue recrystallised from water to give the title 
compound (50 mg, 45%; m.p. 172-3 “C). (Found: C, 60.3; H, 5.4; N, 12.9. 
C 11H 12N2O3 requires C, 60.0; H, 5.5; N, 12.7%.) 8^  1.36 (3H, t, CH2CH3), 3.52 
(3H, s, NCH3), 4.20 (2H, q, CH2), 7.32 (2H, m, 6- and 7-H), 7.47 (2H, m, 5- and
8-H). (These assignments are provisional.) ./CH2CH3 7. 6^ 13.1 (CH2CH 3), 30.0 
(N CH 3), 70.8 (CH2), 112.4 (C-8), 115.5 (C-5), 124.2 (C-7), 124.7 (C-6), 125.7 
(C-4a), 126.5 (C-8a), 145.9 (C-3), 155.5 (C-2). m/z 220 (M+-, 80%), 192 (8), 176 
(13), 164 (24), 147 (100), 119 (68) gfc.
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l “(3 -H y d ro x y p ro p o x y )-4 -m e th y lq u in o x a lin e -2 ,3 -d io n e  (313), A
solution of l-hydroxy-4-methylquinoxaline-2,3-dione (0.10 g, 0.5 mmol) and
3-iodopropanol (0.11 g, 0.6 mmol) in dry N,7V-dimethylformamide (2 cm^) containing 
triethylamine (0.06 g, 0.6 mmol) was stirred at 95 “C for 15 h, then cooled to room 
temperature, diluted with water and concentrated under reduced pressure (Kugelrohr) to 
dryness. The residue was recrystallised from water to give 0.07 g (58%) of product; 
m.p. 187-8 °C. (Found: C, 54.0; H, 6.2; N, 10.65. C 12H 14N2O4.H2O requires C, 
53.7; H, 6.0; N, 10.4%.) 6^  1.92 (2H, quin, CH2C //2CH2), 3.52 (3H, s, CH3), 3.60 
(2H, q, C //2OH), 4.22 (2H, t, OCH2), 4.65 [IH, t, OH (exchangeable with D2O)],
7.32 (2H, m, 6- and 7-H), 7.48 (2H, m, 5- and 8-H). (These assignments are 
provisional.) ôc  30.2 and 30.9 (CH3 and CH2CH2CH 2), 57.4 (CH2OH), 72.7 
(OCH2), 112.4 (C-8), 115.4 (C-5), 124.2 (C-7), 124.8 (C-6), 125.7 (C-4a), 126.3 
(C-8a), 150.0 (C-3), 155.3 (C-2). m/z 250 (M+-, 57%), 192 (29), 176 (33), 164 (50), 
147 (100), 119 (64) etc.
l-E th o x y “6-n itro -2-trifluorom ethy lbenzim idazo le  (315). A solution 
of 5-nitro-2-trifluoromethyIbenzimidazole 3-oxide (0.12 g, 0.5 mmol) and triethylamine 
(6 drops, 0.6 mmol) in dry A^,A^-dimethylformamide (1.5 cm^) had added to it ethyl 
iodide (0.09 g, 0.6 mmol) at room temperature. After 24 hours, the solution was diluted 
with water and the buff-coloured product filtered off and dried in vacuo; yield 0.10 g 
(71%); m.p. 117 “C. (Found: C, 43.7; H, 2.7; N, 15.2. C10H 8F 3N 3H 3 requires C, 
43.65; H, 2.9; N, 15.3%.) Ôr 1.44 (3H, t, CH3). 4.60 (2H, q, CH2), 8.10 (IH, d,
4-H), 8.27 (IH, dd, 5-H), 8.82 (IH, d, 7-H). VcHzCHs 7, 74,5 9, 7s ,7 2 Hz. ôc 13.1 
(CH3), 77.5 (CH2), 107.8 (C-7), 117.7 (CF3, q, 7 c ,f  271 Hz), 119.2 (C-4), 122.6 
(C-5), 130.5 (C-7a), 140.0 (C-2, q, 7c,F 32 Hz), 140.1 (C-6), 145.6 (C-3a). m/z 275 
(M+\ 75%), 256 (8), 247 (100), 227 (9), 201 (14), 184 (19), gfc.
l-(3 -H y d ro x y p ro p o x y )-6 -n itro -2 -triflu o ro m eth y lb en z im id azo le  
(316). A solution of 5-nitro-2-trifIuoromethylbenzimidazole 3-oxide (0.12 g.
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0.5 mmol) and triethylamine (6 drops, 0.6 mmol) in dry A/,N-dimethylformam ide 
(1.5 cm3) had added to it 3-iodopropanol (0.11 g, 0.6 mmol) and the solution heated to 
120 “C for 6 h, then left at room temperature for 72 h, diluted with water and extracted 
with dichloromethane. The dichloromethane extract was washed with 0.1 M aqueous 
sodium hydroxide, then water, dried (MgSO^) and concentrated to dryness (excess 
N,N-dimethylformamide was removed on a Kugelrohr) to furnish 0.13 g (87%) of 
product; m.p. 68-69 “C (from water). Ôr (CDCI3) 2.00 (2H, quintet, CH2C //2CH2), 
3.64 (2H, q, Œ 2OH), 4.61 (2H, t, OCH2), 4.78 (IH, t, OH), 8.10 (IH, d, 4-H), 8.27 
(IH , dd, 5-H), 8.82 (IH , d, 7-H). /cH zCH a 7, 74,5 9, J ^ j  2 Hz. ô c  31.0 
(C H 2C H 2C H 2), 57.0 (CH2OH), 79.1 (OCH2), 108.1 (C-4), 118.1 (CF3 , q, 
7c,F 264 Hz), 119.8 (C-7), 123.1 (C-6 ), 130.8 (C-3a), 140.3 (C-2, q, 7c,F 35 Hz),
140.6 (C-5), 146.0 (C-7a). m/z 305 (M+-, 41%), 247 (96), 231 (14), 201 (15), 69 
(29), 59 (100), etc. The sample was not purified sufficiently for microanalysis.
A ^-(3-N itro-2-pyridyl)sarcosine ethyl ester (190). A suspension of 
sarcosine (2.67 g, 30 mmol) and sodium hydrogen carbonate (10.08 g, 120 mmol) in 
water (60 cm3) was added to a stirred solution of 2-chloro-3-nitropyridine (4.78 g, 
30 mmol) in ethanol (150 cm^) at room temperature. The solution was heated tinder 
reflux for 4 h, then concentrated under reduced pressure to 70 cm^, extracted with ether 
and the aqueous layer acidified with HCl. The precipitate was filtered off and 
recrystallised from propan-2-ol/water to give 4.51 g (71%) of A /-(3-nitro-
2-pyridyl)sarcosine; m.p. 121-4 °C (dec.). The mother liquor afforded a further crop of 
product (0.63 g, 10%); m.p. 121-4 “C (dec.) (lit.i^i 126-8 “C). Overall yield: 81%. ôy 
3.02 (3H, s, CH3), 4.32 (2H, s, CH2), 6.90 (IH, dd, 5-H), 8.25 (IH, dd, 4-H), 8.30 
(IH , dd, 6-H). 74 5 8 , 7g 6 4.6, 74 5 1.6 Hz. ôc 40.1 (CH3), 52.2 (CH2), 112.7 
(C-5), 132.0 (C-3), 135.9 (C-4), 150.8 (C-6), 150.9 (C-2), 170.5 (CO).
N-(3-Nitro-2-pyridyl)sarcosine (4.99 g, 23.6 mmol) was dissolved in ethanol 
(100 cm^) containing dry HCl (2.4 g) and heated under reflux for 5 h. The solution was 
concentrated under reduced pressure to 50 cm^, then poured into vigorously stirred
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ice/water (200 cm^). The precipitate was filtered off and recrystallisation was attempted 
from ethanol/water, but an oil persisted, so this was concentrated under reduced pressure 
to give the title compound (4.13 g, 73%); m.p. 49-50 “C (lit.^^^ 52 °C). Ôr (CDCI3)
1.25 (3H, t, CH2C //3), 2.95 (3H, s, NCH3), 4.20 (2H, q, C //2C H 3), 4.32 (2H, s, 
NCH2), 6.75 (IH, m, 5-H), 8.10 (IH, dd, 4-H), 8.25 (IH, dd, 6-H). g 8 , 75,6 4.6, 
74 6 17  Hz.
l-H y d ro x y -4 -m e th y lp y rid o [2 ,3 -^ ]p y raz in e -2 ,3 -d io n e  (191). N~{3-
Nitro-2-pyridyl)sarcosine ethyl ester (3.59 g, 15 mmol) and potassium carbonate 
(2.07 g, 15 mmol) were stirred in ethanol (90 cm^) at room temperature for 48 h. The 
precipitate was filtered off, dissolved in water and acidified (HCl), to give 0.46 g (16%) 
of the title compound; m.p. 244-6 “C (lit.^^i 242-4 °C). 6r  3.49 (3H, s, CH3), 7.35 
(IH , dd, 7-H), 7.85 (IH, d, 8-H), 8.29 (IH, d, 6-H). 5.0, 7y,g 8.0, 76,g 1.6 Hz.
ÔC 28.7 (CH3), 119.6 (C-8), 120.7 (C-7), 124.4 (C-8a), 137.6 (C-4a), 142.6 (C-6 ),
150.0 (C-3), 155.8 (C-2).
l - E t h o x y - 4 - m e t h y l p y r i d o [ 2 , 3 - i > ] p y r a z i n e - 2 , 3 - d i o n e  (317). A
solution of l-hydroxy-4-methylpyrido[2,3-/?]pyrazine-2,3-dione (0.19 g, 1 mmol), 
triethylamine (0.11 g, 1.1 mmol) and ethyl iodide (0.17 g, 1.1 mmol) in dry 
A,A/-dimethylformamide (2 cm^) was stirred at room temperature for 24 h, then diluted 
with water and the buff-coloured product filtered off and dried in vacuo; 70 mg (32%); 
m.p. 164 “C (from water). (Found: C, 53.2; H, 4.8; N, 18.7. C10H 11N3O3.O.25 H2O 
requires C, 53.2; H, 5.1; N, 18.6%.) 5 r  1.35 (3H, t, CH2C //3), 3.55 (3H, s, NCH3), 
4.20 (2H, q, CH2), 7.34 (IH, dd, 7-H), 7.82 (IH, dd, 8-H), 8.28 (IH, dd, 6-H). 
7CH2CH3 7, 76,7 4.6, 77,8 8, 76,g 1.5 Hz. ôc 13.0 (CH2C H 3), 28.3 (NCH3), 71.0 
(OCH2), 119.4 (C-8), 120.0 (C-7), 123.2 (C-8a), 137.7 (C-4a), 142.5 (C-6), 149.7 
(C-3), 156.0 (C-2). m/z 221 (M+-, 66%), 193 (9), 177 (13), 165 (29), 148 (100), 120 
(71), etc.
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l-(3 -H y d ro x y p ro p o x y )-4 - iiie th y lp y r id o [2 ,3 -6 ]p y raz in e -2 ,3 -d io n e  
(318). A solution of l-hydroxy-4"methyIpyrido[2,3-&]pyrazine-2,3-dione (0.11 g, 
1 mmol), triethylamine (0.11 g, 1.1 mmol) and 3-iodopropanol (0.20 g, 1.1 mmol) in 
dry -dimethyIformamide (2 cm^) was stirred at room termperature for 24 h, heated to 
110 “C for 2 h, then cooled to room temperature, diluted with water and extracted with 
dichloromethane. The organic extract was dried (MgS0 4 ) and concentrated to dryness 
(Kugelrohr) to yield 0.15 g (60%) of the title compound; m.p. 130-132 “C (from water). 
(Found: C, 50.9; H, 4.9; N, 16.1. C 11HX3N3O4.I /3 H2O requires C, 51.4; H, 5.2; N, 
16.3%.) ÔH 1.91 (2H, quintet, CH2C //2CH2), 3.55 (3H, s, NCH3), 3.60 (2H, q, 
C //2OH), 4.23 (2H, t, CH2O), 4.64 (IH , t, OH), 7.34 (IH, dd, 7-H), 7.83 (IH, dd,
8-H), 8.28 (IH , dd. 6-H). 5, / 7,g 8, 76,8 1.4 Hz. ôc  28.5 (NCH3), 30.7
(CH2CH2CH2), 57.2 (CH2OH), 72.6 (CH2ON), 119.5 (C-8), 120.0 (C-7), 123.2 
(C-8a), 137.8 (C-4a), 142.7 (C-6), 149.8 (C-3), 156.2 (C-2). m/z 251 (M+-, 55%), 
193 (45), 177 (49), 165 (53), 148 (100), 120 (66), etc.
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